Multimodality imaging of coronary artery bypass grafts by Salm, L.P.
MULTIMODALITY IMAGING OF CORONARY 
ARTERY BYPASS GRAFTS





DE GRAAD VAN DOCTOR AAN DE UNIVERSITEIT LEIDEN,
OP GEZAG VAN DE RECTOR MAGNIFICUS DR. D.D. BREIMER,
HOOGLERAAR IN DE FACULTEIT DER WISKUNDE EN
NATUURWETENSCHAPPEN EN DIE DER GENEESKUNDE,
VOLGENS BESLUIT VAN HET COLLEGE VOOR PROMOTIES








Promotores Prof. Dr. E.E. van der Wall
 Prof. Dr. A. de Roos
Co-promotor Dr. H.W. Vliegen
Referent Prof. Dr. P.J. de Feyter (Erasmus Universiteit, Rotterdam)
Overige leden Prof. Dr. J.J. Bax
 Dr. J. Doornbos
 Prof. Dr. J.W. Jukema
 Prof. Dr. A.C. van Rossum (Vrije Universiteit, Amsterdam)
© L.P. Salm. Utrecht, the Netherlands, 2006. No parts of this publication may be 
reproduced, stored or transmitted in any form or by any means without prior permission 
of the author. 
Cover design and lay-out by Wendy Karsten.
Printed by Drukkerij Macula b.v., Boskoop, the Netherlands.
Printed on Freelife paper, containing 50% recycled fibre. 
ISBN-10: 90-9021156-X
ISBN-13: 978-90-9021156-5
The research described in this thesis was performed at the department of Cardiology and 
Radiology of the Leiden University Medical Center, Leiden, the Netherlands.
Financial support by the Netherlands Heart Foundation for the publication of this thesis 
is gratefully acknowledged. 
Forever trusting who we are










Cardiovascular magnetic resonance and computed tomography 
of coronary artery bypass grafts
Chapter 21 in: MRI and CT of the cardiovascular system. 
Second edition. Lippincott Williams & Wilkins 2005 
PART II  CARDIOVASCULAR MAGNETIC RESONANCE
Chapter 3 41
Evaluation of saphenous vein coronary artery bypass graft flow 
by cardiovascular magnetic resonance
J Cardiovasc Magn Reson 2005; 7, 4, 631-637
Chapter 4 55
Blood flow in coronary artery bypass vein grafts:
volume versus velocity at cardiovascular MR imaging
Radiology 2004; 232, 3, 915-920 
Chapter 5 69
Functional significance of stenoses in coronary artery bypass grafts. 
Evaluation by single-photon emission computed tomography 
perfusion imaging, cardiovascular magnetic resonance, and angiography
J Am Coll Cardiol 2004; 44, 9, 1877-1882
Chapter 6 81
Validation of a high-resolution, phase contrast cardiovascular magnetic
resonance sequence for evaluation of flow in coronary artery bypass grafts
Accepted for publication in J Cardiovasc Magn Reson
7
PART III  COMPUTED TOMOGRAPHY
Chapter 7 99
Comprehensive assessment of patients after coronary artery
bypass grafting by 16-detector row computed tomography 
Am Heart J 2005; 150, 4, 775-781
Chapter 8 113
Global and regional left ventricular function assessment with 
16-detector row CT: comparison with echocardiography and 
cardiovascular magnetic resonance
Eur J Echocardiogr 2006; 7, 4, 308-314
PART IV  SPECT AND DOPPLER FLOW VELOCITY
Chapter 9 127
Hemodynamic evaluation of saphenous vein coronary artery bypass grafts: 
relative merits of Doppler flow velocity and SPECT perfusion imaging
J Nucl Cardiol 2005; 12, 5, 545-552
Editorial 
Defining the “gold standard”: a changing paradigm 
J Nucl Cardiol 2005; 12, 5, 520-522
PART V  SYNOPSIS
Chapter 10 149
Summary and future perspectives
Samenvatting en toekomstperspectieven












CORONARY ARTERY BYPASS GRAFT SURGERY
Coronary heart disease (CHD) is the most common cause of death worldwide, accounting 
for nearly 2 million deaths each year in Europe alone (1). CHD is most commonly due 
to obstruction of the coronary arteries by an atheromatous plaque (2). Manifestations 
of CHD include unstable and chronic angina pectoris, and myocardial infarction. 
Therapeutic options for CHD are directed towards prevention of further progression 
of disease or symptom-relief. This is achieved by obtaining revascularization either by 
percutaneous coronary intervention or coronary artery bypass graft surgery (CABG), if 
pharmacological treatment alone is insufficient. 
In CABG, revascularization of the myocardium is obtained by rerouting or bypassing the 
bloodstream around the coronary obstruction. Garrett et al. performed the first human 
CABG in 1967 as a “bailout” procedure (3). Since then, the surgical technique is further 
developed and refined. At first, graft material was harvested from the saphenous veins 
in the lower limbs. Subsequently, arteries were also used as bypass grafts, such as left 
and right internal mammary arteries (IMA), radial artery and gastro-epiploic artery. 
CABG was demonstrated to be an effective treatment for CHD in short- and intermediate-
term (4;5). However, graft disease occurs frequently, beginning with accelerated 
atherosclerosis early after surgery in vein grafts (6;7). Arterial grafts have a superior 
outcome compared with vein grafts, still obstruction and occlusion do occur (8;9). In a 
recent study, comparing the outcome of vein and IMA grafts, patency at 10 years was 
61% for vein grafts compared with 85% for IMA grafts (p<0.001) (10). 
The gold standard for evaluating bypass grafts is coronary angiography. Although 
coronary angiography offers a rapid and complete exploration of the native coronary 
arteries and grafts, it is an invasive procedure, requiring arterial puncture, x-ray 
exposition, and hospitalization. Complications include ventricular arrhythmias, 
myocardial infarction, cardiac perforation, necessary emergency CABG, and death, even 
though the risk is small (11;12). Furthermore, coronary angiography does not provide 
a functional assessment of the myocardial region, perfused by the respective coronary 
artery or graft. A noninvasive anatomical and functional examination of the coronary 
arteries and bypass grafts would be preferable to detect insufficiency and identify a 
target for re-intervention.   
NONINVASIVE IMAGING OF CORONARY ARTERY BYPASS GRAFTS 
Several noninvasive imaging modalities are available in order to detect bypass graft 
insufficiency. Using cardiovascular magnetic resonance (CMR), anatomy and function 
of bypass grafts may be assessed. MR angiography allows an accurate evaluation of 
patency in both arterial and vein grafts (13-15). The degree of graft stenosis can, thus far, 
only be evaluated in vein graft bodies, excluding the recipient coronary arteries (16). 
A functional parameter that may be evaluated by CMR is the blood flow velocity. Blood 
flow velocity of native coronary arteries and bypass grafts can be derived invasively at 
rest and during pharmacological stress using the Doppler flow wire (17). Subsequent 
calculation of the coronary flow velocity reserve (CFVR) by dividing the stress by the rest 
parameter provides insight in the physiological condition of the vessel (18;19). Previous 
studies have shown that flow velocity measurements may be used to evaluate the 
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hemodynamic consequences of stenoses in native coronary arteries (20;21), and bypass 
grafts (22), although studies focusing on bypass grafts are few. Using the phase-contrast 
MR technique, it is feasible to perform flow velocity measurements noninvasively by CMR 
in both vein (15;23) and arterial grafts (24). The value of CMR flow velocity measurements 
in predicting the presence of a stenosis in vein grafts was successfully researched (25;26). 
CMR flow velocity measurements of arterial grafts remain challenging because of the 
small luminal diameter of the internal mammary arteries, and metal clip artefacts. In 
earlier studies demonstrating the feasibility to measure flow in left IMA grafts, CMR 
sequences were limited by low spatial and temporal resolution (24;27;28).
With computed tomography (CT) angiography, assessment of bypass graft patency was 
extensively investigated (29-31).When it became possible to use multiple detectors in a 
single spiral CT acquisition, graft patency could be assessed with very high accuracy 
(32;33). The evaluation of stenoses in grafts by multi-detector row CT is still a challenge 
because of motion artefacts, metal clip artefacts or beam hardening from calcium 
deposits (32-34). Since a cardiac CT examination to evaluate native coronary arteries and 
bypass grafts requires scanning of the entire heart, reconstruction of the left ventricular 
(LV) function is also achievable. Several studies showed that 4-detector row CT allowed 
accurate assessment of global and regional LV function (35;36). Validation of the next 
generation CT equipment in assessing LV function has yet to be conducted.
Single-photon emission computed tomography (SPECT) perfusion imaging is a well-
established technique by which to detect CHD by evaluating regional myocardial 
perfusion at rest and during stress. Excellent sensitivities and specificities of SPECT 
to detect stenoses in native coronary arteries (37;38) and bypass grafts (39) were 
demonstrated. More recently, for SPECT imaging the emphasis has shifted from 
detection of CHD to hemodynamic evaluation of stenoses. Comparative studies between 
SPECT imaging and invasive assessment using the Doppler flow wire have been 
performed, demonstrating a good agreement (ranging from 72% to 96%) between these 
two techniques for the evaluation of the hemodynamic consequence of an intermediate 
native coronary artery stenosis (21;40;41). Studies evaluating the hemodynamic 
consequences of bypass graft lesions are lacking.
OUTLINE OF THE THESIS
The aim of the thesis was to describe multiple modalities to examine coronary artery 
bypass grafts, and to further develop noninvasive imaging techniques to detect or exclude 
stenoses in native coronary arteries and bypass grafts in patients who experienced 
recurrent chest pain after CABG. 
Part I of the thesis provides an introduction to noninvasive imaging. In chapter 2, 
noninvasive imaging of coronary artery bypass grafts by CMR and CT is reviewed in 
detail. 
Part II of the thesis focuses on CMR flow velocity imaging in vein and arterial grafts. 
In chapter 3, a model to detect or exclude stenoses in vein grafts by CMR volumetric 
flow measurements is described. In chapter 4, two analysis methods for the CMR flow 
velocity maps, i.e. velocity and volumetric flow, are compared, using flow velocity 
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maps of vein grafts. In chapter 5, the functional significance of bypass graft stenoses 
is investigated by SPECT perfusion imaging and CMR, and compared with findings at 
coronary angiography. In chapter 6, a novel CMR phase-contrast sequence to measure 
flow velocity in arterial and vein grafts is introduced and validated. 
Part III of the thesis concentrates on multi-detector row CT imaging of coronary artery 
bypass grafts. In chapter 7, a comprehensive assessment by 16-detector row CT of patients 
after CABG is investigated. In chapter 8, global and regional LV function evaluated by 
16-detector row CT is compared with evaluation by echocardiography and CMR. 
Part IV focuses on the hemodynamic consequences of vein graft lesions. In chapter 9, the 
relative merits of invasive Doppler flow velocity measurements and SPECT perfusion 
imaging are studied in assessing the hemodynamic significance of stenoses in vein grafts, 
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INTRODUCTION
Coronary artery bypass grafting (CABG) is a commonly performed surgical procedure 
for alleviation of symptoms and prolonging survival for patients with ischemic heart 
disease. Bypass graft disease is a common consequence, requiring x-ray coronary angio-
graphy for diagnosis. Coronary angiography is an invasive procedure that includes x-
ray exposure, hospitalization, and a small risk of complications, including arrhythmias, 
coronary artery dissection, and cardiac death. A noninvasive diagnostic method for the 
assessment of bypass graft anatomy and function is of great benefit. This chapter reviews 
the research that has been performed in evaluating bypass grafts noninvasively using 
cardiovascular magnetic resonance (CMR) and computed tomography (CT).
 
CARDIOVASCULAR MAGNETIC RESONANCE OF CORONARY ARTERY BYPASS GRAFTS
Anatomy Assessment: Angiography
During the past decades, a considerable amount of effort has been invested to achieve 
noninvasive visualization of the coronary arteries and bypass grafts with CMR. The 
relatively larger size, straight course, and immobility during the cardiac cycle of coronary 
bypass grafts allowed the evaluation of graft patency even in the earliest studies, whereas 
assessment of the coronary arteries could not be achieved at that stage. In these initial 
investigations, two-dimensional (2D) spin-echo and gradient-echo techniques were 
Author Patients Grafts Graft type Magnetic  Assessable Sensitivity Specificity
    resonance grafts (%) (%) (%)
    technique
White et al (4) 25 72 vein 2-D SE 90 72 91
Rubinstein et al (6) 20 47 vein 2-D SE 100 72 90
Jenkins et al (3) 22 45 vein 2-D SE 100 73 89
Frija et al (2) 28 52 vein and arterial 2-D SE 100 71 97
White et al (5) 10 28 vein and arterial 2-D GE 100 86 93
Aurigemma et al (1) 20 45 vein and arterial 2-D GE 100 100 88
Vanninen et al (7) 8 8 GEA 2-D GE 100 100 100
Galjee et al (8) 47 84 vein 2-D SE 92 84 98
    2-D GE 92 88 98
Weighted Mean 2D      95 81 94
       
Kessler et al (11) 8 21 vein and arterial 3-D NAV 90 100 87
Engelmann et al (9) 16 55 vein and arterial 3-D CE 100 85 95
Vrachliotis et al (14) 15 45 vein and arterial 3-D CE 98 93 97
Wintersperger et al (15) 27 76 vein and arterial 3-D CE 100 81 95
Kalden et al (10) 22 59 vein and arterial 3-D CE 100 93 93
Molinari et al (13) 18 51 vein and arterial 3-D NAV 96 92 97
Langerak et al (12) 38 56 vein 3-D NAV 100 83 98
Wittlinger et al (16) 34 82 vein and arterial 3-D NAV 90 78 96
Bunce et al (17) 34 79 vein and arterial 3-D CE 100 73 85
       
Weighted Mean 3D     96 85 94
SE = spin-echo; GE = gradient-echo; GEA = gastroepiploic artery; NAV = navigator; CE = contrast-enhanced
Table 2.1




applied to acquire successive axial slices during repetitive breath-holds (1-8). With the 
spin-echo technique, absence of signal at different levels was considered to indicate the 
presence of a patent graft because in normal grafts, rapid blood movement is present. To 
obtain adequate contrast, however, sufficient flow between the graft lumen and the wall 
is needed, whereas the presence of metallic clips, stents, or calcifications may result in a 
signal void that can be mistaken for graft stenosis or occlusion. In contrast, flowing blood 
is depicted as a bright signal during imaging with gradient MR techniques. As shown 
in Table 2.1, both acquisition techniques have been evaluated in several studies with 
conventional angiography as the standard of reference, demonstrating sensitivities and 
specificities varying from 71% to 100% and 89% to 100%, respectively. Pooled analysis of 
these eight studies (with 180 patients and 381 grafts) revealed a weighted mean sensitivity 
and specificity of 81% and 94%, with inclusion of 95% of grafts. Despite these promising 
results in the distinction between patent and occluded grafts, these 2D techniques were 
still limited by their low signal-to-noise ratio and low spatial resolution. Substantial 
progress in image quality was achieved by the development of three-dimensional (3D) 
imaging techniques, allowing the acquisition of volume slabs containing several thin 
slices and imaging with high spatial resolution. To improve patient comfort, navigator 
techniques have been developed that permit real-time monitoring of diaphragm motion 
and thus free-breathing during data acquisition. In addition, improved enhancement of 
blood/muscle contrast can be expected by the administration of intravascular contrast 
agents. An example of a typical MR acquisition protocol with navigator respiratory 
gating is depicted in Figure 2.1. In Figure 2.2 a resulting 3D reconstruction is shown, 
and an example of a patent bypass graft as confirmed by conventional angiography is 
provided in Figure 2.3.
Pooled analysis of nine studies using 3D techniques, with more than 200 patients 
included, revealed a slight increase in weighted sensitivity from 81% to 85%, with no 
loss in specificity (Figure 2.4) (9-17). Sensitivity and specificity for the different types of 
grafts (as reported in seven studies) are shown in Figure 2.5.  No difference in diagnostic 
accuracy for detection of graft occlusion was noted between arterial and vein grafts. In 
particular, the sensitivity and specificity of arterial grafts were 85% and 95% compared 
with 86% and 93% in vein grafts (9;10;12-14;16;17). These studies illustrate the potential 
of CMR to evaluate graft patency in clinical routine. Its safe and noninvasive nature 
in combination with the high specificity (~94%) and negative predictive value (~96%) 
suggests that in patients presenting with recurrent symptoms after bypass grafting, 
CMR may function as a first-line investigation tool to rule out graft occlusion before 
more invasive diagnostic procedures. 
However, few attempts thus far have been made to evaluate graft stenosis in addition 
to assessment of patency. Langerak and colleagues observed a sensitivity and specificity 
of 82% and 88% for the detection of ≥50% luminal narrowing in vein bypass grafts (12). 
In contrast, a discouraging sensitivity of 38% was reported by Kalden et al. (10). Because 
the presence of graft stenosis rather than total occlusion of the graft may be the cause 
of recurrent complaints, the value of MR angiography (MRA) to evaluate graft stenosis 
needs to be further explored before routine use of the technique is feasible. In addition, 
recurrent anginal complaints may also be attributable to progression of coronary artery 
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disease in native coronary vessels, and assessment in these vessels is still severely 
hampered by the current spatial and temporal resolution. A possible solution to this 
limitation may lie in the combination of MRA with MR flow mapping, since the latter 
provides a functional measurement of the entire vascular tree beyond the level of the 
flow measurement. Moreover, because the functional graft status is not directly related 
to the degree of luminal narrowing, improved diagnostic accuracy and management 




 Typical magnetic resonance (MR) acquisition protocol. (A) Typical plan-scan for cardiovascular 
magnetic resonance (CMR) angiography. Axial imaging volume (horizontal lines); volume 
used for localized shimming (large box); position in the right hemidiaphragm of the respiratory 
navigator (rectangular box); position of a saturation band for suppression of image artifacts (left 
box). (B) With the use of axial scout images, the three-point plan-scan is used to select three 
points in space, one at the origin of the coronary artery or bypass graft, one at the most distal 
point, and one in the middle of the first two points. From this information, an imaging plane 
is automatically calculated in plane with the coronary artery or bypass graft of interest. (C) 
CMR angiography of a patient with a bypass of the left coronary system (white arrow) and a 
visible native right coronary artery (black arrow). This imaging approach can be used clinically 
to assess bypass graft patency. AO = aorta; LV = left ventricle. (Courtesy of H.J. Lamb) A full 




 Whole-heart CMR angiography of a vein bypass graft to the right coronary artery at different 
rotation angles. (Courtesy of Dr. H. Sakuma) A full colour version of this illustration can be 
found in the full colour section (page 165).
Figure 2.3 
 MR angiogram of a vein graft (right) in comparison with a coronary angiogram (left). 
 Multiplanar reformat reconstruction is shown of a free-breathing, three-dimensional (3D), 
navigator-gated sequence used for acquisition of the MR angiogram.  
CMR and CT of coronary artery bypass grafts
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Figure 2.4 
 Sensitivities and specificities of two-dimensional (2D) and 3D MR angiography (MRA) 
acquisition techniques (data based on references 1-17).
Figure 2.5 
 Performance of 3D MRA in arterial and vein grafts (data based on references 9,10,12-
14,16,17).
Functional Assessment: Flow Velocity 
A vessel narrowing, visualized by means of angiography, may or may not impair flow 
through that vessel (18;19). The assessment of blood flow through coronary arteries and 
bypass grafts has gained wide attention. To evaluate the hemodynamic impairment 
of a lesion, flow is measured at rest and during pharmacologically induced stress, for 
instance with adenosine or dipyridamole (20). By dividing the flow value during stress 
by the flow value at rest, the coronary flow reserve (CFR) is calculated (21;22). Flow-
limiting stenoses cause a compensatory vasodilatation at rest to maintain sufficient blood 
flow to the myocardium. As a consequence, the vessel cannot respond adequately to 
an increase in absolute blood flow by vasodilatation during pharmacologically induced 
stress, and CFR will be reduced. At first, blood flow was determined by means of 
Doppler flow transducers at open-chest procedures (18;21-25), limitating extensive use 
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of CFR in clinical practice. When the diameter of intravascular catheter-based Doppler 
ultrasonographic devices could be reduced to 0.018 inch, it became feasible to measure 
the velocity of the blood flow and calculate the coronary flow velocity reserve (CFVR) 
for coronary arteries in patients during catheterization. Blood flow correlated well 
with Doppler-derived velocity of blood flow both in vitro and in vivo (26-28). Invasive 
Doppler-derived CFVR has proven its potential in numerous clinical applications, such 
as in identifying hemodynamic significant stenoses in native coronary arteries and vein 
grafts (29;30), in the functional assessment of stenoses of intermediate severity (31), in the 
determination of the need for and the outcome after coronary intervention (32-34) and in 
the prediction of restenosis (35). 
With the use of MR, blood flow velocity can be measured using phase-contrast, 
velocity-encoded sequences (36). To use such a sequence accurately, an imaging 
plane perpendicular to the target vessel has to be selected by means of survey images. 
Throughout the cardiac cycle, the acquisition yields anatomic modulus images, paired 
with phase images, in which every pixel contains a different velocity value. Volume 
flow (in milliliters/min) can be obtained by calculating the integrated volumetric flow 
rate of all pixels in the vessel lumen per heartbeat and multiply it with the heart rate. To 
display the flow pattern, a flow rate-versus-time graph can be presented. Alternatively, 
the central peak velocity (in centimeters per second) can be obtained by selecting several 
pixels in the vessel center. Figure 2.6 depicts a typical example of a MR velocity mapping 
examination in a vein graft.
Early magnetic resonance studies in vein grafts
For vein grafts, feasibility to quantify flow and characterize the flow pattern noninvasively 
by MR was demonstrated (37;38). To establish feasibility, an attempt to measure flow in 
49 vein grafts with ≤50% luminal stenosis at coronary angiography in 27 patients was 
made (38). In 84% of grafts, flow could be measured adequately. In another early study, 
23 vein grafts in 18 patients were studied to distinguish normal from dysfunctional grafts 
by MR with flow mapping plus coronary angiography as the gold standard (39). They 
found that graft flow <20 ml/min and a loss of the biphasic flow pattern, typical for 
bypass grafts, would indicate a dysfunctional graft. On top of comparing spin-echo with 
cine gradient-echo MR assessment of vein graft patency, Galjee et al. (8) investigated vein 
graft function by phase-velocity imaging. In 62 of the 73 angiographically patent grafts 
(85%), adequate biphasic flow profiles could be obtained. A significant difference in flow 
between single grafts and sequential grafts to three vascular regions was demonstrated. 
These early vein graft flow studies were limited by the use of a gradient-echo sequence 
with limited spatial resolution (1.9x1.2x5 mm3) and no compensation for respiratory 
motion on 0.5 to 0.6 Tesla (T) magnets. 
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Figure 2.6 
 MR flow velocity study. Survey image visualizing a vein graft in plane (A). A plane perpendicular 
to the graft is selected, and modulus and phase images are acquired (B,C). The graft is pictured 
as a white, respectively black spot in the center of the image. In every image in the cardiac cycle 4 
pixels in the center of the graft are selected to obtain a velocity curve (D). The MR flow velocity 
acquisition is repeated during adenosine-induced stress to obtain the stress velocity curve (black 
graph). Ao = aorta; PA = pulmonary artery; SCV = supracaval vein.
Early magnetic resonance studies in arterial grafts
Feasibility to quantify flow in native and grafted internal mammary arteries (IMAs) 
was demonstrated in 10 volunteers and 15 patients using a free-breathing gradient-echo 
sequence on a 1.5 T MR scanner (40). Patients had recently undergone IMA grafting; no 
control angiography of the arterial grafts was performed. A large intersubject variation 
of IMA graft flow (range 28-164 ml/min) was observed. Mean flow and peak velocity 
were lower in IMA grafts compared with native IMAs. In a different feasibility study, 
respiratory motion was compensated using a breath-hold segmented k-space gradient-
echo sequence to quantify velocity in native and grafted IMAs (41). IMA grafts were 
investigated within 6 months after CABG; no control angiography was available. 
Comparison with a free-breathing techique in native IMAs demonstrated a higher peak 
velocity using the breath-hold sequence because of elimination of respiratory motion 
artifacts and averaging of velocities. This sequence allowed imaging time to decrease 
from approximately 4 minutes at free-breathing to a 20-second breath-hold. By means 
of a view-sharing reconstruction, an effective temporal resolution of 64 ms could be 
maintained, allowing an acquisition of 7 to 13 temporal phases in a cardiac cycle. 
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Angiographically controlled magnetic resonance studies in vein and arterial grafts
To evaluate the diagnostic value of MR flow velocity in bypass grafts, several 
angiographically controlled studies were performed. In addition to investigating the 
accuracy of contrast-enhanced MRA in the evaluation of bypass grafts postoperatively, 
Brenner et al. (42) performed additional MR velocity mapping of the grafts. Only 65% of 
the 247 obtained MR velocity images could be evaluated because of metal clip artifacts 
in IMA grafts. Concerning the MR velocity measurements, they concluded that this 
technique was not qualified for the detection of bypass graft stenoses. 
With the use of breath-hold sequences, flow measurements at rest and during 
pharmacologically induced stress with determination of CFR in bypass grafts could be 
achieved. Langerak et al. (43) validated a breath-hold turbo-field echo-planar imaging 
sequence by demonstrating a good correlation with a free-breathing technique for aortic 
and native IMA flow in volunteers. This sequence was subsequently used to measure 
flow at rest and during adenosine-induced stress in 2 arterial and 18 vein grafts, which 
were patent at coronary angiography. A significant increase at adenosine-induced 
stress for flow and velocity parameters was observed, and CFR (mean 2.7 ± 1.1 for 
single grafts) could be calculated. In another study, MR-derived velocity measurements 
correlated well with invasive Doppler-derived velocity measurements in 27 grafts (26 
vein/1 arterial graft) (44). A significant difference between grafts with <50% stenosis 
and ≥50% stenosis was demonstrated for MR-derived average peak velocity during 
adenosine-induced stress (20.2 ± 0.4 vs. 12.2 ± 0.4 cm/s), and diastolic peak velocity 
during adenosine-induced stress (35.3 ± 0.3 vs. 25.6 ± 0.3 cm/s). Measurements obtained 
at rest did not show a significant difference between grafts with <50% stenosis and ≥50% 
stenosis. The detection of ≥70% angiographic stenosis in IMA grafts by breath-hold MR 
flow velocity at rest and during dipyridamole-induced stress was investigated (45). In 24 
early postoperative patients, successful MR flow measurements were performed in the 
mid-IMA graft. At CABG surgery, titanium clips were used to avoid metal artifacts at 
MR imaging. A significant difference between grafts with <70% and ≥70% stenosis was 
demonstrated for baseline mean blood flow (79.8 ± 38.2 ml/min vs. 16.9 ± 5.5 ml/min) 
and the diastolic-to-systolic velocity ratio (1.88 ± 0.96 vs. 0.61 ± 0.44). Threshold values 
of 35 ml/min for baseline mean flow and 1.0 for diastolic-to-systolic velocity ratio was 
proposed to separate IMA grafts with <70% and ≥70% stenosis. Respective sensitivity 
and specificity were 86% (95% confidence interval [CI]: 49.5-98.7%) and 94% (95% CI: 
79.2-99.5%) for the threshold value of baseline mean flow, and 86% (95% CI: 48.6-99.2%) 
and 88% (95% CI: 72.9-93.8%) for the threshold value of diastolic-to-systolic velocity ratio. 
CFR did not differ significantly between IMA grafts with <70% and ≥70% stenosis. 
The value of MR flow in the prediction of vein graft disease was assessed (46). Forty 
vein grafts in 21 patients were examined by contrast-enhanced MRA and breath-hold 
gradient-echo MR flow at rest and during adenosine-induced stress and coronary angio-
graphy. An algorithm was formulated combining baseline flow <20 ml/min or CFR<2 
to detect grafts or run-offs with a significant stenosis (≥50%) or a myocardial infarction 
in the graft vascular territory, yielding a sensitivity of 78% with a specificity of 80%. The 
algorithm was designed to exclude normal-functioning vein grafts from further invasive 
examinations. A different approach for the detection of stenotic vein and arterial grafts 
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or recipient vessels by MR with velocity mapping was also developed (47). In this study, 
166 grafts were examined by breath-hold MR velocity at rest and during adenosine- 
induced stress, controlled by coronary angiography. In 80% of grafts full MR examination 
was successful. Single and sequential vein and arterial grafts were separately analyzed. 
Marginal logistic regression was used to predict the probability for the presence of ≥50% 
or ≥70% stenosis per graft type using multiple MR velocity parameters, including CFVR. 
Sensitivity and specificity for detecting single vein grafts or recipient vessels with ≥50% 
and ≥70% stenosis were 94% (95% CI: 86-100%) and 63% (95% CI: 48-79%), and 96% 
(95% CI: 87-100%) and 92% (95% CI: 84-100%), respectively; for detecting ≥50% and 
≥70% stenosis in sequential vein grafts these values were 91% (95% CI: 78-100%) and 82% 
(95% CI: 64-100%), and 94% (95% CI: 83-100%) and 71% (95% CI: 52-91%), respectively. 
A proposed cut-off point for separating <70% and ≥70% stenosis in single vein grafs 
was 1.43 for CFVR. Not enough stenoses in arterial grafts were present to formulate an 
adequate logistic regression model for those grafts.  
These studies show that MR flow velocity assessment has high potential to become a 
valuable, diagnostic tool in predicting patency and even the presence or absence of a 
significant stenosis in both vein and IMA grafts in clinical practice. Future studies should 
focus on an integration of bypass graft and native coronary artery MR flow velocity 
assessment, by which an absence of significant stenosis can be predicted with high 
accuracy to avoid unnecessary invasive coronary angiographic examinations.
Applied studies using magnetic resonance flow velocity in bypass grafts
Some studies were conducted using MR flow velocity as a tool to evaluate a certain 
procedure (surgical or percutaneous intervention) or noninvasive modality. Miller et 
al. (48) used a comprehensive approach of breath-hold contrast-enhanced MRA, non-
breath-hold MR flow quantification at rest, and MR cardiac function assessment to 
evaluate the status of IMA grafts after minimally invasive direct CABG surgery. The 
protocol was successfully completed in six patients postoperatively. Patency of the grafts 
was accurately assessed by this MR approach, compared with coronary angiography. 
To evaluate the value of color-Doppler echography and MRA with navigator-gated 
flow measurements to assess bypass graft patency postoperatively, a comparison with 
intraoperative flow measurements was performed (49). Only IMA grafts could be 
evaluated with color Doppler. They found that both modalities were useful to assess 
IMA graft patency after surgery, but MR flow measurements had the best correlation 
with intraoperative flow measurements. In one study, the success of percutaneous 
interventions in 15 veins was evaluated by breath-hold MR flow, and reference values 
for rest and adenosine-stress MR flow and velocity parameters were formulated using 
data of 39 single and 20 sequential vein grafts with <50% stenosis (50). Significant 
improvements by MR flow after a percutaneous intervention were observed for baseline 
(before: 9.2 ± 6.6 cm/s; after 12.9 ± 7.9 cm/s) and adenosine-induced stress (before: 12.9 ± 
6.3 cm/s; after: 27.1 ± 13.9 cm/s) mean velocity. CFVR did not significantly improve after 
an intervention (before: 2.4 ± 1.4; after: 2.6 ± 0.9), as a result of an equal recovery of both 
baseline and stress mean velocity. Reference values confirmed a significant difference 
between single and sequential vein graft values, underscoring the need to evaluate 
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these grafts separately. Because a MR velocity map can be analyzed to evaluate both 
flow and velocity, the diagnostic accuracy of the flow and velocity analysis approach 
was investigated using velocity maps of 80 single vein grafts (51). A similar diagnostic 
accuracy was demonstrated for the flow (92%) and velocity analysis (93%) in the detection 
of ≥70% stenosis. Velocity analysis seemed to be the preferred method, because it is less 
time-consuming compared with flow analysis. 
The functional significance of a bypass graft stenosis was evaluated by single-photon 
emission computed tomography (SPECT), breath-hold MR velocity at rest and during 
adenosine-induced stress, and coronary angiography (52). In 18 out of 20 (90%) grafts 
with a normal myocardial perfusion as determined by SPECT, preserved CFVR (≥2.0) 
was observed, whereas a reduced CFVR was noted in 19 of 26 grafts (69%) with abnormal 
perfusion on SPECT. Accordingly, agreement between SPECT perfusion imaging and 
MR velocity assessment was 80% (κ=0.61). In relation to invasive coronary angiography 
the following was observed: In grafts with a stenosis <50% and normal perfusion on 
SPECT, normal CFVR was observed in 86%, whereas reduced CFVR was observed in 
78% of grafts with a stenosis ≥50% and abnormal perfusion. All grafts with a stenosis 
≥50% and normal perfusion, suggesting no hemodynamic significance of the stenosis, 
had normal CFVR. Finally, reduced CFVR was observed in 33% of grafts with a stenosis 
<50% and abnormal perfusion (suggestive of microvascular disease). 
Functional Assessment: Left Ventricular Function, Contrast-enhancement, Viability
Few studies have been performed evaluating patients after CABG surgery by a functional 
MR examination. In one study, global and regional left ventricular (LV) function by 3D 
MR served as the gold standard for the assessment of LV function by 99m-technetium-
sestamibi gated SPECT in patients post-CABG surgery (53). After cardiac surgery, 
exaggerated systolic anteromedial translation of the entire heart within the chest has 
been observed, enhancing difficulties in assessing regional wall motion (especially 
in the septum). They demonstrated that an automated software algorithm (54;55) for 
the assessment of LV function by SPECT agreed well compared with MR functional 
assessment in this particular group of patients.
Several studies focused on evaluating myocardial injury by contrast-enhanced MR 
during off-pump and on-pump CABG surgery. Conventional on-pump surgery uses 
a cardiopulmonary bypass and aortic cross-clamping, which may lead to a systemic 
inflammatory response syndrome with multiorgan dysfunction (56) and myocardial 
damage as the result of ischemia (57). Selvanayagam et al. (58) randomized 60 patients to 
either off-pump or on-pump CABG surgery and examined those patients before and after 
surgery by contrast-enhanced MR. Troponin I measurements were also obtained, which 
correlated with mean mass of new myocardial hyperenhancement. The authors found 
that off-pump CABG resulted in a significantly better LV function early after surgery; 
however, it did not reduce the incidence or extent of irreverible myocardial injury. 
Correlation of elevated biochemical markers (creatinine kinase-MB, troponin I and T) 
after CABG with the amount of perioperatively infarcted myocardium was confirmed 
in another study (59). A 6-month follow-up contrast-enhanced MR examination was 
then performed in the same patient group to assess the diagnostic value of MR contrast 
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enhancement in predicting viability, and to assess late regional wall motion recovery (60). 
A strong correlation between the transmural extent of hyperenhancement and regional 
function recovery at 6 months was demonstrated, revealing contrast-enhanced MR as a 
powerful predictor of myocardial damage after CABG surgery.  
COMPUTED TOMOGRAPHY OF CORONARY ARTERY BYPASS GRAFTS
CT has been intensively investigated in its ability and value to visualize bypass grafts 
noninvasively. Early studies were using conventional CT scanners to assess bypass 
graft patency postoperatively, in comparison with coronary angiography. Repeated 
axial images were acquired at multiple levels of the graft. If the contrast agent was able 
to visualize the graft at two levels at least, a graft was scored as patent (61;62). This 
technique required an intravenous bolus of 20 to 50 ml contrast agent per image and 
therefore burdened the patient with a relatively large quantity of x-ray radiation. Then, 
CT scanners could be programmed to acquire multiple axial images after one bolus 
injection of contrast agent (dynamic scanning), allowing faster acquisition of images (63-
69). Scans could be repeated after a 1- to 4-second interval, and per bolus injection four to 
six sequenced scans could be obtained. Diagnostic accuracy for this technique to detect 
bypass graft patency ranged from 45% to 95%. Ultrafast CT scanning allowed acquisition 
of one axial image in 50 ms, and repeating of scans after 8 ms (70-72). Total image 
acquisition time was 10 to 30 heartbeats, using electrocardiograph (ECG) triggering. 
Sensitivity to detect bypass graft patency using this technique was 93% to 96%, with a 
specificity of 89% to 100%. With spiral CT scanning the complete heart could be scanned 
in one breath-hold acquisition of 24 to 30 s (9;73-75). Optimal in-plane spatial resolution 
using this technique was 0.29 mm2. Reported diagnostic accuracy for the detection of 
graft patency was 96% for vein grafts and 88% for arterial grafts (75). Then, it became 
feasible to use four detectors in a single spiral CT acquisition, allowing detection of graft 
patency with very high accuracy: 98% to100% for vein grafts and 97% to 100% for arterial 
grafts (76-82). 
Another approach in assessing bypass graft patency is to estimate the graft blood flow. 
The contrast clearance curve of a contrast bolus injection is evaluated by cine CT (83). 
This technique was tested in patients, showing a good agreement with observations 
at coronary angiography (κ=0.75) (84). In addition to assessment of bypass graft 
patency, the extent of graft disease may be evaluated by CT. With four-detector row CT 
technology, adequate stenosis assessment of all grafts was prevented by motion artifacts, 
metal clip artifacts, or beam hardening from calcium deposits (80-82). Table 2.2 shows 
the percentage of graft segments that could be analyzed and the sensitivity, specificity, 
and diagnostic accuracy in detecting significant stenoses in patent bypass grafts. Bypass 
grafts have been examined by 16-detector row spiral CT, allowing a scanning range of 
the proximal IMA insertion to the heart apex. By using retrospective ECG gating and a 
segmental reconstruction algorithm, images with an in-plane spatial resolution of up to 
0.35 mm2 can be acquired in a single breath-hold (85-87). In Figure 2.7, a typical 16-slice 
multislice computed tomography (MSCT) protocol is explained, whereas the different 




Author Patients Grafts Graft type Assessable  Sensitivity  Specificity 
    grafts (%) (%) (%)
Ropers et al (82) 65 124 vein and arterial 62 75 92
Nieman et al (81) 24 39 vein 95 83 90
Marano et al (80) 57 92 vein and arterial 67 80 96
Martuscelli et al (89) 96 278 vein and arterial 88 90 100
Salm et al (87) 25 67 vein and arterial - 100 95
      
Weighted Mean  600  80 84 9
Table 2.2
 Accuracy of multislice spiral computed tomography in the detection of significant 
stenoses (≥50% luminal narrowing) in bypass grafts, controlled by coronary angiography 
In comparison with coronary angiography, the 16-detector row CT technique was 
demonstrated to detect bypass graft stenosis of 50% to 100% with a sensitivity of 96% 
and specificity of 95% (88). In another study, ≥50% angiographic stenoses in patent 
grafts were detected with a sensitivity of 90% with a specificity of 100% (89). Diagnostic 
accuracy to detect graft patency was 100%.
Multidetector row CT was used to preoperatively assess the surgical site before totally 
endoscopic CABG, and the results were correlated with findings at coronary angiography 
and during surgery (90). Multidetector row CT demonstrated extended information about 
the coronary target site and is recommended as a planning tool before complex cardiac 
surgery, such as endoscopic bypass grafting or minimally invasive direct CABG. 
Retrospective ECG gating allows reconstruction of CT images at 0% to 90% during the 
cardiac cycle. The best reconstruction interval to view coronary artery bypass grafts 
anastomosed to the right coronary artery and branches was shown to be at 50%, whereas 
grafts anastomosed to the left anterior descending or circumflex artery (or branches) 
were best viewed at 60% to 70% of the cardiac cycle (79).
As illustrated in Figure 2.9, multidetector row CT (MDCT) technology allows a very 
accurate evaluation of vein and arterial bypass graft patency. Also, significant stenosis in 
bypass grafts may be assessed by MDCT. CT technology is rapidly evolving, with 32- and 
64-detector row technology being readily available. A simultaneous assessment of native 
coronary arteries, coronary artery bypass grafts, and recipient vessels noninvasively by 
MDCT may soon be a part of daily clinical practice. 
SUMMARY
CMR and CT have made rapid progress in the last two decades in detecting patency/
occlusion and eventually stenoses in coronary artery bypass grafts. Other applications of 
CMR and CT include pre- and postoperative assessment of the CABG procedure. Future 
studies should focus on integrating assessment of native coronary arteries and bypass 
grafts as a full noninvasive evaluation before coronary angiography. 
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Figure 2.7 
 Typical 16-slice multislice computed tomography (MSCT) acquisition protocol. Typical 
coronary computed tomographic angiography (CTA) protocol starts with correct supine patient 
positioning, positioning of intravenous line, placement of three electrocardiograph (ECG) 
leads, and patient instruction concerning breath-holding. First, a scanogram for overview is 
acquired (A). Approximate cranial and caudal imaging margins (white lines) to acquire a second 
noncontrast localizer with prospective ECG triggering (30-40 slices, 3-mm slice thickness, 120 
kV at 200 mA). (B) On the basis of the second localizer, the exact cranial and caudal margins 
are defined. These margins are depending on the clinical setting, for example, for CTA of arterial 
graft, such as the left internal mammary artery (IMA) graft, a higher cranial slice is needed (B, 
arrow) than for CTA of vein grafts (C, arrow). The actual contrast-enhanced helical acquisition 
should be planned from 1 cm above the defined cranial margin to 1 cm below the caudal margin, 
i.e. the apex of the heart (D, arrow). For optimal timing of the contrast arrival in the coronary 
arteries and bypass grafts, automated bolus tracking is applied by placement of a region of 
interest in the ascending aorta. (continues)
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Figure 2.7 (continued) 
 (E) After the signal intensity reaches a predefined threshold (see graph), the final CTA scan 
starts automatically. Two levels are shown from the resulting CTA of a vein coronary artery 
bypass graft (F,G, arrows). CTA was performed with retrospective ECG gating (0.5-mm slice 
thickness, 120 kV at 250 mA, pitch and rotation time depending on heart rate).
Figure 2.8
 For the evaluation of MSCT angiograms, several imaging displays can be used. (A) Original 
axial slice. (B) Curved multiplanar reconstruction of a vein graft. (C) Maximum intensity 
projection of an arterial graft. (D) For an overview of the coronary arteries and bypass grafts, 
3D volume-rendered reconstructions can be useful. A full colour version of this illustration can 
be found in the full colour section (page 166).
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Figure 2.9 
 Arterial and vein bypass grafts. Images obtained with contrast-enhanced multidetector row 
CT angiography (A, E-I, maximum intensity projections; D, 3D volume rendering) and 
corresponding conventional angiography (B,C) show a left IMA graft (LIMA) connected to the 
left anterior descending coronary artery (LAD). Saphenous vein graft (SVG) runs from the aorta 
to the diagonal branch (D1), with consecutive jumps to the posterolateral branch (RPL) and 
posterior descending coronary artery (PDA). Surgical clips (arrowheads) and bypass indicator 
(arrow in D,E) appear as bright structures. Location of labeled right coronary and posterior 
descending coronary arteries (arrows in I). GCV = great cardiac vein; RCA = right coronary 
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ABSTRACT
Cardiovascular magnetic resonance (CMR) with flow velocity mapping has emerged 
as a noninvasive method to measure flow in saphenous vein coronary artery bypass 
grafts. The aim of the current study was to retrospectively test two previously described 
analysis methods on a large CMR data set, and compare their diagnostic accuracy in 
detecting diseased vein grafts. In 125 vein grafts of 68 patients volume flow parameters 
(volume flow, systolic and diastolic peak flow, diastolic-to-systolic flow ratio at rest and 
during adenosine stress, and flow reserve) were derived from the velocity maps. Method 
1 implemented basal flow <20 ml/min or flow reserve <2, yielding a sensitivity and 
specificity of 70% and 38% in the detection of a diseased graft or recipient vessel. Method 
2 used receiveroperating characteristic (ROC) curve analysis and implemented all 
significant volume flow parameters in a logistic regression model, yielding a sensitivity 
of 74% with a specificity of 68% in the detection of a diseased graft or recipient vessel. 
Evaluating single and sequential grafts separately, this method yielded a sensitivity and 
specificity of 79% and 87% for single grafts, and 62% and 94% for sequential grafts in the 
detection of ≥50% stenosis in grafts or recipient vessels. Cut-off values were formulated 
for the respective volume flow parameters, which maximally separate grafts with and 
without ≥50% stenosis. 
Using ROC curve analysis with logistic regression the specificity of the analysis method 
improved considerably. For the current data set the best results were acquired when 





To determine the significance of a stenosis in coronary artery bypass grafts, flow velocity 
can be measured during catheterization using the Doppler flow wire (1). However, this 
invasive procedure carries a small risk of serious complications (2-4). Cardiovascular 
magnetic resonance (CMR) with flow velocity mapping has emerged as a potential 
noninvasive method to measure flow velocity in both arterial (5) and saphenous vein 
coronary artery bypass grafts (6-8). In one study (7) 40 vein grafts were analyzed by CMR 
and an algorithm was formulated to detect stenoses in vein grafts or recipient arteries 
by implementing basal volume flow <20 ml/min or flow reserve <2. Their algorithm 
yielded a sensitivity and specificity of 78% and 80%, respectively, in discrimination 
of grafts with a stenosis <50% and normal recipient vessel and grafts with a stenosis 
≥50% or a diseased recipient vessel. A graft supplying a region with a prior myocardial 
infarction, considered to have an impaired flow reserve, was defined in the algorithm as 
a graft with a diseased recipient vessel. 
Langerak et al. analyzed peak velocity of MR velocity maps in single and sequential 
vein grafts separately and described a model, developed using receiver operating 
characteristic (ROC) curve analysis and logistic regression, to detect a stenosis ≥50% and 
≥70% in the graft or recipient vessel (8). For the detection of a stenosis ≥50% sensitivity 
and specificity were 94% and 63% in single vein grafts, and 91% and 82% in sequential 
vein grafts. 
In native coronary arteries many studies have researched an optimal cut-off value for the 
coronary flow reserve (CFR) to separate normal from diseased arteries (9-12). In these 
invasive studies CFR cut-offs ranging from 1.7 to 2.0 have been used. An optimal cut-off 
value for CFR derived by CMR formulated to differentiate normal from diseased vein 
grafts has never been investigated. 
Accordingly, the aim of the current study was 1) to retrospectively test two previously 
described analysis methods on a large, well documented CMR data set, and compare 
their diagnostic accuracy in detecting diseased vein grafts, and 2) to formulate cut-off 




A total of 68 patients with a history of bypass surgery underwent coronary angiography 
because of recurrent chest pain. Patient characteristics are summarized in Table 3.1. 
These  patients were part of a study describing the diagnostic value of CMR in detecting 
significant stenoses in both vein and arterial grafts by analyzing peak velocity on MR 
velocity maps (8). In the current study only vein grafts are described, and volume flow 
analysis has been used. Coronary angiography was performed according to a standard 
protocol using the Seldinger technique. In order to determine the stenosis severity of 
grafts and recipient vessels objectively quantitative coronary arteriography (QCA) was 
performed by an independent core lab (Heart Core, Leiden, the Netherlands). QCA was 
performed according to standardized methods (8;13;14). 
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CMR Examination
All patients underwent CMR examination, using a flow velocity mapping sequence 
to measure volume flow in bypass grafts. For the CMR examination a 1.5 T Gyroscan 
ACS-NT MR-scanner (Philips Medical Systems, Best, the Netherlands), equipped with 
Powertrak 6000 gradients, a cardiac research software patch and 5-element cardiac 
synergy coil was used. First, gross cardiac anatomy was visualized by means of a scout 
scan (Figure 3.1). Then, transverse ECG-gated 2D gradient-echo survey scans at the 
level of the ascending aorta were performed to localize the grafts. When a graft was not 
visualized on the survey scan, it was considered occluded at CMR examination, and 
defined to contain zero flow. When a graft was visualized, a plane perpendicular to the 
proximal section of the graft was planned on two differently angulated survey scans. A 
fast breathhold Turbo Field Echo Planar Imaging (TFEPI) sequence was used for the flow 
velocity mapping at rest and during stress (adenosine 140 μg/kg/min. intravenously), 
applying the following parameters: TR/TE of 11.0/4.6 ms, flip angle of 20°, temporal 
resolution of 23 ms, field of view of 200 x 100 mm, data acquisition matrix of 128 x 60 mm, 
in-plane spatial resolution of 1.6 x 1.6 mm, reconstructed to 0.8 x 0.8 mm by means of 
zero filling of k-space, section thickness of 6 mm, scan duration of 20 heart beats, velocity 
encoding of 75 cm/s and prospective ECG triggering. The CMR flow mapping sequence 
was previously validated against Doppler flow data in vitro, using a flow phantom, and 
in patients with vein grafts (15;16).
Image Analysis
Volume flow analysis of the bypass grafts was performed by means of an analytic 
software package (FLOW, Medis, Leiden, the Netherlands). Velocity maps consisted of 
paired modulus and phase images (Figure 3.1). For volume flow analysis contours of 
the cross-sectional area of each graft were traced manually on the modulus images and 
transferred to the phase images. In the phase images each pixel contained a velocity 
value, and the average velocity of the cross-sectional area was defined as the average 
velocity of all the pixels within the contour. The position and size of each contour was 
adjusted according to the cardiac phase. The flow rate (ml/s) was then calculated by 
multiplying the average velocity of the cross-sectional area with the cross-sectional area 
for each cardiac phase. Flow rate versus time curves were reconstructed and volume 
flow (ml/min) was obtained by multiplying the integrated volumetric flow per heart 
beat with the heart rate. Systolic peak flow rate (SPF; ml/s) and diastolic peak flow rate 
(DPF; ml/s) were defined as maximal flow rate during systole and diastole, respectively. 
CFR was calculated as the ratio of volume flow during adenosine stress and volume flow 
at rest. The ratio between DPF and SPF was regarded as the diastolic-to-systolic flow 
ratio (DSFR).
Assessment of Prior Myocardial Infarction
Myocardial infarction (MI) in the bypass graft region was evaluated by two cardiologists 
(H.W.V., J.W.J.) in consensus based on clinical investigations (patient history, 
electrocardiography, echocardiography, left ventricular contrast angiography, single-




 Example of a CMR study. Panel A shows a sagittal scout scan, on which the transversal survey 
scans at the level of the ascending aorta are planned. Panel B depicts the transversal survey 
scans showing two vein grafts, one sequential to the circumflex region (white arrow) and one 
single to the left anterior descending artery (outlined arrow). Panel C shows a coronal, oblique 
survey scan of the two vein grafts. Two differently orientated survey scans are used to plan the 
flow velocity scan. 
 Panel D illustrates the flow velocity scan (modulus and phase image) in mid-diastole of the 
sequential graft at rest, which is used to obtain volume flow. Ao = aorta; PT = pulmonary trunk; 
SCV = supra-caval vein
Statistical Analysis
Method 1
The aforementioned algorithm stated that basal volume flow <20 ml/min or CFR <2 
would indicate a diseased graft or recipient vessel (7). A diseased graft or recipient vessel 
was defined as either showing a stenosis ≥50% or perfusing a region with previous MI. 
Grafts were not divided into single and sequential grafts. This algorithm was applied 
to our data set. Sensitivity and specificity were calculated in a 2 x 2 cross tabulation, 
in which sensitivity was defined as the proportion of diseased grafts that are correctly 
identified by the algorithm, and specificity as the proportion of normal grafts that are 
correctly identified by the algorithm. 
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Method 2
According to the second method (8) ROC curve analysis with logistic regression was 
performed on the CMR data set. To quantify the diagnostic performance of the individual 
flow parameters (volume flow, SPF, DPF, DSFR at rest and during stress, and CFR) ROC 
areas-under-the-curve (AUC) were calculated for each parameter (univariate analysis). 
Logistic regression analysis was performed using the parameters with significant AUC 
in univariate analysis to determine the diagnostic performance of the volume flow 
parameters (multivariate analysis). First, single and sequential grafts combined were 
analyzed in order to compare methods 1 and 2. A diseased graft or recipient vessel 
was defined as either showing a stenosis ≥50% or perfusing a region with previous MI. 
Sensitivities and specificities of methods 1 and 2 were compared by a McNemar test. 
Since prior MI may only partially compromise vein graft flow, ROC curve analysis with 
logistic regression was performed on the data set in separating grafts (and recipient 
vessels) with mild (<50%) and significant (≥50%) stenosis. Since significant differences in 
vein graft flow for single and sequential grafts were demonstrated previously (17), vein 
grafts were then divided into single and sequential grafts, and separately analyzed. Using 
the univariate ROC curves, a cut-off value for each parameter with significant AUC was 
formulated, defined as the intersection of sensitivities and specificities. Sensitivities and 
specificities are presented with their 95%-confidence intervals (95%-CI).
Influence of prior myocardial infarction
In order to assess whether a MI had an impact on the flow parameters, as formulated in 
method 1, single and sequential vein grafts with a stenosis <50% were divided into grafts 
supplying a region with and without MI, and the CMR flow parameters were compared 
using a Student t-test. 
A p-value <0.05 was considered statistically significant. 
RESULTS
Method 1
A total of 125 vein grafts were investigated by coronary angiography and CMR flow 
velocity mapping, including single and sequential grafts (Table 3.1). Of the 125 vein 
grafts, CMR flow velocity mapping either at rest or during stress was not completed in 
15 grafts, due to artefacts or minor adenosine side-effects. Accordingly, these 15 grafts 
were discarded, since calculation of CFR requires both measurements at rest and during 
stress. On the 110 remaining grafts, the algorithm could be applied, discriminating 
between grafts and recipient vessels with a stenosis <50%, and grafts or recipient vessels 
with a stenosis severity ≥50% or a MI in the perfused region. The 2x2 cross tabulation 
is displayed in Table 3.2. Method 1 yielded a sensitivity of 70% (95%-CI 61-79%) and a 
specificity of 38% (95%-CI 29-47%). 
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Number of patients (n) 68
Male/female 57/11
Age (years) 66 ± 9
Time after CABG (years) 9 ± 5
Hypercholesterolemia 53 (77%)
Diabetes mellitus 13 (19%)
Hypertension 36 (52%)
Current smokers 9 (13%)
Positive family history for cardiovascular disease  42 (61%)
Bypass grafts included in analysis methods (n) 110
 Single vein grafts 72
 Sequential vein grafts 38
Bypass graft region 
 Left anterior descending artery 29
 Left circumflex artery 44
 Right coronary artery 37
Prior myocardial infarction in bypass graft region 50 (45%)
Percentage diameter stenosis (QCA) 53 ± 39%
 Stenosis <50% 55 (50%)
 Stenosis ≥50% 55 (50%)
Table 3.1
 Patient and graft characteristics









w  QCAMethod 1 Diseased  Nondiseased Totals
 grafts grafts
Basal volume flow <20 ml/min or CFR <2 51 23 74
Basal volume flow ≥20 ml/min and CFR ≥2 22 14 36
Totals 73 37 110
Table 3.2
 2 x 2 table of CMR volume flow and QCA according to method 1
 Diseased grafts are defined as vein grafts or recipient vessels with a stenosis severity ≥50% 
or a prior myocardial infarction in the bypass graft region. Nondiseased grafts represent vein 
grafts and recipient vessels with a stenosis <50%. QCA = quantitative coronary arteriography; 
CFR = coronary flow reserve
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 Single vein grafts Sequential vein grafts
Flow parameter Cut-off AUC Flow parameter Cut-off AUC
Volume flow baseline  22.7 0.79 † Volume flow baseline  40.9 0.75 *
(ml/min)   (ml/min)
Volume flow stress 47.9 0.82 † Volume flow stress 93.6 0.77 *
(ml/min)   (ml/min)
SPF baseline (ml/s) 0.73 0.78 † SPF baseline (ml/s) 1.17 0.80 *
SPF stress (ml/s) 1.49 0.81 † SPF stress (ml/s) 2.28 0.78 *
DPF baseline (ml/s) 1.15 0.79 † DPF stress (ml/s) 3.60 0.75 *
DPF stress (ml/s) 2.03 0.84 †
CFR 1.56 0.81 †
DSFR baseline  0.93 0.79 †
DSFR stress 1.05 0.82 †
Table 3.3 
 Optimal cut-offs of significant flow parameters of vein grafts derived from univariate analysis. 
AUC = area-under-the-curve; SPF = systolic peak flow; DPF = diastolic peak flow; 
 CFR = coronary flow reserve; DSFR = diastolic-to-systolic flow ratio; * p<0.01; † p<0.001
Method 2
For method 2, the same 15 of 125 grafts were discarded, because either rest or stress flow 
velocity mapping was not completed. First, the remaining 110 grafts were analyzed to 
differentiate grafts with <50% stenosis from grafts with ≥50% or a MI in their perfused 
region. In univariate analysis all parameters had a significant AUC, and were included 
in the multivariate analysis. Using ROC curve analysis with logistic regression an AUC 
of 0.72 (p<0.001) was found with a sensitivity of 74% (95% CI 66-82%) and a specificity of 
68% (95% CI 59-78%). Compared with method 1, method 2 yielded a similar sensitivity, 
however with a significantly higher specificity. 
Second, the diagnostic performance of CMR volume flow was analyzed by determining 
its ability to separate grafts with <50% stenosis from grafts with ≥50% stenosis. In 
multivariate analysis an AUC of 0.80 (p<0.001) was demonstrated, yielding a sensitivity 
of 65% (95% CI 56-74%) and a specificity of 85% (95% CI 78-92%). 
Third, grafts were divided into single (n = 72) and sequential grafts (n = 38). For single 
vein grafts in univariate analysis significant AUC were demonstrated for all parameters. 
For sequential vein grafts significant AUC were found for volume flow baseline and 
stress, SPF baseline and stress, and DPF stress. AUC and optimal cut-off values are shown 
in Table 3.3. In multivariate analysis using ROC curve analysis with logistic regression, 
implementing CMR flow parameters with significant AUC, the following regression 
equation was formulated for single vein grafts:
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logit(P) = 0.009*volume flowbaseline - 0.002*volume flowstress + 0.042*SPFbaseline - 1.48*SPFstress 
+ 1.44*DPFbaseline + 0.056*DPFstress + 0.10*CFR - 0.35*DSFRbaseline - 1.68*DSFRstress + 2.34 (1)
in which P is the predicted probability for the presence of a stenosis ≥50% in the graft or 
recipient vessel. Optimal cut-off for P is for single vein grafts 0.411, yielding a sensitivity 
of 79% (95%-CI 70-88%) and specificity of 87% (95%-CI 79-95%). In the ROC curve 
analysis an AUC of 0.87 was found (p<0.001). 
For sequential vein grafts the regression equation was formulated as follows: 
logit(P) = -0.019*volume flowbaseline + 0.01*volume flowstress - 0.40*SPFbaseline - 0.87*SPFstress + 
0.005*DPFstress + 2.42 (2)
Optimal cut-off for P is 0.696 for sequential vein grafts, generating a sensitivity and 
specificity of 62% (95%-CI 47-77%) and 94% (95%-CI 86-100%) with an AUC of 0.81 
(p=0.001). ROC curves of the multivariate analysis are presented in Figure 3.2. 
Figure 3.2 
 ROC curves of the multivariate analysis, including all significant CMR flow parameters from 
the univariate analysis, of single vein grafts (black line; AUC 0.87) and sequential vein grafts 
(grey line; AUC 0.81) in the detection of a stenosis ≥50%. Optimal cut-offs are indicated by an 
arrow. For single vein grafts the cut-off yielded a sensitivity and specificity of 79% and 87%, 
and for sequential vein grafts 62% and 94%, respectively. 
 ROC = receiver operating characteristic; AUC = area-under-the-curve
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Influence of Prior Myocardial Infarction
When grafts with and without a MI in their vascular area were compared, for single and 
sequential grafts, respectively, no statistically significant differences were found for the 
flow parameters. In single vein grafts without a significant stenosis, and without a MI in 
their perfused territory (n = 25) mean CFR was 2.9 ± 2.9 versus 2.8 ± 0.9 in patients with 
sustained MI (n = 11; p = 0.84). When a vein graft has a sustained MI in its vascular area, 
vein graft flow is not necessarily impaired.  
DISCUSSION
In the present study two previously described analysis methods were retrospectively 
tested on a large, well documented CMR data set, and their diagnostic accuracy in 
detecting diseased vein grafts was compared. Method 1, using a previously described 
algorithm (7), yielded a sensitivity and specificity of 70% and 38% for discriminating 
between grafts without a significant stenosis (<50%) and grafts with a significant stenosis 
or a diseased recipient vessel. Using ROC curve analysis with logistic regression, method 
2 yielded a sensitivity and specificity of 74% and 68% in the detection of a diseased graft. 
For the present data set the optimal approach for evaluating vein graft flow by CMR 
would be to analyze single and sequential grafts separately. For single grafts a sensitivity 
and specificity of 79% and 87% was demonstrated in the detection of ≥50% stenosis in 
grafts or recipient vessels. And for sequential grafts a sensitivity of 62% with a specificity 
of 94% was found. 
Method 1
Method 1 stated that basal volume flow <20 ml/min or CFR <2 would indicate a diseased 
graft or recipient vessel, yielding a sensitivity of 78% and a specificity of 80% (7). When 
applied to a different, larger data set, similar sensitivity with a much lower specificity 
was demonstrated. 
As a reference for the cut-off values, the study performed by Hoogendoorn et al. (18) 
was used, in which 23 vein grafts were investigated by CMR with flow mapping. Of the 
23 grafts 6 were occluded, and one graft had a stenosis. The quantity of affected grafts in 
that study was too low to calculate cut-off values. In the present study a cut-off point of 
22.7 ml/min was calculated for single vein grafts (n = 72), and 40.9 ml/min for sequential 
vein grafts (n = 38), underscoring the need to use separate reference values for single and 
sequential grafts, as was recently shown (17). 
Method 2
The cut-off value <2 for CFR is commonly used when native coronary arteries are 
examined by Doppler flow wire (19;20). However, vein grafts display a different 
physiology than native coronary arteries (21;22), and therefore different cut-off values 
should be used. Using method 2, the best cut-off for CFR was demonstrated at 1.56 for 
single vein grafts. Several studies found a lower flow reserve in non-stenotic saphenous 
vein grafts, intra-operative, early and late after surgery, in comparison with non-stenotic 
native coronary arteries (23;24). Thus, a lower cut-off than 2 could be expected. 
For sequential vein grafts CFR did not show a significant AUC at ROC analysis (p = 
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0.09). Absolute parameters (rest and stress volume flow, rest and stress SPF, stress DPF) 
did show significance in detecting bypass graft stenosis ≥50%, suggesting that absolute 
flow parameters, rather than relative parameters (CFR, DSFR), should be used in the 
evaluation of sequential vein grafts. 
Influence of Prior Myocardial Infarction
In method 1 (7), a diseased graft run-off was defined as a distal coronary artery run-
off with significant stenosis (≥50%) or a prior MI in the perfusion territory of the graft. 
However, the perfused territory may only partially be compromised by the MI, in 
particular in sequential grafts where the perfused area is large. In method 1 no distinction 
was made between subendocardial or transmural myocardial infarctions. In a study 
using a canine model small and large infarctions were induced and volume flow was 
measured invasively before occlusion and reperfusion of the left anterior descending 
artery, and one week after occlusion (25). Between the large and small infarctions 
(transmural extent 67-100% versus <50%) there was a significant difference in mean CFR 
after one week. Between small infarctions and the control group no significant differences 
in mean CFR were found. In our study no significant differences were found for the CMR 
flow parameters with or without sustained MI, in both single and sequential vein grafts. 
When a prior MI was not taken into account in method 2, the regression model improved 
for the data collected in the present study. Further research is required to quantify the 
extent of MI in the graft vascular area combined with a CFR determination, which could 
both be acquired by CMR (26;27).
CONCLUSION
Two previously described methods to evaluate vein graft flow by CMR display different 
results, when subjected to retrospective testing. Using ROC curve analysis and logistic 
regression the specificity of the analysis method improved considerably. For the current 
data set the best results were acquired when single and sequential grafts were separately 
analyzed, demonstrating a sensitivity of 79% and specificity of 87% for single grafts, 
and a sensitivity of 62% with a specificity of 94% for sequential grafts. Moreover, 
different cut-off values may be used for the individual CMR flow parameters in single 
and sequential vein grafts. Absolute parameters appear to be more discriminative than 
relative parameters.
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ABSTRACT
Forty-nine patients with previous bypass surgery underwent coronary angiography and 
cardiovascular magnetic resonance (MR) imaging of single vein bypass grafts. Volume 
flow and velocity analyses were performed and compared on MR velocity maps. Bland-
Altman analysis showed close agreement between the two types of analysis. Comparison 
of areas under the receiver operating characteristic curve revealed no significant 
differences between the analyses for detection of stenoses of 70% or greater. Diagnostic 
accuracy for volume flow and velocity parameters was 92% and 93%, respectively. 
Velocity analysis appears to be the preferred method, because it is less time-consuming 





Volume flow and peak velocity measurements have been used as physiologic markers 
of stenosis severity in coronary arteries. Volume flow is of direct clinical value, since the 
quantity of blood flowing through a vessel within 1 minute is measured, and coronary 
flow reserve (CFR) is correlated with stenosis severity (1); however, direct invasive 
measurement is restricted to “open chest” procedures. Peak velocity measured by 
using a Doppler guidewire has been proven to correlate well with volume flow both 
in vitro and in vivo (2) and has evolved into a well-established method to evaluate 
stenoses in coronary arteries and bypass grafts in the catheterization laboratory (3,4). 
Cardiovascular magnetic resonance (MR) velocity mapping is a noninvasive technique 
used to measure coronary flow and velocity in native coronary arteries (5-8) and bypass 
grafts (9-12). Both volume flow and velocity can be analyzed on a MR velocity map. MR 
volume flow analysis has been validated as being an accurate noninvasive method of 
measuring volume flow (13-15). With this approach, the mean velocity for the whole 
luminal area of the vessel is multiplied by the luminal area. All pixels are included in 
the analysis; however, partial volume effects may occur at the edges of the lumen (16). 
Moreover, this analytical approach is time-consuming. In velocity analysis, the velocity 
in the center of the vessel is measured. This approach is less time-consuming and has 
been used successfully in several clinical studies (6,7,17,18). The present study was 
performed to evaluate whether MR volume flow analysis and MR velocity analysis have 
comparable diagnostic accuracies for the detection of significant (≥70%) stenosis in single 
vein coronary artery bypass grafts. 
MATERIALS AND METHODS
Patients
A total of 49 patients, who had previously undergone bypass graft surgery, underwent 
coronary angiography because of recurrent chest pain and, in addition, underwent MR 
imaging according to the study protocol. Approval of the local medical ethics committee 
was obtained, and all patients gave informed consent. This study was prospective 
and was performed in a university hospital (Leiden University Medical Center). MR-
related exclusion criteria included implanted metallic devices, unstable angina, irregular 
heart rhythm, claustrophobia, and the inability to lie flat. Adenosine-related exclusion 
criteria included chronic obstructive pulmonary disease and second- or third-degree 
atrioventricular block. Mean age (± standard deviation) in patients was 66.4 years ± 8.7 
(range 43-79 years). There were 40 men and 9 women, with mean ages of 65.7 years ± 9.1 
(range 43-79 years) and 69.7 years ± 6.3 (range 60-77 years), respectively. Table 4.1 gives 
pertinent information regarding the 49 patients. 
IMAGING AND ANALYSIS
Coronary Angiography
Coronary angiography was performed according to a standard protocol by using the 
Seldinger technique. Single vein grafts and recipient vessels (n = 80) were studied in 
49 patients. To objectively determine the severity of stenosis, quantitative coronary 
arteriography was performed by members of an independent core laboratory (Heart Core, 
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Number of patients (n) 49
Male/female 40/9
Age (years) 66.4 ± 8.7
Time after bypass surgery (years) 13.5 ± 5.3
Number of grafts studied 80
Hypercholesterolemia 40 (82%)
Hypertension 24 (49%)
Current smokers 6 (12%)
Diabetes mellitus 8 (16%)
Family history for cardiovascular disease 28 (57%)
Table 4.1
 Patient Characteristics
Leiden, the Netherlands). An experienced analyst from Heart Core, who was blinded 
to the results of the MR imaging, performed the quantitative coronary arteriography 
analyses. Quantitative coronary arteriography enabled digital measurement of the 
diameter of the stenosis (in millimeters) and of a nonstenotic segment of the same vessel 
(reference diameter). The percentage of stenosis was calculated as the ratio between the 
diameter of the stenosed segment and the reference diameter. This method of quantitative 
coronary arteriography was standardized and extensively validated by Reiber et al 
(19,20). A reduction in vessel diameter of 70% or greater was considered a significant 
stenosis.
MR Imaging
For MR imaging, a 1.5-T imager (Gyroscan ACS-NT; Philips Medical Systems, Best, 
the Netherlands) equipped with Powertrak 6000 gradient system, a cardiac research 
software patch, and a 5-element cardiac synergy coil was used. The investigator (S.E.L.) 
who performed the MR imaging was blinded to the results of coronary angiography. 
Information regarding the coronary artery bypass procedure was used as a reference 
for the course of the grafts. First, gross cardiac anatomy was visualized by means of 
a scout image. Then, transverse electrocardiographically gated 2-dimensional gradient-
echo survey MR images were obtained at the level of the ascending aorta to localize 
the grafts. A plane perpendicular to the proximal section of the graft was planned on 
two differently angled survey images, and, for MR velocity mapping, a fast breath-hold 
turbo-field echo-planar imaging sequence was used at rest and during stress (140 μg of 
adenosine per kilogram of body weight per minute administered intravenously). The 
turbo-field echo-planar imaging sequence included the following parameters: 11.0/4.6 
(repetition time msec/echo time msec), flip angle of 20°, temporal resolution of 23 msec, 
field of view of 200x100 mm, data acquisition matrix of 128x60, in-plane spatial resolution 
of 1.6x1.6 mm reconstructed to 0.8x0.8 mm by means of zero filling of k-space, section 
thickness of 6 mm, image duration of 20 heartbeats, velocity encoding of 75 cm/sec, and 
prospective electrocardiographic triggering (9,10). 
Volume flow analysis and velocity analysis were performed with an analytic software 
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package (FLOW; Medis, Leiden, the Netherlands) by the same investigator (S.E.L.), and 
the flow and velocity analyses of the same velocity map were separated by a minimum of 
4 weeks to avoid bias. The duration (in minutes) of the volume flow and velocity analyses 
per patient was registered from the start of the image analysis to report generation. 
For the volume flow analysis, the luminal area was traced manually on the modulus 
image and transferred to the phase image (Figure 4.1). The position and size of each 
contour were adjusted according to the cardiac phase. The flow rate (in milliliters per 
second) was calculated by multiplying the average velocity over the luminal area with 
the luminal area for each cardiac phase. Flow rate-versus-time curves were reconstructed, 
and the volume flow rate (in milliliters per minute) was obtained by multiplying the 
integrated volumetric flow rate per heartbeat with the heart rate (Figure 4.2). Systolic 
peak flow rate and diastolic peak flow rate were defined as maximal flow rate during 
systole and diastole, respectively, both measured in milliliters per second. CFR was 
calculated as the ratio of volume flow during adenosine-induced stress and volume flow 
at rest. The ratio between diastolic and systolic peak flow rates was regarded as the 
diastolic-to-systolic flow ratio. 
Velocity images consisted of paired modulus and phase images. For the velocity analysis, 
a region of interest of 2 x 2 pixels was placed in the center of the vessel in each phase 
image (Figure 4.1). The mean velocity of the 4 pixels was defined as the central velocity 
for that cardiac phase. Velocity-versus-time curves were drawn (Figure 4.2), which were 
similar to flow rate curves. Systolic peak velocity and diastolic peak velocity were defined 
as the maximal central velocity during systole and diastole, respectively, measured in 
centimeters per second. The mean central velocity was regarded as the average peak 
velocity. Coronary flow velocity reserve (CFVR) was calculated as the ratio between 
average peak velocities during adenosine-induced stress and at rest. Diastolic-to-systolic 
velocity ratio was the ratio between diastolic and systolic peak velocities.
Figure 4.1
 Sagittal oblique images from a typical phase-contrast MR examination. Modulus (top) and phase 
(bottom) images, obtained with a breath-hold turbo-field echo-planar (11.0/4.6) sequence, show 
the cross section of a vein graft (arrow) to the left anterior descending coronary artery and an 
arterial bypass graft (arrowhead) to the first diagonal branch during late diastole. Enlargements 
of the vein graft cross section (right) are shown to illustrate the volume flow and velocity 
analyses. PA = pulmonary artery; # = artefact derived from sternal wires on the chest wall
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Figure 4.2 
 Top: Flow rate-versus-time curve. The integral of the curve (hatched area) indicates the volume 
flow per heartbeat. The volume flow per heartbeat multiplied with the heart rate results in the 
volume flow per minute. Bottom: Velocity-versus-time curve from the same bypass graft displays 
the velocity parameters that were distracted from the curve. Flow rate- and velocity-versus-time 
curves were used to quantify volume flow and velocity parameters. SPF = systolic peak flow; 
DPF = diastolic peak flow; SPV = systolic peak velocity; DPV = diastolic peak velocity; APV = 
average peak velocity
Statistical Analysis
Paired correlations of the flow and velocity parameters were determined by calculating 
the Pearson correlation coefficient. Limits of agreement between the volume flow and 
velocity analyses were evaluated by means of Bland-Altman analysis (21). Receiver 
operating characteristic (ROC) curve analysis was employed to determine the diagnostic 
performance of each flow and velocity parameter for demonstrating a significant stenosis 
using the Simpson rule (univariate analysis). 
Significant parameters from the univariate analysis were subsequently used to perform 
stepwise multivariate logistic regression and ROC curve analyses to determine the 
diagnostic performance of the combined set of flow or velocity parameters, respectively, 
in the detection of a significant stenosis (multivariate analysis). Multiple single vein 
grafts in the same patient were possibly correlated (22), for instance, because they share 
the same risk of stenosis due to systemic factors. This correlation was investigated for 
the calculation of the correlations between the flow and velocity parameters, and for 
the logistic regression analysis by using a robust estimator of the standard errors and 
by the subsequent calculation of the p values. Results indicated no correlation between 
multiple grafts within a patient. Therefore, all grafts were treated independently for 
calculating correlations and areas under the curve in ROC analysis and for comparing 
ROC curves. The optimal cutoff values for flow and velocity parameters needed to 
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predict stenosis were defined as those providing the maximal sum of sensitivity and 
specificity. Sensitivity, specificity, and diagnostic accuracy were based on their standard 
definitions and are presented with 95% confidence intervals. 
For all tests, p<0.05 was considered to indicate a statistically significant difference. 
RESULTS
A total of 80 single vein grafts were analyzed. Sixteen grafts supplied the left anterior 
descending artery territory; 25 grafts, the left circumflex artery territory; and 39 grafts, 
the right coronary artery territory. By means of quantitative coronary arteriography, 
severity of stenosis was determined to range from 0% to 100% with a mean of 50% ± 39. 
Stenosis of 70% or greater was detected in 25 grafts (31%).
At MR imaging, 22 of 80 grafts were not visible in their expected course, and these grafts 
were regarded as occluded. MR velocity mapping was performed in the remaining 
58 grafts. Baseline velocity mapping was unsuccessful in 1 graft because of artifacts. 
Adenosine-induced stress velocity mapping was not possible in 8 grafts because of side 
effects from adenosine. 
Correlations for the volume flow and velocity parameters are shown in Table 4.2. Highly 
significant correlations were found for all paired parameters both at rest and during 
stress (p<0.01 for all correlations).
Agreement between CFR and CFVR and between diastolic-to-systolic flow ratio and 
diastolic-to-systolic velocity ratio was quantified by means of Bland-Altman analysis. 
Figure 4.3 displays the Bland-Altman plot for the CFR and CFVR. There was a close 
agreement between the two methods of analysis. The mean difference between the CFVR 
and CFR was not significant. Similar results were found for diastolic-to-systolic flow ratio 
and diastolic-to-systolic velocity ratio by using baseline and stress parameters. Direct 
comparison of the remaining parameters was not possible because units of measure were 
not equivalent; volume flow parameters were measured in milliliters per second, while 
velocity parameters were measured in centimeters per second. 
At univariate analysis, all parameters for both volume flow and velocity methods were 
significantly different between grafts with and those without stenoses (≥70% stenosis; 
p<0.001). At multivariate analysis, the diagnostic value of all significant univariate flow 
parameters (volume flow; systolic and diastolic peak flow rates; diastolic-to-systolic flow 
ratio at baseline and during stress; CFR) were compared with all significant univariate 
velocity parameters (average, systolic, and diastolic peak velocities; diastolic-to-systolic 
velocity ratio at baseline and during stress; CFVR) in the detection of a graft stenosis of 
70% or more. The estimated regression parameters, selected in the model, are given in 
Table 4.3. The area under the ROC curve was 0.93 (95% confidence interval: 0.87, 0.99) 
for the flow parameters and 0.96 (95% confidence interval: 0.92, 1.00) for the velocity 
parameters. Both ROC areas were significantly larger than 0.50 (p<0.001). When the ROC 
areas were compared, the results showed no significant difference (p = 0.41). Optimal 
cut-off points for the ROC curves are displayed in Figure 4.4. The optimal sensitivity, 
specificity and accuracy for the volume flow parameters were 90% (95% confidence 
interval: 83%, 97%), 92% (95% confidence interval: 86%, 98%), and 92% (95% confidence 
interval: 86%, 98%), respectively. The optimal sensitivity, specificity and accuracy for the 
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velocity parameters were 95% (95% confidence interval: 90%, 100%), 92% (95% confidence 
interval: 86%, 98%), and 93% (95% confidence interval: 87%, 99%), respectively. No 
significant differences in sensitivity, specificity, or accuracy were found between the 
methods of analysis for demonstrating a bypass graft stenosis of 70% or greater.
The mean duration for performing a volume flow analysis was 25.9 minutes ± 4.3, 
whereas a velocity analysis was performed in 11.1 minutes ± 2.2 (p<0.05).
Figure 4.3
 Bland-Altman plot of CFR and CFVR derived from the volume flow and velocity analysis, 
respectively. Solid horizontal line shows the mean difference between CFR and CFVR, and 
dashed lines are ± 2 standard deviations. The plot shows a close agreement between the two 
analysis methods. The mean difference between CFVR and CFR was not significant.
Figure 4.4 
 Graph shows ROC curves of single vein grafts with luminal stenosis 70% or greater derived 
from flow and velocity parameters. When the area under the ROC curve for flow parameters 
was compared with that for velocity parameters, no significant differences were found. Optimal 
cutoff points are indicated by arrows.
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Paired parameters Correlation coefficient
CFR and CFVR 0.85
Baseline 
 Volume flow and average peak velocity 0.85
 Systolic peak flow and velocity 0.84
 Diastolic peak flow and velocity 0.86
 Diastolic-to-systolic flow and velocity ratios 0.90
Adenosine-induced stress 
 Volume flow and average peak velocity 0.95
 Systolic peak flow and velocity 0.90
 Diastolic peak flow and velocity 0.90
 Diastolic-to-systolic flow and velocity ratios 0.83
Table 4.2
 Correlations for paired flow and velocity parameters*
 * For all correlations p<0.01. Flow and velocity parameters are derived from the volume flow and 
velocity analysis of the MR velocity maps of 58 single vein bypass grafts. 
 Volume flow Velocity
Parameter b SEE b SEE
Average peak    
 Baseline 0.054 0.036 1.72 0.55
 Stress - - - -
Reserve * - - 3.12 1.01
Systolic peak    
 Baseline - - -0.82 0.28
 Stress -2.15 0.81 -0.28 0.12
Diastolic peak    
 Baseline - - - -
 Stress - - - -
Diastolic-to-systolic ratio - - - -
Baseline - - - -
Stress -1.32 0.37 -7.74 2.14
Constant 1.50 0.58 1.51 0.60
Table 4.3
 Estimated regression parameters of the forward stepwise multivariate logistic regression model
 * Refers to the CFR or CFVR. b = regression coefficient; SEE = standard error of the estimate
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DISCUSSION
In the present study, two approaches used to analyze MR velocity maps, MR volume 
flow analysis and MR velocity analysis, were compared in a head-to-head fashion in 
single vein bypass grafts. Close agreement was shown between the volume flow and 
velocity methods when comparing CFR, CFVR, diastolic-to-systolic flow ratio, and 
diastolic-to-systolic velocity ratio. Fair sensitivity, specificity, and diagnostic accuracy 
were shown for both approaches in depicting significant (≥70%) stenosis. Therefore, a 
single approach would be sufficient when analyzing MR velocity maps. 
The concept of CFR was proposed by Gould et al (1) in the early 1970s, when the necessity 
arose for a hemodynamic assessment of coronary stenoses visualized on the coronary 
angiogram. Absolute coronary blood flow could be measured only by using perivascular 
flow transducers in “open chest” procedures. CFR was therefore validated in animal 
models or in patients undergoing bypass graft surgery (1,23,24); however, extensive use 
in the clinical setting was not possible. When the diameter of intravascular catheter-
based Doppler ultrasonographic devices could be reduced to an 0.018-inch diameter, 
it became feasible to measure absolute velocity of blood flow and calculate CFVR in 
coronary arteries in patients during catheterization. Absolute blood flow correlated 
well with Doppler-derived absolute velocity and volume flow both in vitro and in 
vivo (2,25,26). Doppler-derived velocity and CFVR proved their potential in numerous 
clinical applications, such as in identification of hemodynamically significant stenoses 
in native coronary arteries and vein grafts (3,4), in the functional assessment of stenoses 
of intermediate severity (27), in the determination of the need for and the outcome after 
coronary intervention (28-30), and in the prediction of restenosis (31). 
With MR imaging and a velocity mapping sequence, both CFR and CFVR can be 
calculated, as was described in Materials and Methods. In clinical studies, both the volume 
flow analysis (8,5,12) and the velocity analysis (7,17,18) have been used successfully. In 
our study, the accuracies of volume flow and velocity analyses were not significantly 
different when evaluating MR velocity maps. Other factors, such as errors in phase-
contrast MR imaging and the time necessary to analyze the MR velocity maps, become 
important in choosing a method for analysis. 
When obtaining flow measurements at phase-contrast MR imaging, several errors might 
occur (32). Some errors are dependent on the prescription of the MR velocity mapping 
sequence (eg. inadequate spatial and temporal resolution, mismatched encoding velocity, 
deviation of the perpendicular imaging plane from the flow direction). In the present 
study, an effort was made to keep the effects of errors minimal. Encoding velocity was 
adequately matched to avoid aliasing, and two survey images obtained at different angles 
were used to plan the imaging plane perpendicular to the graft. Phase-offset errors are 
dependent on local magnetic-field inhomogeneities and are usually small. In the analysis 
of MR velocity maps, all of these errors affect both volume flow and velocity analyses. 
In volume flow analysis, all pixels in the cross-sectional area of the graft lumen are 
included. Pixels on the vessel edge may average signals both from the vessel lumen and 
from surrounding tissue. This type of error, known as partial volume effect, could either 
increase or decrease apparent flow (13,33). The extent of partial volume effect depends 
predominantly on spatial resolution and relative signal intensity of stationary tissue (16). 
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With the current MR imaging techniques, spatial resolution for flow measurements in 
small vessels is limited and, due to background noise velocity, is not zero in stationary 
tissue, enhancing partial volume effects. However, velocities at the vessel edge are 
expected to be low, as there is a pulsatile laminar flow pattern in bypass grafts with the 
highest velocity in the center of the vessel (34). Since diagnostic accuracy of the volume 
flow and velocity analyses did not differ significantly in our study, this might indicate 
that this type of error has a relatively minor role when MR imaging is used to measure 
flow in single vein bypass grafts.
In our study, a volume flow analysis required 25.9 minutes ± 4.3 to complete, whereas a 
velocity analysis required only 11.1 minutes ± 2.2. If clinical acceptance of a diagnostic test 
is to be achieved, performance and analysis of the test should be fast and straightforward. 
Since the diagnostic accuracy from both analyses was similar, velocity analysis appears 
to be the preferable method.
Our study had limitations in that other issues associated with MR velocity mapping, 
such as reference values of the MR flow and velocity parameters, spatial and temporal 
resolution of the acquired MR images, and proximal location of the imaging plane in 
the vessel were not addressed; this is because our purpose was to compare volume flow 
and velocity analyses of MR velocity maps. In addition, the sample size of our study 
was small. The study was not designed to test equivalence of the analysis methods. To 
demonstrate equivalence, a larger data set would be necessary.   
CONCLUSION
In the evaluation of MR velocity maps of single vein coronary artery bypass grafts, there 
is close agreement between volume flow and velocity analyses. For detection of a stenosis 
70% or greater, velocity analysis has a diagnostic accuracy similar to that of volume 
flow analysis, and is less time-consuming. Therefore, velocity analysis appears to be the 
method of preference in the analysis of MR velocity maps of bypass grafts.
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ABSTRACT
Objectives: This study was designed to perform a head-to-head comparison between 
single-photon emission computed tomography (SPECT) and cardiovascular magnetic 
resonance (CMR) to evaluate hemodynamic significance of angiographic findings in 
bypass grafts.
Background: The hemodynamic significance of a bypass graft stenosis may not always 
accurately be determined from the coronary angiogram. A variety of diagnostic tests 
(invasive or noninvasive) can further characterize the hemodynamic consequence of a 
lesion. 
Methods: Fifty-seven arterial and vein grafts in 25 patients were evaluated by angiography, 
SPECT perfusion imaging, and coronary flow velocity reserve determination by CMR. 
Based on angiography and SPECT, four different groups could be identified: 1) no 
significant stenosis (<50%), normal perfusion; 2) significant stenosis (≥50%), abnormal 
perfusion; 3) significant stenosis, normal perfusion (no hemodynamic significance); and 
4) no significant stenosis, abnormal perfusion (suggesting microvascular disease).  
Results: A complete evaluation was obtained in 46 grafts. SPECT and CMR provided 
similar information in 37 of 46 grafts (80%), illustrating good agreement (κ=0.61, p<0.001). 
Eight grafts perfused a territory with scar tissue. When agreement between SPECT and 
CMR was restricted to grafts without scar tissue, it improved to 84% (κ=0.68). Integration 
of angiography with SPECT categorized 14 lesions in group 1, 23 in group 2, 6 in group 3, 
and 3 in group 4. SPECT and CMR agreement per group was 86%, 78%, 100%, and 33%, 
respectively. 
Conclusions: Head-to-head comparison showed good agreement between SPECT and 
CMR for functional evaluation of bypass grafts. CMR may offer an alternative method to 




Determination of stenosis severity by coronary angiography has been considered the gold 
standard for the assessment of obstructive coronary artery disease, but the hemodynamic 
significance of a stenosis may not be determined accurately from the coronary angiogram 
(1;2). In order to decide whether conservative (medical) treatment or a percutaneous 
intervention is required, further clinical evaluation may be necessary. 
A variety of tests have been proposed for the evaluation of the hemodynamic significance 
of a stenosis in native coronary arteries and bypass grafts. One method is flow velocity 
measurement during cardiac catheterization, using the Doppler flow wire at rest and 
during pharmacologic stress. Subsequent calculation of the coronary flow velocity 
reserve (CFVR) is an invasive method that can be performed to assess the hemodynamic 
significance of a stenosis, but its use remains limited to centers with experience (3;4). 
Alternatively, noninvasive techniques may be of value; myocardial perfusion imaging with 
single-photon emission computed tomography (SPECT) in particular is a well-established 
technique to evaluate the hemodynamic significance of a stenosis (5;6). Based on the 
integration of angiographic findings and SPECT results, four different categories can be 
identified: 1) no significant stenosis, normal perfusion; 2) a significant stenosis, abnormal 
perfusion; 3) a significant stenosis, normal perfusion (no hemodynamic significance); 
and 4) no significant stenosis, abnormal perfusion (suggesting microvascular disease). 
Thus, integration of anatomical information (angiography) and functional information 
(SPECT) may allow more precise characterization of lesions. 
More recently, the feasibility of CFVR assessment using cardiovascular magnetic 
resonance (CMR) with velocity mapping in coronary arteries and bypass grafts was 
demonstrated (7;8). The relative merits of SPECT and CMR to provide noninvasive 
information in addition to angiography are unknown.
Accordingly, the aim of the present study was to perform a head-to-head comparison 
between SPECT and CMR to assess the hemodynamic significance of angiographic 
findings in bypass grafts.
METHODS
Study Population
Consecutive patients with a history of bypass surgery who underwent elective coronary 
angiography for recurrent chest pain were invited to participate in the study. All patients 
gave informed consent. The protocol was approved by the medical ethics committee of 
our institution. Coronary angiography was performed according to a standard protocol 
using the femoral approach. In order to determine the stenosis severity objectively, 
quantitative coronary arteriography (QCA) was performed by an independent core lab 
(Heart Core, Leiden, the Netherlands). QCA was performed according to standardized 
methods (8-10). If two or more stenoses were present in either the graft or recipient 
vessels, the most severe lesion was taken into account.  
Gated SPECT
For the gated SPECT examination a two-day stress-rest protocol was used (11). The stress 
protocol included a symptom-limited treadmill exercise test. Whenever possible, beta-
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blocking agents and calcium channel antagonists were discontinued at least 24 hours 
before scintigraphy. Test endpoints were physical exhaustion, dyspnea, angina pectoris, 
significant decrease in blood pressure (>10 mm Hg), or achievement of the maximum 
age-related heart rate. Blood pressure, heart rate, and electrocardiographic findings 
were monitored during the test. Technetium-99m tetrofosmin (500 MBq) was injected 
intravenously at peak exercise, which was continued for 1 minute after tracer injection. In 
patients unable to exercise (n = 11) adenosine stress was used. On the second day, resting 
images were obtained using 500 MBq technetium-99m tetrofosmin. The resting studies 
were acquired using electrocardiogram gating, allowing assessment of left ventricular 
(LV) ejection fraction and LV volumes (12). 
Imaging was performed using a triple-head SPECT camera system (GCA 9300/HG, 
Toshiba Corp., Tokyo, Japan) equipped with low-energy, high-resolution collimators. A 
20% window was used around the 140 keV energy-peak of technetium-99m tetrofosmin. 
A total of 90 projections (step-and-shoot mode, 35 s/projection, total imaging time 23 
min) were obtained over a 360˚ circular orbit. Data were stored in a 64 x 64 matrix. The 
raw scintigraphic data were reconstructed by filtered back projection using a Butterworth 
filter (cutoff frequency at 0.26 cycle/pixel, of order 9). No attenuation correction was 
employed. Reconstruction of the images yielded standard long- and short-axis projections 
perpendicular to the heart axis. Reconstructed slices were 6.4 mm in all projections. The 
short-axis slices were displayed in polar map format, adjusted for peak myocardial 
activity (100%). The myocardium was divided into 17 segments, as recently proposed (13). 
Segmental tracer activity was expressed as percentage of maximum. Perfusion defects on 
stress images were considered present when tracer activity was <75% of maximum tracer 
uptake. Mild to moderate defects were defined as having 50% to 75% of normalized 
tracer uptake and severe defects as having <50% of normalized tracer uptake. When 
significant fill-in (>10% increase of normalized tracer activity) of perfusion defects was 
observed on the resting images, segments were classified as reversible (ischemic); defects 
without fill-in were classified as irreversible defects (scar) (14). The individual segments 
on the SPECT images were assigned to the distinct native coronary arteries, according to 
recently published guidelines (13). The anastomoses of the bypass graft on the different 
native coronary arteries then defined the vascular territory that the graft perfused. 
Cardiovascular Magnetic Resonance 
For the CMR examination a 1.5-T Gyroscan ACS-NT MR-scanner (Philips Medical 
Systems, Best, the Netherlands), equipped with Powertrak 6000 gradients, a cardiac 
research software patch, and five-element cardiac synergy coil was used. Transverse, 
electrocardiogram-gated, two-dimensional gradient-echo survey scans at the level of the 
ascending aorta were performed to localize the bypass grafts. A plane perpendicular to 
the proximal section of the graft was planned on two differently angulated survey scans, 
and for MR velocity mapping a fast breathhold Turbo field echo planar imaging (TFEPI) 
sequence was used at rest and during stress (adenosine 140 μg/kg/min intravenously). 
The TFEPI sequence is validated and described in more detail by Langerak et al. (15;16). 
Analyses of the velocity maps were performed with an analytic software package 
(FLOW, Medis, Leiden, the Netherlands) by an experienced investigator. A region 
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Number of patients (n) 25
Gender (M/F) 22/3
Age (years) 65 ± 9
Time after CABG (years) 11 ± 5
Hypercholesterolemia 22 (88%)
Diabetes mellitus 6 (24%)
Hypertension 15 (60%)
Current smokers 2 (8%)
Myocardial infarction 8 (32%)
Positive family history for cardiovascular disease  17 (68%)
Medication  
 Beta-blockers 20 (80%)
 Nitrates 19 (76%)
 Calcium antagonists 18 (72%)
 ACE inhibitors 10 (40%)
 Statins 22 (88%)
 Oral anticoagulants/aspirin 24 (96%)
Table 5.1 
 Patient Characteristics
 CABG = coronary artery bypass grafting; ACE = angiotensin-converting enzyme
of interest of 2 x 2 pixels was placed in the center of the vessel in each phase image. The 
mean velocity of the four pixels was defined as the central velocity for that cardiac phase. 
The mean central velocity was regarded as the average peak velocity (APV; cm/s). CFVR 
was calculated as the ratio of APV during adenosine stress and APV at rest.
Statistical Analysis
Results are displayed as mean ± SD. Based on the integration of angiographic findings 
and SPECT results, four categories were distinguished: 1) a stenosis <50% on angiography 
and normal perfusion on SPECT; 2) a stenosis ≥50% and abnormal perfusion on SPECT, 
indicating a stenosis with hemodynamic consequences; 3) a stenosis ≥50% and normal 
perfusion on SPECT, indicating a stenosis without hemodynamic consequences; and 4) a 
stenosis <50% and abnormal perfusion, implying microvascular disease.
The agreement between SPECT and CMR results was evaluated using kappa statistics, 
with a kappa value <0.4, between 0.4 and 0.75, and >0.75 representing poor, fair to good, 
and excellent agreement, respectively. Grafts in which CFVR was not available were 
discarded. A p value <0.05 was considered significant.
RESULTS 
Study Population
A total of 25 patients were included in the study. Patient characteristics are presented 
in Table 5.1. Fifty-seven bypass grafts were evaluated. Bypass graft characteristics are 
presented in Table 5.2. Stenosis severity, as measured by QCA, ranged from 0% to 100% 
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Number of bypass grafts (n) 57
Arterial/vein grafts 12/45
Single/sequential grafts 39/18
Vascular territory perfused by graft 
 LAD 26 (46%)
 LCX 13 (23%)
 RCA 18 (32%)
Percentage diameter stenosis (QCA) 55 ± 36%
 <50% 23
 ≥50% 34
Minimal luminal diameter (mm) 1.26 ± 0.50
Table 5.2 
 Bypass Graft Characteristics
 LAD = left anterior descending artery; LCX = left circumflex artery; RCA = right coronary 
artery; QCA = quantitative coronary arteriography
with a mean percentage diameter stenosis of 55 ± 36%. Based on the QCA results, the 
grafts were divided into grafts with angiographically nonsignificant (<50%, n = 23), and 
significant stenoses (≥50%, n = 34). 
Gated SPECT
Gated SPECT demonstrated an average LV ejection fraction of 53 ± 17% (range 24% to 
85%). Mean end-systolic and end-diastolic volumes were 65 ± 50 ml and 122 ± 64 ml, 
respectively. 
In the vascular territories supplied by the 57 grafts, stress myocardial perfusion was 
normal in the territories allocated to 25 grafts, mild or moderately reduced in territories 
of 17 grafts, and severely reduced in territories of 15 grafts. Rest perfusion was normal 
in 39 grafts, mild to moderately reduced in 15 grafts, and severely reduced in three 
grafts. Accordingly, perfusion was normal in the vascular territory of 25 grafts, ischemia 
was present in the territory of 22 grafts, and irreversible defects (indicating scar tissue) 
were present in the territory of 10 grafts. Perfusion defects per vascular territory are 
summarized in Table 5.3. 
 Normal perfusion Ischemia Scar
 (n = 25) (n = 22) (n = 10)
LAD territory (n = 26) 13 9 4
LCX territory (n = 13) 4 5 4
RCA territory (n = 18) 8 8 2
Table 5.3 
 SPECT Perfusion Results per Vascular Territory of the Bypass Graft
 SPECT = single-photon emission computed tomography; other abbreviations as in Table 5.2
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SPECT Perfusion versus Angiographic Stenosis 
Based on integration of the angiographic findings and SPECT results, 18 of 57 grafts 
(32%) were classified as stenosis <50% with normal perfusion; 27 (47%) had a stenosis 
≥50% with abnormal perfusion, seven (12%) had a stenosis ≥50% with normal perfusion, 
indicating no hemodynamic significance of the stenosis; and five (9%) grafts had a 
stenosis <50% with abnormal perfusion, indicating microvascular disease. Mean percent 
diameter stenosis for the four categories were 16 ± 20%, 79 ± 20%, 65 ± 18%, and 36 ± 
20%, respectively. Differences in percent diameter stenosis between the categories with 
equivalent stenosis percentages (<50% or ≥50%) were not significant. Mean minimal 
luminal diameter for the four categories were 1.51 ± 0.52 mm, 1.14 ± 0.50 mm, 1.33 ± 0.54 
mm, and 1.03 ± 0.28 mm, respectively (p = NS).
Cardiovascular Magnetic Resonance 
In 46 of 57 grafts, full CMR with velocity mapping at rest and during adenosine stress was 
successful. In 11 grafts velocity mapping failed for the following reasons. In one graft, 
the baseline velocity map could not be analyzed because of insufficient technical quality. 
In four grafts, stress velocity maps could not be obtained because of minor adverse 
reactions to adenosine, such as chest pain, dyspnea, headache, and flushing. All adverse 
reactions resolved within a few minutes after termination of adenosine infusion. In six 
grafts, velocity mapping could not be completed because of limitation of total research 
time, reserved for the CMR examination. One full CMR examination took approximately 
1.5 hours to complete. 
Fourteen of 57 grafts (25%) were not found in their expected course on the survey scan 
(zero flow) and were considered to be occluded. 
Mean APV increased from 6.9 ± 5.5 cm/s (range 0 to 19.5 cm/s) at baseline to 15.2 ± 12.0 
cm/s (range 0 to 35.6 cm/s) during stress, resulting in a mean CFVR of 1.7 ± 1.3 (range 
0 to 3.7). When a cutoff value for CFVR of 2.0 was used (17), normal CFVR (≥2.0) was 
found in 25 grafts with a mean CFVR of 2.7 ± 0.5 and reduced CFVR (<2.0) in 21 grafts 




  CMR 
 CFVR ≥2.0 CFVR <2.0 Total
Normal perfusion 18 2 20
Abnormal perfusion 7 19 26
Total 25 21 46 
Table 5.4 
 Agreement of SPECT Perfusion and CMR
 Only grafts with available CFVR (n = 46) were included. 
 SPECT = single-photon emission computed tomography; CMR = cardiovascular magnetic 
resonance; CFVR = coronary flow velocity reserve
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  CMR 
 CFVR ≥2.0 CFVR <2.0 Total
Stenosis <50% / normal SPECT perfusion 12 2 14
Stenosis ≥50% / abnormal SPECT perfusion 5 18 23
Stenosis ≥50% / normal SPECT perfusion  6 0 6
Stenosis <50% / abnormal SPECT perfusion 2 1 3











 Agreement Between SPECT and CMR in Four Categories
 Only grafts with available CFVR (n = 46) were included. Abbreviations as in Table 5.4
Relation between SPECT Perfusion and CMR
Grafts for which CFVR was not available (n = 11) were discarded. In 18 of the 20 grafts 
(90%) with normal perfusion on SPECT, CFVR was preserved (Table 5.4). Conversely, 
in 19 of 26 grafts (69%) with abnormal perfusion on SPECT, CFVR was reduced. 
Accordingly, SPECT and CMR provided similar information in 37 of 46 grafts (80%; κ = 
0.61), illustrating a good agreement between SPECT and CMR (p<0.001). 
The relation between SPECT and CMR in the four categories (see Statistical Analysis 
section) is depicted in Table 5.5. Grafts (n = 14) with a stenosis <50% and normal 
perfusion on SPECT had normal CFVR in 86%; 78% of grafts (n = 23) with a stenosis ≥50% 
and abnormal perfusion had reduced CFVR. Grafts with a stenosis ≥50% and normal 
perfusion, indicating no hemodynamic significance of the stenosis, also had normal 
CFVR in 100%. Finally, 33% of grafts with a stenosis <50% and abnormal perfusion 
(suggesting microvascular disease) also had reduced CFVR. 
Influence of Scar Tissue
According to the SPECT results, scar tissue was present in the perfused territory of 8 of 
46 grafts with available CFVR. When the analysis was restricted to grafts without scar 
tissue on SPECT, the agreement between SPECT and CMR improved to 84% (32 of 38 
grafts; κ = 0.68).
DISCUSSION
In the present study a head-to-head comparison between SPECT and CMR to evaluate 
the hemodynamic significance of angiographic findings in bypass grafts was performed. 
Similar results of SPECT perfusion and CFVR assessed by CMR were demonstrated in 
80% of grafts (κ = 0.61), indicating that both noninvasive approaches provide similar 
information concerning the hemodynamic significance of the lesions detected invasively. 




Characterization of Angiographic Lesions by SPECT
SPECT perfusion imaging is a well-established technique to evaluate ischemic heart 
disease by assessing regional perfusion. A wealth of data is present demonstrating 
excellent sensitivities and specificities of (gated) SPECT to detect stenoses in native 
coronary arteries using coronary angiography as the gold standard (5;14). Less data are 
available in patients who underwent bypass surgery. A sensitivity of 80% with a specificity 
of 87% for the detection of >50% bypass graft stenosis has been reported (6). However, 
the hemodynamic significance of an angiographic stenosis cannot be determined on 
the coronary angiogram alone (1;2). A different approach is to use functional testing to 
further characterize the hemodynamic significance of an angiographic lesion. Chamuleau 
et al. (18) used this concept to further characterize intermediate stenoses (40% to 70%) 
in native coronary arteries by SPECT and by invasively acquired CFVR and used the 
results of the functional testing for deferral of a percutaneous coronary intervention in 
191 patients. Safe deferral was demonstrated, when CFVR was ≥2.0 (event rate 6%). Both 
CFVR and SPECT were predictive of subsequent cardiac events. In the present study, 
SPECT was used to characterize angiographic findings into four categories: 1) both tests 
show normal results (n = 18); 2) both tests show abnormal results (n = 27); 3) discordance: 
angiographic significant stenosis but normal SPECT results, implying no hemodynamic 
consequence of the lesion (n = 7); and 4) discordance: no stenosis, but perfusion defects 
on SPECT, implying microvascular disease (n = 5). 
 
Agreement between SPECT and CMR
It was previously demonstrated that SPECT perfusion imaging agreed well with CFVR 
established during cardiac catheterization using the Doppler guide wire. An agreement 
of 76% between SPECT perfusion and invasively acquired CFVR was demonstrated in 
patients with two-vessel coronary artery disease (17). 
CMR with flow velocity mapping is a new noninvasive technique to assess CFVR, 
and evaluate the functional significance of a stenosis. Recently, the value of CMR with 
velocity mapping in the detection of stenoses in bypass grafts and recipient vessels 
was demonstrated. A sensitivity of 94% with a specificity of 63% for the detection of 
angiographically significant stenoses in single vein grafts has been reported (8). In 
another study, CMR with velocity mapping yielded a sensitivity and specificity of 78% 
and 80% for detecting vein grafts with a significant stenosis (19). 
In the present study, agreement between SPECT perfusion imaging and CFVR acquired 
by CMR was assessed, showing both diagnostic tests to agree well in the identification of 
the hemodynamic significance of a stenosis in bypass grafts. In the aforementioned four 
categories of functional characterization of angiographic lesions, the agreement of SPECT 
and CMR results was evaluated. When angiography showed a nonsignificant (<50%) 
stenosis and SPECT showed normal perfusion, the agreement with CMR was good. Also, 
when angiography showed a significant stenosis and SPECT showed abnormal perfusion, 
the majority of lesions had reduced CFVR on CMR. Most importantly, 100% of the lesions 
with a significant stenosis on angiography but normal perfusion on SPECT (indicating no 
hemodynamic significance) had preserved CFVR on CMR, underscoring the capability 
of CMR with flow velocity mapping to accurately characterize angiographic lesions. The 
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category without a significant stenosis on angiography and abnormal SPECT, suggesting 
microvascular disease, contained few grafts. To draw any conclusions on this particular 
group, a larger sample size is needed.
Influence of Scar Tissue
A prior myocardial infarction, as evidenced by scar tissue on SPECT perfusion imaging, 
is known to affect CFVR (20;21). The extent of infarcted myocardium is an important 
factor in the impairment of CFVR. Conversely, when a graft is placed on a partially 
infarcted area, it can still display a preserved CFVR. Accordingly, when grafts with scar 
tissue in their perfused territory were eliminated from the analyses in the present study, 
agreement of SPECT and CFVR increased to 84%.
Study Limitations
Several limitations of the study need to be addressed. First, the current study did not 
investigate the safety of deferral of patients with significant stenoses in bypass grafts 
when negative test results were demonstrated by SPECT or CMR. 
Full CMR examination with baseline and stress velocity mapping could not be completed 
in 11 grafts. In 10 grafts this was due either to minor adverse reactions to adenosine or a 
short period of time available for research in between the standard scanning procedures; 
only in one graft was it technically unfeasible to acquire CFVR. 
Both exercise-induced and adenosine-induced stressors were used at SPECT imaging. 
However, previous studies with thallium-201 or technetium-99m tetrofosmin SPECT 
demonstrated comparable accuracies for both stressors to detect coronary artery disease 
(22;23). In the current study, exercise-induced and adenosine-induced stressors were 
equally distributed in the four distinguished categories and provided no source of 
disagreement between SPECT and CMR results. 
In the present study sequential stenoses within a graft were not separately investigated. 
The most severe graft stenosis was considered the most flow-limiting lesion. Additional 
research is required to evaluate the influence of sequential stenoses in bypass grafts on 
SPECT perfusion imaging and CMR.  
Our sample size is small. The category of grafts with a stenosis <50% and abnormal 
perfusion contained three grafts, which is inadequate to formulate a conclusion. 
Differences between groups based on specific disease categories could not be assessed. 
In the current study multiple grafts in a single patient were investigated. A possible 
correlation of these grafts was not taken into account in the analysis.  
CONCLUSIONS
The integration of anatomical and functional information obtained with angiography 
and SPECT, respectively, allows precise characterization of lesions. Head-to-head 
comparison showed good agreement between SPECT and CMR for this purpose in 
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ABSTRACT
The aim was to validate a magnetic resonance high-resolution, phase-contrast sequence 
for quantifying flow in small and large vessels, and to demonstrate its feasibility to 
measure flow in coronary artery bypass grafts.   
A breathhold, echo planar imaging (EPI) sequence was developed and validated in a 
flow phantom using a fast field echo (FFE) sequence as reference. In 17 volunteers aortic 
flow was measured using both sequences. In 5 patients flow in the left internal mammary 
artery (LIMA) and aorta was measured at rest and during adenosine stress, and coronary 
flow reserve (CFR) was calculated; in 7 patients vein graft flow velocity was measured. 
In the flow phantom measurements, the EPI sequence yielded an excellent correlation 
with the FFE sequence (r=0.99; p<0.001 for all parameters). In healthy volunteers, aortic 
volume flow correlated well (r=0.88; p<0.01), with a minor overestimation. It was feasible 
to measure flow velocity in the LIMA and vein grafts of the 12 patients.  
The high-resolution, breathhold MR velocity-encoded sequence correlated well with a 
free-breathing, FFE sequence in a flow phantom and in the aortae of healthy volunteers. 
Using the EPI sequence, it is feasible to measure flow velocity in both LIMA and vein 




Coronary artery bypass grafting (CABG) is one of the therapeutic options in obstructive 
coronary artery disease. Over time, atherosclerosis may progress in these bypass grafts 
and graft stenosis may develop, requiring invasive angiography to assess the severity 
of the lesions. However, the hemodynamic consequences of the stenotic lesions cannot 
be assessed from angiography (1;2). Measurement of flow velocity and flow reserve by 
phase-contrast velocity-encoded cardiovascular magnetic resonance (CMR) has recently 
been demonstrated for the evaluation of vein graft disease (3;4). Imaging of arterial grafts 
remains challenging because of the small luminal diameter of the internal mammary 
arteries, and metal clip artefacts. Earlier studies demonstrated the feasibility to measure 
flow in left internal mammary artery (LIMA) grafts by free-breathing and breathhold 
CMR sequences, but these sequences generated a limited spatial and temporal resolution 
(5-7). The aim of the present study was to validate a recently developed velocity-encoded 
CMR sequence to measure flow velocity in small and large vessels, and to demonstrate 
its feasibility to measure flow in coronary artery bypass grafts. 
METHODS
In Vitro Validation
In order to validate the velocity-encoded CMR sequence in small vessels, a calibrated 
flow simulator (UHDC flow simulator, Shelley Medical Imaging Technologies, London, 
Ontario, Canada) was used to create biphasic flow velocity patterns, such as observed 
in nonstenotic bypass grafts and coronary arteries, in a MRI compatible phantom. The 
design of the pump and its value in application for MR flow studies were described before 
(8;9). The simulator provided an ECG-signal to allow triggering by the MR-system. The 
phantom consisted of a cylindrical container filled with water, with a 4-mm-diameter 
glass tube running through the middle. The glass tube was connected to the flow 
simulator by two hoses, and filled with a blood-mimicking solution. The phantom was 
positioned in the bore of a 1.5 Tesla MRI scanner (Gyroscan ACS/NT, Philips Medical 
Systems, Best, the Netherlands) with Powertrak-6000 gradients (gradient strength 
25mT/m, slow rate 100 T/m/s) and commercially available cardiac software (release 
9). Scout scans of the glass tube were made, and a plane perpendicular to the tube was 
planned for the velocity measurements. A multishot echo planar imaging (EPI) velocity-
encoded sequence yielded a field of view (FOV) of 60x150 mm with an acquisition matrix 
of 55x144 voxels. Per acquisition 55 k-lines were scanned. Multi-shot gradient echo EPI 
was performed by acquisition of 5 EPI-readouts twice per frame (Figure 6.1). For each 
time frame in the cardiac cycle a velocity-sensitive and a velocity-insensitive image was 
acquired, and for each image signals were averaged (NEx=2), resulting in an acquisition 
time of 22 heartbeats. Number of phases to be acquired during the cardiac cycle was 
set to 30 by retrospective ECG-gating. The repetition time (TR), defined as the time to 
acquire 5 k-lines after one RF pulse, was 15 ms, rendering a temporal resolution of 30 ms 
(2xTR). Additional scan parameters were: echo time (TE) of 7 ms, in-plane resolution of 
1.0x1.0 mm, interpolated to 0.29x0.29 mm by zero padding, slice thickness of 6 mm, flip 
angle of 40°, velocity encoding of 50-150 cm/s.
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Figure 6.1.
 Schematic presentation of the EPI sequence. Per heart beat 30 frames could be acquired, 
each consisting of two shots, each representing one radiofrequency pulse and 5 EPI-readouts. 
ECG-signal was recorded simultaneously for retrospective ECG-triggering.
Stepwise increasing velocities in a biphasic pattern resembling bypass graft flow 
were implemented in the simulator and subsequently imaged. The series of velocity 
measurements was repeated using a free-breathing fast field echo (FFE) sequence, 
previously validated at our institution (10), using the following parameters: TR/
TE 5.5/3.5, FOV of 370 mm, RFOV 60%, acquisition matrix 77x128 voxels, temporal 
resolution of 30 ms, pixel size of 3x3 mm, interpolated to 1.45x1.45 mm, slice thickness of 
6 mm, flip angle of 20°, retrospective ECG gating, scan duration of 256 heart beats. For 
determination of interstudy variability the velocity measurements were repeated using 
the EPI sequence.  
Image analysis
Velocity image acquisition consisted of paired modulus and phase images. For the 
velocity analysis a region of interest (ROI) of 1 pixel (2.1 mm²) was placed in the center 
of the glass tube in each phase image for the free-breathing sequence, using FLOW 
software (version 4.0.4, Medis, Leiden, the Netherlands). Owing to the improved spatial 
resolution of the EPI sequence, 24 pixels (2.02 mm²) were selected in the center of the 
tube in order to compare the two sequences. The peak velocity was defined as the mean 
velocity in the ROI for each time frame. The average peak velocity (APV; cm/s) was then 
defined as the average velocity measured in the ROIs over the cardiac cycle. Systolic 
peak velocity (SPV; cm/s) and diastolic peak velocity (DPV; cm/s) were defined as the 




In 17 healthy volunteers aortic flow was measured using the EPI and FFE sequence. 
A scout scan in three planes of the thorax was made. Aortic flow was acquired in a 
transverse plane planned through the ascending aorta by both free-breathing FFE and 
EPI sequence. For this measurement FOV was increased to 370 mm in the EPI sequence, 
resulting in a voxel size of 2.6x2.6 mm, interpolated to 0.7x0.7 mm. All breathholds were 
initiated at end-expiration in order to avoid aortic flow changes due to high intrathoracic 
pressures (11). 
Feasibility Study
In 10 healthy volunteers LIMA and aortic flow were measured using the EPI sequence. 
Two surface coils were used, one placed at the proximal native LIMA and one placed 
at the center of the thorax to measure aortic flow. First, a scout scan in three planes of 
the thorax was made. A transversal balanced turbo field echo (bTFE) survey scan of the 
proximal part of the LIMA was made to identify the arterial anatomy. The proximal 
portion of the LIMA was selected in order to avoid artefacts derived from metal clips 
in patients with LIMA grafts. The proximal part of the LIMA was scanned in plane in 
two perpendicular planes in order to plan a third plane orthogonally. The EPI sequence 
was applied to measure velocity in a single breathhold. The sequence validated in the 
phantom study was used. Then, aortic flow was acquired as described in the previous 
section.
In 5 randomly selected patients with LIMA grafts, who underwent coronary angiography 
because of recurrent chest pain, aortic and proximal LIMA graft flow was measured in 
the same manner. After acquiring the baseline aortic and LIMA flow, adenosine was 
administered intravenously in dosage of 140 μg/kg/min in order to achieve maximal 
hyperemia (12). Aortic and LIMA flow velocity scans were repeated during adenosine 
stress. 
In 7 randomly selected patients with vein grafts, baseline flow velocity was measured. By 
means of the bTFE survey scan, vein grafts were visualized at the level of the ascending 
aorta. On two perpendicular survey images showing the graft in plane, a plane was 
planned perpendicular to the graft and velocity was obtained using the EPI sequence. 
Beforehand, the nature of the study was fully explained to the patients, and all patients 
gave informed consent. The study was approved by the medical ethics committee of our 
institution. 
All patients underwent coronary angiography because of recurrent chest pain by a standard 
procedure prior to the CMR examination. The MR operators were blinded to the results 
of invasive angiography. Angiograms were evaluated by an experienced cardiologist for 
potential stenoses in the examined bypass grafts and recipient vessels. If more than one 
stenosis was present in either bypass graft or recipient vessel, the most severe stenosis was 
taken into account. 
Image analysis
For the image analysis aortic and LIMA contours were traced by automatic contour 
detection, using FLOW 4.0.4 (Medis, Leiden, the Netherlands) (13;14). In the flow rate-
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versus-time curves the area-under-the-curve was multiplied with the heart rate to obtain 
aortic and LIMA volume flow (ml/min). The maximal flow rate at systole and diastole 
were defined as the systolic peak flow (SPF; ml/s) and diastolic peak flow (DPF; ml/s), 
respectively. The diastolic-to-systolic flow ratio (DSFR) was defined as the ratio of DPF 
and SPF. The ratio of hyperemic to baseline volume flow was defined as coronary flow 
reserve (CFR). As values of LIMA flow are known to vary widely between individuals 
(5), LIMA flow was also expressed as a percentage of the aortic flow at rest and during 
stress. 
For vein grafts it has been demonstrated previously that the accuracy of volume flow 
analysis and peak velocity analysis is similar (15). Therefore, only peak velocity analysis 
was performed, in which 4 pixels at the center of the vessel were selected and defined as 
the peak velocity for every phase in the cardiac cycle. APV, SPV, and DPV were derived 
from the velocity-versus-time curves, such as described for the flow simulator. 
Statistical Analysis
Parameters were expressed as mean ± SD. The velocity parameters, measured by 
the flow phantom, and the flow parameters, measured in healthy volunteers, were 
compared using Pearson correlation and Bland-Altman analysis. Interstudy variability 
was expressed as correlation and calculated as the mean difference divided by the mean 
of the two measurements. Baseline and stress values in LIMA grafts were compared 
using a paired Student t-test. A p-value <0.05 was considered significant.
RESULTS
In Vitro Validation
When comparing the FFE and EPI sequence with the flow simulator, an excellent 
correlation was demonstrated for APV (y=1.06x-2.6; r=0.99; p<0.001), as for SPV and 
DPV (y=1.05x-2.1; r=0.99 and y=1.05x-1.3; r=0.99; p<0.001). In the Bland-Altman analysis, 
the mean differences (95% limits of agreement) were for APV –1.26 cm/s (-2.89 to 0.36), 
for SPV –1.05 cm/s (-2.64 to 0.55), and for DPV 0.19 cm/s (-2.84 to 3.23), indicating good 
agreement. A good reproducibility of the EPI sequence was demonstrated, expressed 
by the following correlations: y=x+0.2 for APV, y=x-0.5 for SPV and y=x+2.2 for DPV 
(r=0.99 and p<0.001 for all correlations). Interstudy variabilities were –0.2% for APV, 
-2.4% for SPV, and 5.5% for DPV.
In Vivo Validation
In 17 healthy volunteers (mean age 30 years, range 20 to 60, male/female 7/10) aortic flow 
was measured by free-breathing FFE and breathhold EPI sequence. For 2 volunteers, image 
quality was insufficient due to inability to sustain the obligatory breathhold, and these 
individuals were excluded from further analysis. A good correlation was shown for the 
FFE and EPI sequences (Figure 6.2). The regression equation, y=1.2x-301, demonstrated a 
slight overestimation of volume flow, when the EPI sequence was used (r=0.88; p<0.01). 
The EPI sequence correlated well with the FFE sequence for SPF (y=1.04x-21; r=0.94; 
p<0.001). Bland-Altman analysis illustrated the overestimation of aortic flow with the 
EPI sequence with a mean difference of 560 ml/min (95% limits of agreement –872 to 




In 10 volunteers native LIMA flow was adequately measured using the EPI sequence. 
Mean LIMA flow was 66.5±22.3 ml/min (range 32.0 to 106.2), mean SPF was 5.2±1.4 ml/
s (range 3.1 to 7.3), and mean aortic flow was 5365±1302 ml/min (range 3331 to 7493). 
When LIMA flow was expressed as percentage of aortic flow, the mean percentage was 
1.2±0.4% (range 0.6 to 2.0). 
Figure 6.2.
 Correlation and Bland-Altman analysis of the comparison of FFE and EPI sequence for aortic 
flow in healthy volunteers. Identity lines (y=x) are shown in the correlation plots in gray. In the 
Bland-Altman plots, solid lines represent the mean, and dotted lines represent the 95% limits of 
agreement.
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Figure 6.3. 
 Modulus (left) and phase (right) images of a sequential LIMA graft (arrowheads) to anterolateral 
and obtuse marginal branch in diastole, acquired using the EPI sequence. Top images represent 
baseline flow velocity and bottom images flow velocity during adenosine stress. 
Figure 6.4.
 Flow curve of the LIMA graft depicted in Figure 3. Black squares represent the flow rate at 
baseline. Open squares characterize adenosine stress flow rate. LIMA volume flow was 58.3 
ml/min at baseline and 159.5 ml/min during adenosine stress, resulting in a CFR of 2.7.
In 5 male patients (mean age 56 years, range 43 to 73) with 5 LIMA grafts, proximal LIMA 
graft and aortic flow were successfully measured at rest and during adenosine stress, see 
Figure 6.3. Grafts were anastomosed to the left anterior descending (LAD) artery (n=1), 
first diagonal branch and LAD (n=2), anterolateral branch and obtuse marginal (OM) 
branch (n=1). In one patient the LIMA was anastomosed to the first diagonal branch and 
LAD, and a free right IMA was anastomosed from the LIMA to the OM and posterior 
descending branch. Mean interval between bypass surgery and CMR examination was 
48 months (range 8 to 104). A biphasic flow pattern was obtained in all grafts (Figure 
6.4). The measured flow parameters are summarized in Table 6.1. All LIMA grafts were 
patent at coronary angiography. Stenoses in LIMA grafts or recipient vessels distal from 
the anastomosis were not observed.  
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In 7 male patients (mean age 67 years, range 57 to 75 years) flow velocity in 9 vein grafts 
at rest was obtained (mean time interval after CABG 9 years, range 5 to 15). Single vein 
grafts perfused the LAD (n=3), OM (n=2), or posterolateral branch (n=1). Sequential vein 
grafts were anastomosed to OM and posterior descending branch (n=3). The velocity 
parameters are presented in Figure 6.5. At coronary angiography 7 grafts had no 
significant stenosis (≥50%), in 2 single grafts a diameter stenosis of 80% was observed. 
In concordance with previous studies (3;16), the velocity parameters of single vein grafts 
were lower than sequential vein graft values. Two grafts with significant stenosis showed 
low velocity values at rest. Using the EPI sequence it is feasible to measure flow velocity 
in both arterial and vein grafts.
DISCUSSION
In this study validation of a high-resolution, phase contrast CMR sequence was 
described. This sequence correlated well with a previously validated FFE sequence in 
a flow phantom and for aortic flow measured in healthy volunteers. In addition, the 
feasibility to measure LIMA and vein graft flow velocity using the proposed sequence 
was demonstrated.
In Vitro and in Vivo Validation 
MR phase contrast imaging has succesfully been used before to measure flow velocity 
in arterial and vein bypass grafts (3-7). In the current study an improved phase contrast 
EPI sequence was validated in vitro and in vivo against an established FFE sequence 
(10), and the feasibility to measure bypass graft flow velocity was demonstrated. The 
EPI sequence used segmented filling of k-space (factor 5), and had an in-plane resolution 
of 1.0x1.0 mm, interpolated to 0.29x0.29 mm, with a temporal resolution of 30 ms. The 
measurements were obtained at breathholding, and with the use of retrospective ECG-
gating, data could be collected during the full cardiac cycle. 
 Baseline Stress
LIMA flow (ml/min) 37.1±13.9 (22.3-58.3) 101.1±45.6 (39.7-159.5) *
SPF LIMA (ml/s) 1.28±0.49 (0.70-2.03) 2.88±0.72 (2.33-4.05) *
DPF LIMA (ml/s) 1.03±0.42 (0.54-1.64) 2.79±1.55 (0.96-5.11) *
DSFR 0.89±0.44 (0.38-1.44)  1.03±0.70 (0.31-2.19)
Aortic flow (ml/min) 5142±901 (4116-6185) 6275±1208 (4237-7116)
SPF aorta (ml/s) 406±51 (334-473) 442±59 (397-524)
LIMA/aortic flow (%) 0.71±0.17 (0.52-0.94) 1.56±0.52 (0.94-2.27) †
  
CFR  2.70±0.88 (1.78-4.14) 
Table 6.1. 
 LIMA graft and aortic flow
 Results are presented as mean ± SD (range). LIMA= left internal mammary artery, 
SPF= systolic peak flow, DPF= diastolic peak flow, DSFR= diastolic-to-systolic flow ratio, 
CFR= coronary flow reserve. * p<0.05, † p<0.01.
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Figure 6.5.
 Diagram of the velocity parameters, measured in the vein grafts. APV = average peak velocity, 
 SPV = systolic peak velocity, DPV = diastolic peak velocity.
In comparison, spatial and temporal resolution of formerly established breathhold phase 
contrast sequences were 2.5x1.9 mm and 128 ms (6), 1.6x0.8 mm and 112 ms (7), 1.6x1.6 
mm and 23 ms (3), and 0.9x1.5 mm and 125 ms(4), respectively. In LIMA grafts with 
a mean diameter of 2.42±0.45 mm (17), an improvement of 0.5 mm in in-plane spatial 
resolution is of important benefit. A temporal resolution of 30 ms is adequate to accurately 
measure the systolic and diastolic peak in peak flow velocity measurements (18). The 
formerly established breathhold sequences all used prospective ECG-triggering, with 
which the flow of late diastole may not be measured correctly. The presented sequence 
used retrospective gating, providing data collection throughout the whole cardiac cycle. 
Particularly in bypass grafts, where flow is maximal during diastole, this is an important 
improvement.
For validation purposes, quantitative flow velocity measurements with FFE phase 
contrast imaging have been shown to be accurate (19-22). An excellent agreement 
between the EPI sequence and the conventional sequence was demonstrated in vitro, 
and the sequences correlated well in vivo.
In healthy volunteers aortic volume flow showed a minor overestimation using the EPI 
sequence, which may be explained in part by the fact that the EPI sequence had a better 
spatial resolution, causing partial volume effects to be less prominent (23). Also, eddy 
current effects or Maxwell concomitant terms may be more prominent using an EPI 
Chapter 6
91
approach. These artefacts were not specifically investigated in this study. Moreover, at 
end-expiration left ventricle stroke volume was previously demonstrated to be higher 
than the average stroke volume in healthy volunteers (24). Thus, when aortic volume 
flow is measured over 22 heart beats in an end-expiratory breathhold, measured volume 
flow may be higher than averaged over 256 heart beats in normal breathing, due to low 
intrathoracic pressure.
The phase-contrast EPI sequence was initially developed for measuring flow velocity in 
bypass grafts. The results of the current study showed that this sequence may additionally 
be used in large arteries as part of an integrated CMR approach.
CMR Flow Velocity in Bypass Grafts
Arterial grafts 
Absolute LIMA graft flow ranged considerably between patients without stenoses in the 
graft or recipient vessel of the graft. Standardized thresholds of the flow parameters are 
necessary to be able to detect flow-limiting stenoses. Ishida et al. studied volume flow by 
CMR in 24 LIMA grafts at rest and during dipyridamole stress in patients shortly after 
CABG, and the authors proposed threshold values for the detection of >70% stenosis 
of 35 ml/min for baseline LIMA volume flow, 1.0 for diastolic-to-systolic velocity ratio, 
and 1.5 for CFR (7). These parameters however are known to change over time (17;25). 
Langerak et al. formulated a regression model to detect ≥50% and ≥70% stenoses in vein 
grafts by using CMR with velocity mapping (3). Arterial grafts (n=41) were additionally 
investigated, but a sufficient number of stenoses to formulate a model for the identification 
of graft disease was lacking. Future studies are necessary to formulate a model to detect 
significant stenoses in arterial grafts noninvasively by velocity-encoded CMR. Such a 
study may be performed using the currently presented sequence.
Another application of LIMA flow measurements by CMR is assessment before and 
after surgical revascularization to evaluate patency of the graft. Stauder et al. (26) 
demonstrated the feasibility of a combined CMR protocol, including contrast-enhanced 
MR angiography and phase contrast flow measurements, for assessment of patency in 
42 LIMA grafts. The presented CMR flow velocity sequence may also be used for this 
purpose. 
Metal clips used in bypass graft surgery formed no obstacle in the present study, since 
proximal CMR measurements were performed. Metal clip artefacts did however prevent 
the acquisition of distal flow measurements. As CMR imaging gains acceptance as 
noninvasive follow-up after surgery, MR compatible clips, e.g. titanium clips, may be 
used at CABG in a standard fashion.
Vein grafts
Vein graft flow velocity has been studied more extensively by CMR in previous studies 
(3;4;27;28). Two models were described to identify diseased vein grafts yielding a 
sensitivity and specificity of 94% and 63%, and 78% and 80%, respectively, using velocity-
encoded CMR (3;4). Measurement of flow velocity in vein grafts using this sequence was 
demonstrated to be feasible.  
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Study Limitations
In this study the results in patients are to show the feasibility of the EPI sequence to be 
used to measure flow velocity in bypass grafts. A future study validating this sequence 
to measure bypass grafts flow compared with a prospectively-triggered, breathhold 
sequence with similar spatial resolution is needed.
Also, artefact sensitivity of EPI was not specifically investigated. Future studies may 
further focus on this issue. 
CONCLUSION
In conclusion, the presented velocity-encoded CMR sequence allows accurate 
measurements of velocity in small vessels with good reproducibility, demonstrated by 
means of a flow simulator. The presented sequence correlated well with a conventional 
sequence for measurement of aortic flow in healthy volunteers. In addition, the feasibility 
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ABSTRACT
Background: Multi-detector row computed tomography (MDCT) is a versatile modality 
to evaluate stenoses in native coronary arteries and bypass grafts. Acquired MDCT data 
can additionally be used to assess left ventricular ejection fraction (LVEF). The purpose 
was to use MDCT for the assessment of bypass graft and coronary artery disease 
combined with evaluation of LVEF.
Methods: Twenty-five patients underwent 16-detector-row CT examination and 
coronary angiography. Bypass grafts and nongrafted coronary artery segments at MDCT 
were evaluated on eligibility, patency and ≥50% stenosis. The MDCT data set was used 
to calculate LVEF and was divided into patients with no/subendocardial/transmural 
myocardial infarctions (MIs). 
Results: Ninety vessels were evaluated: 14 arterial grafts/53 vein grafts/23 nongrafted 
vessels. Of 225 segments, 17 were ineligible for evaluation because of metal clips. 
With MDCT, patency in segments of arterial grafts/vein grafts/nongrafted vessels 
could be evaluated with high accuracy in 100%/100%/97% of segments. In arterial 
grafts stenoses ≥50% did not occur at angiography, which was for all eligible segments 
correctly diagnosed at MDCT. Stenosis ≥50% could be correctly detected by MDCT with 
a sensitivity/specificity of 100%/94% for vein grafts, and 100%/89% for nongrafted 
vessels. Negative predictive value was 100% for vein grafts and nongrafted vessels. In 
patients with transmural MI, MDCT revealed a significant lower LVEF as compared with 
patients without or with subendocardial MI (p<0.05).
Conclusion: Comprehensive assessment of bypass grafts, nongrafted vessels, and LVEF 
is feasible with MDCT. Owing to the high negative predictive value this noninvasive 




Recently, multidetector-row computed tomography (MDCT) has gained rapid acceptance 
as a diagnostic cardiac imaging modality, allowing noninvasive visualization of 
cardiac anatomy, coronary arteries, and coronary artery bypass grafts with high spatial 
resolution. With the introduction of 16-detector-row CT, significant stenoses (≥50%) in 
coronary arteries can be detected with high sensitivity and specificity (1;2). Earlier studies 
showed that 4-detector-row CT technology allows adequate detection of significant 
stenosis in both arterial and vein grafts, although with lower spatial resolution than the 
current state-of-the-art 16-detector-row technology (3;4). In addition, 16-detector MDCT 
technology has been used for bypass grafts visualization, although no direct comparison 
with coronary angiography was performed and nongrafted coronary arteries were not 
evaluated at the same time (5;6). As recurrent chest pain after coronary artery bypass 
graft surgery has a high prevalence and conventional coronary angiography has a small 
risk of potentially lethal complications, a noninvasive approach to evaluate both grafts 
and nongrafted coronary arteries in one comprehensive evaluation would be of great 
clinical benefit.  
Furthermore, the acquired MDCT data set can additionally be used to assess global left 
ventricular (LV) function (7). Left ventricular ejection fraction (LVEF), and stroke volume, 
obtained with MDCT, have been shown to correlate well with cine magnetic resonance 
imaging (MRI) (8-10), echocardiography (11), and cine ventriculography (12). For patients 
with previous myocardial infarction (MI) measurement of LVEF is important for risk 
stratification, and adjustment of medical therapy in order to prevent congestive heart 
failure, as underscored in the practice guidelines for both non-ST-segment elevation and 
ST-segment elevation MI (13;14). In addition, LVEF was identified as an independent 
predictor of mortality in patients with previous bypass graft surgery (15;16). In patients 
with prior coronary artery bypass graft surgery presenting with recurrent chest pain, 
early risk stratification and adjustment of medical therapy based on measurement of 
LVEF would be important extra advantages of MDCT. 
Accordingly, the purpose of the present study is to evaluate the use of 16-detector-row 
CT for the comprehensive assessment of bypass graft, as well as native coronary artery 
disease in conjunction with evaluation of global LV function.
METHODS
Study Population
Consecutive patients with a history of bypass graft surgery, who were awaiting coronary 
angiography, were screened for participation in the study. Exclusion criteria were renal 
failure, allergy to contrast agents, irregular heart rhythm, and pregnancy. Included 
patients underwent coronary angiography for recurrent chest pain or a prior episode 
of severe arrhythmia and MDCT examination. No cardiac event occurred between 
angiography and MDCT. All patients gave written informed consent and the study was 
approved by the institutional ethical committee. 
Coronary angiography was performed according to a standard procedure using the 
femoral approach. To determine stenosis severity in coronary arteries or bypass grafts 
objectively, quantitative coronary arteriography was performed by an independent, 
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experienced researcher. Quantitative coronary arteriography was performed according 
to standardized methods (17;18).
For all included patients, the presence of a prior MI was assessed, concerning patient 
history and electrocardiography criteria. Subendocardial infarctions were defined as 
non-Q-wave infarctions, transmural infarctions as Q-wave infarctions.
Multdetector-row Computed Tomography
Multdetector-row computed tomography examination was performed using a 16-
detector-row CT scanner (Aquilion 16, Toshiba, Japan). None of the patients received 
additional β-blockers to reduce heart rate. A localizer scan was obtained to establish the 
scanning range, from proximal origin of the arterial graft from the subclavian artery to 
the heart base. When a patient had only vein grafts the top of the aortic arch was set as 
proximal boundary. The sure-start feature was used to determine the arrival of contrast 
agent in the ascending aorta. Data acquisition was initiated after the contrast agent 
(jobitridol, Guerbet, Aulnay sur Bois, France) appeared in the ascending aorta, and the 
patient was instructed to hold his breath. Additional scan parameters for arterial grafts 
were the following: 16 x 1.0-mm detector collimation, 0.4 to 0.5 seconds rotation time and 
3.2 to 4.0 pitch dependent on patient’s heart rate, 0.8 mm3 pixel size, 120 kV at 320 mA 
tube voltage, 200 to 250 mm scanning range, administration of intravenous contrast agent 
at 4 ml/s to a total of 160 ml, and 25 to 30 seconds breath-hold duration. For vein grafts, 
because of a shorter scanning range (150-200 mm), 16 x 0.5 mm detector collimation was 
allowed, with 0.4 mm3 pixel size. An electrocardiogram was simultaneously recorded, 
and data were retrospectively reconstructed using a segmental reconstruction algorithm, 
obviating the use of additional β-blockers to lower the heart rate. Axial images were 
reconstructed at intervals of 5% throughout the cardiac cycle with 0.8-mm increment for 
arterial grafts and 0.4 mm for vein grafts. 
The reconstructed images were viewed on a Vitrea workstation (Vitrea 2, Vital Images, 
Plymouth, Minn) using 2D axial, 3D, and multiplanar reformat reconstructions. The 
cardiac phase with the least motion artifacts (mostly at 75%, 80% or 85%) was used for 
evaluation of bypass grafts, recipient vessels and nongrafted arteries. An experienced 
cardiologist and radiologist evaluated the scans in consensus. Bypass grafts were 
divided into segments. The course of the graft from its origin to the first anastomosis was 
regarded as one segment (graft body). If one graft had more recipient vessels (sequential 
grafts), the course of the graft from the first anastomosis to the second anastomosis was 
regarded as a separate segment (second graft body), and so on. The recipient vessels 
were regarded as separate segments. Proximal segments of coronary arteries receiving a 
graft were not assessed. Of nongrafted arteries, left main artery, left anterior descending 
artery, circumflex artery, and right coronary artery were distinguished as separate 
segments. All segments were evaluated on eligibility for assessment, and on patency. 
Eligible, patent segments of graft bodies and nongrafted arteries were further searched 
for the presence of a significant stenosis (≥50%). 
Using the CT data set, a short-axis view of the left ventricle was reconstructed by multiplanar 
reformat (11). Endocardial contours were manually traced using cardiac analysis software 




Computed tomography evaluation of vessel segments was compared with angiographic 
analysis. Sensitivity, specificity, diagnostic accuracy, positive predictive value (PPV) and 
negative predictive value (NPV) were based on their standard definitions. Agreements 
between the diagnostic modalities were assessed using κ statistics, with a κ value 
<0.4, between 0.4 and 0.75, and >0.75 representing modest, fair to good, and excellent 
agreement, respectively. Data of LVEF are presented as mean ± SD, and are compared 
using a Student t test. 
RESULTS
Study Population
A total of 30 consecutive patients were screened for inclusion in the study. Of these, 
5 were excluded because of (supra)ventricular arrhythmias and/or renal insufficiency. 
Characteristics of the included 25 patients are shown in Table 7.1. A total of 90 vessels 
were evaluated; vessel characteristics are summarized in Table 7.2. The vessels were 
subdivided into 225 segments: in graft bodies 104 segments (22 in arterial, 82 in vein 
grafts), in recipient vessels 82 segments, in native, nongrafted arteries 39 segments. At 
coronary angiography, 187 (83%) segments were patent. Of these 187 segments, 17 (9%) 
were ineligible for evaluation of ≥50% stenosis because of metal clips used in arterial 
bypass grafting. Of the remaining 170 segments, 91 were segments of grafts bodies 
and nongrafted arteries and were screened for a stenosis ≥50%. In 14 (15%) segments a 
significant stenosis was present at coronary angiography.   
Number of patients 25
Male/female 24/1
Age (years) 66.7 ± 9.4
Diabetes mellitus 8 (32%)
Currently smoking 3 (12%)
Hypertension 13 (52%)
Hypercholesterolemia 16 (64%)
Prior myocardial infarction 14 (56%)
Pacemaker or ICD 2 (8%)
Time after CABG (years) 9.2 ± 5.3
Medication 
 β-blocker 14 (56%)
 ACE-inhibitor 12 (48%)
 Calcium antagonist 14 (56%)
 Nitrate 12 (48%)
 Diuretic 7 (28%)
 Statin 19 (76%)
 Oral anticoagulant 7 (28%)
Table 7.1 
 Patient Characteristics
 ICD = intracardiac defibrillator; CABG = coronary artery bypass grafting; 
 ACE = angiotensin-converting enzyme
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Number of vessels 90
 Single arterial grafts 7
 Sequential arterial grafts  7
 Single vein grafts  25
 Sequential vein grafts 28
 Nongrafted arteries 23






 LAD = left anterior descending artery; LCX = left circumflex artery; 
 RCA = right coronary artery
Figure 7.1
 Example of an arterial and a vein graft. A, a 3D reconstruction of the heart and vessels. The 
white arrows highlight a left internal mammary artery graft to the left anterior descending 
artery from its left subclavian artery origin to the anastomosis. B, after the anastomosis 
the recipient vessel is occluded, also illustrated as multiplanar reformat reconstruction. 
The asterisk represents a vein graft to the posterior descending branch (anastomosis not shown). 
The native RCA is severely diseased. Ao = aorta; RCA = right coronary artery; LV = left ventricle; 




Comparison of MDCT and Coronary Angiography 
Multidetector-row computed tomography examination was successfully accomplished 
in all patients. Heart rate varied from 53 to 85 beats/min (mean 64 ± 9 beats/min). Figures 
7.1 and 7.2 depict typical examples of MDCT reconstructions of arterial and vein grafts. 
Patency on MDCT was scored in all 225 segments. When metal clips prevented adequate 
assessment of arterial graft segments, patency was evaluated by the presence or absence 
of contrast agent in the vessel in between the metal clip artifacts. All grafts were correctly 
identified as either patent or occluded by MDCT. Neither of the arterial graft segments 
(n = 22) were occluded. Accordingly, specificity, accuracy, and NPV were 100% for 
arterial grafts; sensitivity and PPV could not be calculated. Comparison of MDCT with 
coronary angiography for vein grafts, recipient and nongrafted vessels on vessel patency 
is illustrated in Table 7.3. 
In patent graft bodies and nongrafted arteries the presence of a significant stenosis (≥50%) 
was evaluated by MDCT. All eligible arterial graft segments (n = 5) were not stenosed, 
which was correctly recognized by MDCT. Specificity, accuracy, and NPV were 100% 
for arterial grafts in the detection of a significant stenosis. Shown in Table 7.4 are the 
results of MDCT compared with angiography in the evaluation of significant stenoses 
for vein grafts and nongrafted vessels. κ values indicate a good to excellent agreement of 
MDCT and angiography. Particularly, NPV is high in all vessels when assessing patency 
or significant stenosis by MDCT. 
Figure 7.2 
 Example of a patient with multiple vein grafts. A, a 3D reconstruction of the heart, revealing 
4 grafts (white arrows). Two patent grafts supply the obtuse marginal branch and the second 
diagonal branch, respectively; 2 grafts are totally occluded. Lateral from the graft origins, metal 
clips have been placed for identifying the graft locations (white arrowhead marks one of the 
clips). The vein graft to the second diagonal branch has a significant stenosis at its ostium. B and 
C, the multiplanar reformat reconstruction and coronary angiography of the ostium stenosis 
(arrow). RV = right ventricle; LV = left ventricle. A full colour version of this illustration can 
be found in the full colour section (page 168).
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Vessel type Sensitivity Specificity Accuracy PPV NPV κ p
Vein grafts 25/25 (100) 57/57 (100) 82/82 (100) 25/25 (100) 57/57 (100) 1.00 <0.001
Recipient  2/3 (67) 77/79 (97) 79/82 (96) 2/4 (50) 77/78 (99) 0.55 <0.001
vessels
Nongrafted  9/10 (90) 29/29 (100) 38/39 (97) 9/9 (100) 29/30 (97) 0.93 <0.001
vessels
Table 7.3 
 Comparison of MDCT and Coronary Angiography on Vessel Segment Patency
 Values in parentheses are percentages. All arterial grafts were patent and correctly identified by 
MDCT. PPV = positive predictive value; NPV = negative predictive value
 
Vessel type Sensitivity Specificity Accuracy PPV NPV κ p
Vein grafts 3/3 (100) 51/54 (94) 54/57 (95) 3/6 (50) 51/51 (100) 0.64 <0.001
Nongrafted 11/11 (100) 16/18 (89) 27/29 (93) 11/13 (85) 16/16 (100) 0.86 <0.001
vessels
Table 7.4 
 Comparison of MDCT and Coronary Angiography on ≥50% Stenosis
 Values in parentheses are percentages. Only patent vessels, eligible for evaluation, are included. 
Arterial grafts had no stenoses and were correctly identified by MDCT. Abbreviations as in 
Table 7.3
Global LV Function
Of the 25 patients, 14 had a prior MI in their medical history. Six patients had a 
subendocardial MI, 8 a transmural MI. In all patients LVEF could be derived from the 
MDCT examination. Mean LVEF for patients with no, subendocardial, and transmural 
infarctions were 51.1% ± 15.7%, 56.0% ± 17.7%, and 39.9% ± 9.1%, respectively (p = 
NS). Mean LVEF of patients without MI and with subendocardial MI demonstrated a 
significant difference compared with mean LVEF of transmural MI (p<0.05). 
DISCUSSION
In the present study a comprehensive 16-detector-row CT assessment of bypass grafts 
and native coronary arteries together with cardiac function has been shown to be feasible. 
With MDCT, patency and the presence of a significant stenosis in grafts or coronary 
arteries could be evaluated with high accuracy. Additional evaluation of LV function 
can be used in patients with previous MI for risk stratification or adjustment of medical 
therapy.    
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Computed Tomographic Angiography in Native Coronary Arteries
Multidetector-row computed tomography examination is a rapidly evolving, versatile 
technique, gaining acceptance as a diagnostic cardiac imaging tool. Four-detector-row 
CT already demonstrated promising results, when CT angiography was compared with 
coronary angiography, showing sensitivities of 81% to 93%, specificities of 76% to 97%, 
PPV of 57% to 66%, and NPV of 97% to 99% for the detection of ≥50% stenosis in eligible 
native coronary arteries (19-22). In these studies segments of vessels were excluded from 
analysis because of image artefacts from metal objects, calcification, coronary motion, or 
the patients’ inability to perform the necessary breath-hold. With the introduction of the 
16-detector-row CT technique, detection of significant stenoses in native coronary arteries 
improved because of higher spatial and temporal resolution, and shorter scanning time 
(23). Sensitivities of 92% to 95%, specificities of 86% to 95%, PPV of 79% to 80%, and 
NPV of 97% to 98% were reported for the detection of ≥50% stenosis, when compared 
with coronary angiography (1;2;24). If the heart rate exceeded 60 beats/min, additional 
β-blockers were administered in these studies to enhance image quality.
In the current study similar results were demonstrated for native coronary arteries in 
patients who had undergone bypass grafting. Segments were ineligible for evaluation 
by MDCT because of metal clip artifacts. All patients were able to sustain the necessary 
breath-hold, and none of the segments had to be excluded because of coronary motion 
artifacts or calcification. Vessel calcification was mostly observed in grafted arteries 
proximal to the first anastomosis and occluded grafts, proposing no difficulty for the 
eligible segments to be assessed. 
Because of segmental reconstruction of the raw data sets, no prescan β-blockers were 
necessary. Heart rates varied to a maximum of 85 beats/min. Image quality was excellent 
and did not decline with higher heart rates.  
Computed Tomographic Angiography in Bypass Grafts
Both arterial and vein grafts have been investigated with 4-detector-row CT and the 
results, compared with coronary angiography, showed fair diagnostic accuracies in 
the detection of ≥50% stenosis (3;4). However, there was a high number of unevaluable 
grafts in one study (3): only 62% of patent grafts could be assessed for the detection of 
significant stenoses because of metal and motion artifacts. In the study by Nieman et 
al. (4), assessability for the evaluation of stenoses was good for vein grafts (95%-100%), 
whereas for arterial grafts and nongrafted coronary arteries assessability was much 
lower (58%-73% and 66%-69%, respectively). Major causes of non-assessability were 
the patients’ inability to sustain a long breath-hold (35-45 seconds) and cardiac motion 
artifacts. Heart rate had a significant influence on the assessment of nongrafted arteries. 
In patients with a heart rate ≥65 beats/min, assessability was 52% for nongrafted arteries. 
In both studies the proximal part of arterial grafts could not be included in the scan 
because of the limited scanning range. 
Sixteen-detector-row CT technology has been used to assess the patency of arterial grafts 
within a short period (1 week to 12 months) after surgery (6). The entire arterial graft could 
be included in the scan, and graft patency was easily recognized. In addition, both arterial 
and vein grafts were investigated by 16-detector-row CT in one study, demonstrating the 
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ability of this technique to reliably depict grafts with fair diagnostic quality (5). However, 
both studies did not have a head-to-head comparison with coronary angiography, and 
native, nongrafted coronary arteries were not included in the analysis. 
In the current study, arterial and vein grafts, recipient vessels, and native, nongrafted 
coronary arteries were evaluated by MDCT, compared in a head-to-head fashion with 
coronary angiography, demonstrating good diagnostic accuracy in the assessment of 
patency and in the detection of significant stenosis (≥50%). Owing to the high NPV (100% 
for nongrafted arteries, arterial and vein grafts) this approach may be used as gatekeeper 
before coronary angiography. For all arterial grafts the entire graft, from origin to the 
distal recipient vessel, could be assessed. Image quality was excellent for all patients; no 
motion artifacts were observed. Metal clips still proposed a difficulty in the evaluation 
of arterial grafts and recipient vessels, causing 9% of segments to be excluded from 
analysis. Because MDCT is becoming widely available and is gaining acceptance as a 
cardiac diagnostic tool, MDCT-compatible clips may be preferential to be used in bypass 
graft surgery. 
Global LV Function with MDCT
Using 4-detector-row CT global LV function correlated well with cine MRI (8-10), 
echocardiography (11), and cine ventriculography (12). In a recent study, infarct volumes 
assessed by MDCT showed a negative correlation to LVEF measured by contrast 
ventriculography (25). The present study confirmed these findings by demonstrating 
that mean LVEF of patients with prior transmural MI was significantly lower than mean 
LVEF of patients with no or prior subendocardial MI. Both practice guidelines for non-ST-
segment elevation and ST-segment elevation MI emphasize the need to determine LVEF for 
risk stratification and to adjust medical therapy to prevent congestive heart failure (13;14). 
Because an entire scan of the heart is required for the detection of significant stenoses in 
grafts or coronary arteries, determination of LVEF may be performed using the same CT 
data set, obviating the use of an additional diagnostic test. As cardiac CT software is still 
under development, more diagnostic potential of MDCT may be expected (7).
Comparison of MDCT with Established Noninvasive Modalities
Besides MDCT, the number of noninvasive modalities available for simultaneous 
assessment of stenoses in bypass grafts, nongrafted arteries, and LV function is limited. 
Currently, only cardiovascular magnetic resonance may suit this description. Accurate 
assessment of global and regional LV function with cine MRI has been described (26;27). 
However, magnetic resonance angiography still lacks the ability to evaluate stenoses in 
native coronary arteries and bypass grafts with high accuracy (28-30). 
Other noninvasive modalities, such as gated single photon emission computed 
tomography and stress echocardiography (31;32), allow assessment of LV function and 
myocardial perfusion, which is an indirect marker of coronary artery disease; however 




Radiation exposure remains high for cardiac MDCT examinations, which is reported 
to be between 6.7 and 13.0 mSv (33;34). Because cardiac MDCT is becoming a robust 
diagnostic tool, future developments should focus on reducing radiation exposure. 
The sample size of the current study is small. The results must be confirmed in a larger 
study before MDCT can be used as a gatekeeper in patients with prior bypass surgery.
No gold standard for the 16-detector-row CT LVEF measurements is available. Because 
LVEF measurements performed with a 4-detector row CT were proven to be very 
accurate in previous studies (8-12), differences from LVEF derived from 16-detector-row 
CT images are expected to be low. A study, which validates the 16-detector-row CT LV 
function by head-to-head comparison with an established modality, would be fitting. 
CONCLUSION
Comprehensive assessment of bypass grafts, nongrafted vessels and global cardiac 
function is feasible with 16-detector-row CT. Good diagnostic accuracy in the detection of 
significant stenosis (≥50%) in comparison with coronary angiography was demonstrated. 
Owing to the high NPV, this noninvasive approach may be used as gatekeeper before 
conventional coronary angiography.  
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ABSTRACT
Aims: To compare multidetector row computed tomography (MDCT) global and regional 
left ventricular (LV) function assessment with echocardiography and cardiovascular 
magnetic resonance (CMR).
Methods and Results: In 25 patients, who were referred for noninvasive angiography 
with 16-detector row CT, LV function assessment was also performed. A subsequent 
echocardiogram was performed, and in a subgroup of patients, CMR examination was 
completed to evaluate LV function. For global function assessment, the LV ejection 
fraction (LVEF) was calculated. Regional LV function was scored using a 17-segment 
model and a 4–point scoring system.
MDCT agreed well with echocardiography for the assessment of LVEF (r = 0.96; bias 
0.54%; p<0.0001), and regional LV function (κ = 0.78). Eight patients had no contra-
indications and gave informed consent for CMR examination. A fair correlation between 
MDCT and CMR was demonstrated in the assessment of LVEF (r = 0.86; bias –1.5%; 
p<0.01). Regional LV function agreement between MDCT and CMR was good (κ = 0.86).
Conclusion: MDCT agreed well with both echocardiography and CMR in the assessment 
of global and regional LV function. Global and regional LV function may accurately 
be evaluated by 16-detector row CT, and can be added to a routine CT image analysis 





Global and regional left ventricular (LV) function are well-known indicators of cardiac 
disease. For patients with heart failure LV function assessment is often used to identify 
systolic and diastolic LV dysfunction, and to monitor the progression of the disease 
(1). Moreover, after myocardial infarction, left ventricular ejection fraction (LVEF) is an 
important prognostic marker (2-4). 
Noninvasive modalities to measure global and regional LV function include 
echocardiography, cardiovascular magnetic resonance (CMR), and single photon 
emission computed tomography (SPECT). These techniques have been shown to agree 
well with invasively acquired LV function assessment by angiography (5-7). Multidetector 
row computed tomography (MDCT) is a relatively new technique used for noninvasive 
angiography, but does also allow evaluation of LV function. Several studies showed that 
4-detector row CT allowed accurate assessment of global and regional LV function (8-10). 
The first study using the next-generation 16-detector row CT has shown to evaluate LV 
function with similar accuracy (11). However, no validation of global and regional LV 
function assessment with 16-detector row CT has yet been conducted. Accordingly, the 
purpose of the present study is to compare global and regional LV function assessment 
by 16-detector row CT with echocardiography and CMR.
METHODS 
Patients
In patients who were referred for noninvasive coronary angiography by MDCT for 
evaluation of coronary artery disease, LV function assessment was also performed. A 
subsequent echocardiogram was scheduled. If no contra-indications for CMR existed, 
patients were also asked for a CMR examination to assess LV function. Contra-
indications for CMR were metal implants, irregular heart rhythm, and claustrophobia. 
The examinations were performed within three months after the first examination. No 
cardiac events occurred between examinations. All patients gave informed consent and 
the study was approved by the institutional ethical committee. 
MDCT
MDCT examination was performed using a 16-detector row CT scanner (Aquilion 16, 
Toshiba, Japan). Patients did not receive additional β-blockers to reduce heart rate. A 
localizer scan was obtained to establish the scanning range. The sure-start feature was 
used to determine the arrival of contrast agent in the ascending aorta. Data acquisition was 
initiated after the contrast agent (jobitridol, Guerbet, Aulnay sur Bois, France) appeared 
in the ascending aorta, and the patient was instructed to hold his breath. Additional 
scan parameters were: 16 x 0.5 mm detector collimation, 0.4-0.5 s rotation time, 3.2-4.0 
pitch and 97-200 ms temporal resolution dependent on patient’s heart rate, 0.4 mm3 
pixel size, 120 kV at 320 mA tube voltage, 150-200 mm scanning range, administration of 
intravenous contrast agent at 4 ml/s to a total of 160 ml, and 25-30 s breathhold duration. 
An electrocardiogram (ECG) was simultaneously recorded, and data were retrospectively 
reconstructed using a multisegmental reconstruction algorithm, obviating the use of 
additional β-blockers to lower heart rate. Axial images were reconstructed at intervals 
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of 5% throughout the cardiac cycle with 0.4 mm increment. A short axis view of the left 
ventricle was reconstructed by multiplanar reformat (10) by an experienced observer. 
Endocardial contours were manually traced using cardiac analysis software (CT MASS, 
Medis, Leiden, the Netherlands), and LVEF was calculated. An independent, second 
observer additionally performed manual tracing of endocardial contours, blinded to the 
results of the first observer, in order to establish interobserver agreement. For assessment 
of regional LV function, a 17-segment model was used (12). Each segment was assigned a 
wall motion score (WMS), with 1) normal wall motion; 2) hypokinesia; 3) akinesia; and 4) 
dyskinesia. Short axis views at 0% to 95% were presented in cine on a Linux workstation 
and regional LV function was evaluated by an experienced cardiologist. 
Echocardiography
Patients were imaged in the left lateral decubitus position using a commercially available 
system (Vingmed system Seven, General Electric-Vingmed, Milwaukee, Wisconsin, 
USA). Images were obtained using a 3.5-MHz transducer, at a depth of 16 cm in the 
parasternal and apical views (standard parasternal long- and short-axis, apical 2- and 4-
chamber images). The images were saved in cine loop format (triggered to the ECG). The 
LVEF was calculated from the conventional apical 2- and 4-chamber images, using the 
biplane Simpson’s technique and commercially available software (Echopac 6.1, General 
Electric - Vingmed) (13;14). For the evaluation of regional LV function, the same 17-
segment model was used as with MDCT, with a similar scoring system (scores 1 to 4, 
from normokinesia to dyskinesia). The echocardiography LV function assessment was 
performed by an experienced cardiologist, who was blinded to the results of MDCT. 
CMR
For CMR imaging a 1.5 T Gyroscan ACS-NT MR scanner (Philips Medical Systems, 
Best, the Netherlands), equipped with Powertrak 6000 gradients, a cardiac research 
software patch, and 5-element cardiac synergy coil was used. Gross cardiac anatomy 
was visualized by means of a scout scan. A SENSE reference scan was performed in 
order to use this application in the subsequent scans. A 2-chamber view was planned on 
the transversal scout and scanned by means of a breathhold, ECG-triggered, balanced 
fast field echo sequence. A 4-chamber view was then scanned using the 2-chamber view 
for planning. The short-axis view was scanned in 3 breathholds using the 2-chamber 
and 4-chamber views in end-systole and end-diastole for reference. MR parameters for 
the 2-chamber, 4-chamber, and short axis views were: TR/TE 3.6/1.8 ms, flip angle of 
50°, temporal resolution of 32 ms, field of view of 400 x 400 mm, data acquisition matrix 
of 256 x 256 mm, section thickness of 10 mm, scan duration of 26 heart beats. At short 
axis, 12 slices were acquired at 10 mm slice thickness. Image data were transferred to a 
personal computer and viewed using MASS Suite 6.0.6 (Medis, Leiden, the Netherlands). 
For global LV function analysis endocardial contours were manually traced, and LVEF 
was calculated by an experienced observer, who was blinded to the results of MDCT 
and echocardiography. For regional LV function analysis short axis views in cine were 
evaluated by an experienced cardiologist, who was blinded to the results of MDCT and 




Data is presented as mean ± standard deviation. Agreement between the imaging 
methods and observers was calculated as Pearson correlation and by means of Bland-
Altman analysis (15). The 95% limits of agreement were defined as the range of values ± 
2 SD from the mean difference. Agreement between methods on regional function was 
expressed as percentage and κ-value, in which κ-values <0.4, between 0.4 and 0.75, and 
>0.75 represented modest, fair to good, and excellent agreement, respectively. A p-value 
<0.05 was considered significant.
RESULTS
MDCT
A total of 25 patients were enrolled in the study. Patient characteristics are summarized 
in Table 8.1. Heart rate at MDCT scanning varied from 53 to 85 beats per minute (mean 64 
± 9 bpm). For all patients global and regional function could be assessed by MDCT. Mean 
LVEF was 48.9 ± 15.2% (range 15.4 to 73.5%). Interobserver agreement was excellent with 
a correlation coefficient (r) of 0.96, p<0.0001. At Bland-Altman analysis, the bias was 
1.8%, and 95% limits of agreement ranged between -6.7 and 10.3%. For regional function 
assessment, 425 segments were analyzed. A normal WMS was assigned to 325 segments, 
58 segments were hypokinetic, 30 segments akinetic, and 12 dyskinetic.
Echocardiography
All patients underwent 2-dimensional echocardiography. At echocardiography, the 
mean LVEF was 48.3 ± 15.1% (range 19 to 75%). All 425 segments could be analyzed; 325 
segments had normal wall motion, 50 were hypokinetic, 42 akinetic and 8 dyskinetic.
CMR
Eight of 25 patients gave informed consent for the CMR examination. Contra-indications 
for CMR existed for 9 patients, 8 patients refused to give informed consent. Mean LVEF 
derived from MR images was 56.7 ± 16.7% (range 28.4 to 77.6%). A total of 136 segments 
were analyzed for regional LV function assessment. Normal WMS was allocated to 104 
segments, 25 segments were hypokinetic, and 7 akinetic; none were dyskinetic.
Number of patients 25
Gender (M/F) 24/1
Age (years) 66.7 ± 9.4
Diabetes mellitus 8 (32%)
Currently smoking 3 (12%)
Hypertension 13 (52%)
Hypercholesterolemia 16 (64%)
Prior myocardial infarction 14 (56%)
Pacemaker or ICD 2 (8%)
Table 8.1 
 Patient Characteristics
 ICD = intracardiac defibrillator
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MDCT versus Echocardiography
For global LV function evaluation, the LVEF correlated well for MDCT and 
echocardiography. The trendline equalled y = 0.97x + 1.83, r = 0.96, p<0.0001 (Figure 8.1). 
At Bland-Altman analysis a bias of 0.54% was demonstrated, and 95% limits of agreement 
ranged from -7.7% to 8.8%. All data points stayed within 2 SD of the mean difference. For 
regional LV function assessment, MDCT agreed well with echocardiography in 91% of 
segments (κ = 0.78; Table 8.2).
Figure 8.1
 Correlation and Bland-Altman plot of LVEF by echocardiography and MDCT. 
 Identity line (y = x) is shown in the correlation plot in gray. 
 Echocardiography
 WMS 1 2 3 4 Total
 
 1 314 9 2 0 325
 2 10 39 9 0 58
MDCT 3 1 2 27 0 30
 4 0 0 4 8 12
 Total 325 50 42 8 425
Table 8.2 
 Agreement between MDCT and Echocardiography in Wall Motion Score
 Wall motion scores of 1 to 4 were assigned to the different segments: 1 = normal wall motion; 





 Correlation and Bland-Altman plot of LVEF by CMR and MDCT. Identity line (y = x) is shown 
in the correlation plot in gray.
 CMR
 WMS 1 2 3 4 Total
 1 102 4 0 0 106
 2 2 21 1 0 24
MDCT 3 0 0 6 0 6
 4 0 0 0 0 0
 Total 104 25 7 0 136
Table 8.3 
 Agreement between MDCT and CMR in Wall Motion Score 
 Wall motion scores of 1 to 4 were assigned to the different segments: 1 = normal wall motion; 
2 = hypokinesia; 3 = akinesia; 4 = dyskinesia. CMR = cardiovascular magnetic resonance; 
 WMS = wall motion score; MDCT = multidetector row computed tomography
MDCT versus CMR
A fair correlation of MDCT and CMR on LVEF calculation was shown, y = 0.72x + 14.3, 
r = 0.86, p<0.01. At Bland-Altman analysis, the bias for MDCT was -1.5%, with 95% 
limits of agreement ranging from -18.3% to 15.3% (Figure 8.2). At regional LV function 
assessment, MDCT agreed well with CMR in 95% of segments (κ = 0.86; Table 8.3).
DISCUSSION
In the present study, LV function measurements by 16-detector row CT were compared 
with echocardiography and CMR. The results demonstrate a good agreement between 
MDCT and echocardiography/CMR for the evaluation of LVEF and regional wall motion 
abnormalities. Moreover, interobserver agreement for LVEF assessment by MDCT was 
excellent. 
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LV Ejection Fraction with MDCT
Four-detector row CT has been shown to assess LVEF accurately. A comparison 
with echocardiography was performed in patients with unstable angina pectoris, 
demonstrating a good correlation (r = 0.93) and agreement (bias 1.3%) with MDCT for 
assessment of LVEF (10). Also, in comparison with cineventriculography, MDCT showed 
a fair correlation (r = 0.8) in the measurement of LVEF (8). In addition, Juergens et al. 
reported LVEF derived by MDCT to correlate and agree well (r = 0.89; bias 0.25%) with 
LVEF derived by CMR in patients with known or suspected coronary artery disease (9). 
In another direct comparison with CMR however, a significant underestimation in LVEF 
by MDCT (bias -8.5%) was shown (16). This underestimation may be related to the use 
of a standard image reconstruction algorithm, resulting in limited temporal resolution 
of MDCT (125-250 ms, heart rate dependent). Superior resolution can be obtained 
using multisegmental resolution (temporal resolution 75-130 ms), resulting in a better 
agreement between CMR and MDCT for assessment of LVEF (17).
In the present study, LVEF assessment by 16-detector row CT agreed well with both 
LVEF assessment by echocardiography (r = 0.96; bias 0.54%), and by CMR (r = 0.86; 
bias –1.5%). Moreover, for LVEF assessment by MDCT, the interobserver agreement was 
excellent (r = 0.96; bias 1.8%).
LV Wall Motion Analysis with MDCT
An early study compared single-detector row, ECG-gated CT with echocardiography and 
left ventriculography for assessment of regional wall motion (18). A good correlation with 
both echocardiography (86%), and left ventriculography (82%) was shown. Similarly, 
wall motion assessment by 4-detector row CT has been demonstrated to agree well 
with echocardiography (88%; κ = 0.84) (10). Also, good agreement between CMR and 
4-detector row CT for assessment of wall motion was shown (agreement 84% [κ = 0.56] 
when standard image reconstruction was used, and 93% [κ = 0.82] when multisegmental 
reconstruction was used) (17). The results of the current study show that 16-detector row 
MDCT agreed well with both echocardiography (91%; κ = 0.78) and CMR (95%; κ = 0.86) 
for assessment of regional wall motion.  
Why Another Modality for Assessment of LV Function?
Currently, several noninvasive imaging techniques are available for the assessment of LV 
function. The most frequently used technique in daily routine is 2D echocardiography, 
which is fast, easily accessible, and contains no radiation exposure (5;19). For patients with 
obesity, chronic obstructive pulmonary disease (COPD), or prior cardiothoracic surgery, 
echocardiography may be less optimal, due to poor acoustic windows (20). The current 
gold standard to evaluate LV function noninvasively is CMR (6;21). This technique is 
fast, and without radiation exposure. However, CMR is often not readily available, and 
comprises certain contra-indications, such as metal implants, irregular heart rhythm, and 
claustrophobia. SPECT imaging, traditionally used for assessment of perfusion, is yet 
another technique that (with the introduction of ECG gating) allows accurate assessment 
of global and regional LV function, but it exposes patients to radiation (7;22).
Similar to SPECT imaging, MDCT also requires exposure to radiation (7-8 mSv per cardiac 
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study), but allows examination of patients with a pacemaker or other metal implants, 
obesity, COPD, or prior cardiac surgery. With the growing interest in noninvasive 
angiography by MDCT (in particular with the 16-detector and higher detector row 
technology) (23;24), evaluation of function by MDCT is of value, since it can be obtained 
in the same session for noninvasive angiography, without the need for additional contrast 
or prolonged data acquisition. 
Limitations
A limited number of patients underwent CMR imaging, due to contra-indications or 
refusal of informed consent. Therefore, a larger direct comparison of 16-detector row CT 
and CMR in the evaluation of LV function is required to confirm the current findings. 
CONCLUSION
MDCT agreed well with both echocardiography and CMR in the assessment of global 
and regional LV function. Global and regional LV function may accurately be evaluated 
by 16-detector row CT (in the same session, without need for additional contrast), and 
can be added when noninvasive angiography with MDCT is performed.
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ABSTRACT
Background: Coronary angiography is considered the gold standard in evaluating 
vein graft disease; however, angiography does not allow assessment of hemodynamic 
consequences of lesions. In this study, hemodynamic consequences of significant stenoses 
in vein grafts were evaluated by Doppler velocity assessment, and results were compared 
with single-photon emission computed tomography (SPECT) perfusion imaging.
Methods and Results: Angiography was performed in 58 patients after coronary 
artery bypass grafting because of recurrent chest pain. During the procedure, Doppler 
velocity measurements were acquired before and after administration of adenosine. 
Of 58 patients (with 78 vein grafts), 20 patients (with 24 vein grafts) underwent SPECT 
perfusion imaging. 
Grafts were divided into those with non-significant percent diameter stenosis (<50%, n = 
49), and those with significant percent diameter stenosis (≥50%, n = 29). When a cut-off 
value for coronary flow velocity reserve (CFVR) of 1.8 was applied, modest agreement 
(69%, κ = 0.25, p<0.05) between CFVR and angiography was shown. Agreement between 
SPECT and angiography was also modest (63%, κ = 0.28, p = NS). SPECT and CFVR 
provided comparable information in 20 of 24 grafts with available SPECT, illustrating 
good agreement (83%, κ = 0.61, p = 0.001).  
Conclusions: Significant stenoses in vein grafts require further exploration to assess 
their hemodynamic significance. The Doppler velocity results agreed better with SPECT 






Determination of stenosis severity by coronary angiography is considered the gold 
standard for the assessment of obstructive coronary artery disease, but the hemodynamic 
significance of a stenosis cannot be derived from the coronary angiogram (1;2), and 
additional diagnostic testing is required. Invasively, the hemodynamic consequences 
can be determined by flow velocity measurements by use of the Doppler flow wire at 
rest and during hyperemia, as well as calculation of the coronary flow velocity reserve 
(CFVR) (3;4). This technique has been extensively explored in native coronary arteries 
(5-8), but studies in bypass grafts are limited. In vein grafts in particular, discordance 
between the angiographic severity of the stenosis and the hemodynamic consequences 
occurs (4).
Myocardial perfusion imaging with single-photon emission computed tomography 
(SPECT) is a noninvasive imaging technique that also allows evaluation of the 
hemodynamic significance of stenotic lesions in coronary arteries or bypass grafts 
(9;10). For clinical routine use, noninvasive testing may be preferred. However, direct 
comparisons between the invasive flow wire measurements and noninvasive SPECT 
imaging for assessment of the hemodynamic significance of lesions in patients with vein 
grafts are lacking. Accordingly, the aim of this study was to evaluate the relationship 
between angiographic stenosis severity and CFVR in a large number of vein grafts, as 
well as to perform a comparison between the Doppler flow wire and SPECT perfusion 
imaging to evaluate the hemodynamic consequences of stenoses in vein grafts. 
METHODS
Study Population
A total of 58 patients with a history of coronary artery bypass grafting (CABG) underwent 
coronary angiography because of recurrent chest pain. All underwent Doppler flow 
velocity measurements, and in 20 patients SPECT perfusion imaging was performed. 
The protocol was approved by the local medical ethics committee and informed consent 
was obtained from all patients.
Coronary Angiography and Doppler Flow Velocity Measurements
Routine coronary angiography procedures were performed; vascular access was obtained 
via the femoral approach. Doppler flow velocity measurements were performed in vein 
grafts only. A 0.014-inch Doppler guide wire (FloWire, Cardiometrics, Mountain View, 
CA) was advanced proximal into the graft and adjusted until a stable blood flow velocity 
signal was acquired (3;4). After the bolus injection of 18 μg adenosine directly into the graft, 
hyperemic velocity was measured (11). When velocity returned to baseline, measurements 
were repeated. When two baseline measurements differed by more than 10%, a third 
measurement was obtained and values were averaged. Doppler flow velocity measurements 
were previously validated by comparison with flow meters (12;13) and good reproducibility 
of measurements was demonstrated (14). 
Subsequently, angiography of the graft was performed according to the standard 
protocol. All percent diameter stenoses and percent area stenoses in either bypass graft 
or distal coronary arteries supplied by the graft were analyzed objectively by use of 
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quantitative coronary arteriography (QCA) by an independent core laboratory (Heart 
Core, Leiden, the Netherlands). If two or more stenoses were present in either graft or 
recipient vessels, the most severe lesion was considered the most flow limiting stenosis. 
Coronary bypass graft flow velocity was digitized offline by use of a computer with a 
custom-made software program. Digitized peak flow velocity from at least three cardiac 
cycles was averaged to calculate the average peak velocity (APV; cm/s), systolic peak 
velocity (SPV; cm/s), and diastolic peak velocity (DPV; cm/s) at baseline and during 
hyperemia by use of adenosine. CFVR was computed as the ratio of hyperemic to baseline 
APV, and diastolic-to-systolic velocity ratio (DSVR) as the ratio of DPV and SPV.
Gated SPECT Perfusion Imaging
For the gated SPECT examination, a 2-day stress-rest protocol was used (15). The stress 
protocol included a symptom-limited treadmill exercise test. Test endpoints were 
physical exhaustion, dyspnea, angina pectoris, significant decrease in blood pressure 
(>10 mmHg), or achievement of the maximum age-related heart rate. Technetium 99m 
tetrofosmin (500 MBq) was injected intravenously at peak exercise, which was continued 
for 1 minute after tracer injection. In patients unable to exercise (n = 10), adenosine stress 
was used. On the second day, resting images were obtained by use of 500 MBq Tc-99m 
tetrofosmin. The resting studies were acquired by use of electrocardiography gating, 
allowing assessment of left ventricular ejection fraction (LVEF) and left ventricular 
volumes (16). 
Imaging was performed with a triple-head SPECT camera system (GCA 9300/HG, Toshiba 
Corporation, Tokyo, Japan) equipped with low-energy, high-resolution collimators. 
A 20% window was used around the 140-keV energy-peak of Tc-99m tetrofosmin. A 
total of 90 projections (step-and-shoot mode, 35 s/projection, total imaging time of 23 
min) were obtained over a 360˚ circular orbit. Data were stored in a 64 x 64 matrix. The 
raw scintigraphic data were reconstructed by filtered backprojection via a Butterworth 
filter (cutoff frequency at 0.26 cycle/pixel; order 9). No attenuation correction was 
used. Reconstruction of the images yielded standard long- and short-axis projections 
perpendicular to the heart axis. Reconstructed slices were 6.4 mm in all projections. 
The short-axis slices were displayed in polar map format, adjusted for peak myocardial 
activity (100%). The myocardium was divided into 17 segments, as recently proposed 
(17). Segmental tracer activity was expressed as percentage of maximum. Perfusion 
defects on stress images were considered to be present when tracer activity was <75% of 
maximum tracer uptake. Mild to moderate defects were defined as having 50% to 75% of 
normalized tracer uptake and severe defects as having <50% of normalized tracer uptake. 
When significant fill-in (>10% increase of normalized tracer activity) of perfusion defects 
was observed on the resting images, segments were classified as reversible (ischemic); 
defects without fill-in were classified as irreversible (scar) (18). The individual segments 
on the SPECT images were assigned to the distinct native coronary arteries, according to 
recently published guidelines (17). The anastomoses of the bypass graft on the different 




Data are presented as mean ± SD. On the basis of QCA analysis, grafts were divided into two 
categories: those with nonsignificant percent diameter stenosis (<50%; n = 49), and those with 
significant percent diameter stenosis (≥50%; n = 29) in either graft or recipient vessel. Grafts 
were also divided into those with nonsignificant percent area stenosis (<80%; n = 52), and 
those with significant percent area stenosis (≥80%; n = 26). 
Mean Doppler parameters were compared by Student t-test. A previously reported cut-off 
value for CFVR of 1.8 was used to distinguish between normal and diseased grafts (19). 
Agreements between the diagnostic modalities were assessed by use of κ statistics, with a κ 
value <0.4, between 0.4 and 0.75, and >0.75 representing modest, fair to good, and excellent 
agreement, respectively. The association between CFVR and percent diameter stenosis, 
and between CFVR and percent area stenosis on angiography was also assessed by use of 
Pearson correlation. A p-value <0.05 was considered statistically significant.
RESULTS
Study Population
A total of 58 patients were included in the study. Patient characteristics are presented 
in Table 9.1. Coronary angiography and Doppler velocity assessment was performed in 
78 vein grafts. Mean time after CABG was 10.2 ± 5.2 years, ranging from 1 to 23 years. 
Bypass graft characteristics are shown in Table 9.2. The characteristics of the 20 patients 
who underwent SPECT imaging resembled those of the overall patient group. With 
regard to these 20 patients, the mean time after CABG was 10.3 ± 5.0 years, 30% of them 
had diabetes, and 60% were treated for hypertension. The time interval between the 
coronary angiography and SPECT imaging was 3.4 ± 2.8 months. No events happened 
between the examinations. 
Number of patients 58
Male/female 48/10
Age (years) 66.4 ± 8.7
Diabetes mellitus 13 (22%)
Currently smoking 5 (9%)
Hypertension 30 (52%)
Hypercholesterolemia 45 (78%)
Prior myocardial infarction in bypass graft region 22 (38%)
Time after CABG (years) 10.2 ± 5.2
Table 9.1 
 Patient Characteristics 
 CABG = coronary artery bypass grafting
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Number of bypass grafts  78
Single/sequential grafts 47/31
Vascular territory perfused by graft 
 LAD 26 (33%)
 LCX 29 (37%)
 RCA 23 (30%)
Percentage diameter stenosis (QCA) 40 ± 33%
 <50% 49
 ≥50% 29




 Bypass Graft Characteristics
 LAD = left anterior descending artery; LCX = left circumflex artery; RCA = right coronary 
artery
 
Coronary Angiography and Doppler Flow Velocity Measurements
In all 78 vein grafts coronary angiography was successfully performed. Stenosis severity, 
as measured by QCA, ranged from 0% to 100%, with a mean percent diameter stenosis of 
40 ± 33% and a mean percent area stenosis of 52 ± 39%. On the basis of the QCA results, 
grafts were divided into those with angiographically nonsignificant percent diameter 
and area stenoses and those with significant percent diameter and area stenosis (Table 
9.2).
Successful flow velocity signals were acquired in all bypass grafts. A biphasic flow 
velocity pattern, typical for vein grafts, was demonstrated in all 78 grafts. During Doppler 
velocity assessment, the heart rate and mean aortic pressure at baseline were 67 ± 12 
beats/min and 97 ± 15 mm Hg, respectively. After adenosine injection, heart rate and 
mean aortic pressure did not change significantly. Mean Doppler velocity parameters per 
category are displayed in Table 9.3. Baseline peak velocities did not show a statistically 
significant difference between the significantly and nonsignificantly stenosed vessels, 
except for DPV. Doppler peak velocities with adenosine stress demonstrated significantly 
decreased values at ≥50% diameter stenosis, and ≥80% area stenosis. Accordingly, CFVR 
was significantly decreased in ≥50% diameter stenosis, and  ≥80% area stenosis in vein 
grafts. These results are in concordance with those in previously reported studies on 
Doppler flow velocity in native coronary arteries (3;4).
Agreement between Coronary Angiography and Doppler Velocity
Percent diameter stenosis on angiography versus Doppler velocity
The individual data (except for 8 grafts with a total occlusion in the graft or recipient 
vessel) for CFVR as compared with percent diameter stenosis on angiography are shown 
in Figure 9.1 A. In all 70 grafts, CFVR ranged from 0.98 to 5.8. A moderate, inverse 
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correlation between percent diameter stenosis and CFVR existed (y = -0.0085x + 2.53; 
r = 0.30; p<0.05). In 49 grafts with <50% diameter stenosis, CFVR ranged from 1.4 to 5.8. In 
grafts with ≥50% stenosis, CFVR ranged from 0.98 to 3.4, demonstrating that percentage 
diameter stenosis on the coronary angiogram does not reliably reflect hemodynamic 
consequences of vein graft lesions. When the cut-off value for CFVR of 1.8 was applied, 
a modest agreement of 69% (κ = 0.25; p<0.05) between CFVR and percent diameter 
stenosis at coronary angiography was shown (Table 9.4). Disagreement between the two 
parameters was observed in 11 of 49 (22%) grafts with a stenosis <50%, and in 11 of 21 
(52%) grafts with a stenosis ≥50%. The distribution of CFVR in categories with increasing 
percent diameter stenosis is shown in Figure 9.2 A.
 <50% DS ≥50% DS <80% AS ≥80% AS
APV baseline (cm/s) 17.6 ± 9.2 14.4 ± 7.9 17.4 ± 9.3 14.6 ± 7.7
APV stress (cm/s) 38.6 ± 14.2 26.9 ± 12.8 † 37.8 ± 14.7 27.1 ± 12.4 §
CFVR 2.40 ± 0.79 1.99 ± 0.65 * 2.38 ± 0.77 1.97 ± 0.68 ‡
SPV baseline (cm/s) 13.7 ± 7.3 11.6 ± 7.3 13.4 ± 7.4 11.9 ± 7.2
SPV stress (cm/s) 29.9 ± 12.9 21.4 ± 10.1 † 29.3 ± 13.3 21.7 ± 9.2 §
DPV baseline (cm/s) 22.0 ± 12.4 16.5 ± 9.5 * 21.7 ± 12.4 16.6 ± 9.4 ‡
DPV stress (cm/s) 46.5 ± 17.0 30.9 ± 16.0 † 45.5 ± 17.4 31.1 ± 16.0 §
DSVR baseline 1.76 ± 0.77 1.76 ± 1.07 1.77 ± 0.75 1.73 ± 1.12
DSVR stress 1.67 ± 0.48 1.50 ± 0.57 1.68 ± 0.48 1.46 ± 0.56
Table 9.3 
 Mean Values of Flow Velocity Parameters
 * p<0.05; † p<0.01 versus <50% diameter stenosis; ‡ p<0.05; § p<0.01 versus <80% area 
stenosis; DS = diameter stenosis; AS = area stenosis; APV = average peak velocity; SPV = 
systolic peak velocity; DPV = diastolic peak velocity; CFVR = coronary flow velocity reserve; 
DSVR = diastolic-to-systolic velocity ratio
 
Doppler velocity Coronary angiography
 %DS <50% %DS ≥50% %AS <80% %AS ≥80%
CFVR ≥1.8  38 11 41 8
CFVR <1.8 11 10 11 10
Total 49 21 52 18
Table 9.4 
 Agreement between CFVR and Percent Diameter and Area Stenoses on Coronary Angiography
 Only patent grafts were included (n = 70). %DS = percent diameter stenosis;  %AS = percent 
area stenosis; CFVR = coronary flow velocity reserve
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Figure 9.1 
 Scatterplot of CFVR versus percent diameter stenosis (A), and versus percent area stenosis (B). 
Grafts without a total occlusion are included (n = 70). Regression line for CFVR versus percent 
diameter stenosis represents the following: y = -0.0085x + 2.53,  pearson regression coefficient r 
= 0.30, p<0.05. CFVR versus percent area stenosis yielded the following: y = -0.0085x + 2.52, r 
= 0.28, p<0.05. 
Figure 9.2 
 Distribution of CFVR (<1.8 versus ≥1.8) in grafts according to percent diameter stenosis (A), 
and percent area stenosis (B). 
Percent area stenosis on angiography versus Doppler velocity
A moderate correlation was also demonstrated between percent area stenosis and CFVR 
(y = -0.0058x + 2.52; r = 0.28; p<0.05, Figure 9.1 B). When the cut-off value for CFVR of 1.8 
for percent area stenosis of 80% were applied, a modestly improved agreement of 73% 
(κ = 0.33; p<0.01) as compared with percent diameter stenosis was shown. CFVR and 
percent area stenosis disagreed in 11 of 52 grafts (21%) with an area stenosis <80%, and in 
8 of 18 grafts (44%) with an area stenosis ≥80%. In categories with an increasing percent 
area stenosis, allocation of CFVR is depicted in Figure 9.2 B.
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Gated SPECT Perfusion Imaging
Gated SPECT in 20 patients demonstrated a mean LVEF of 54 ± 18% (range 24-85%). Mean 
left ventricular end-systolic and end-diastolic volumes were 66 ± 56 ml and 123 ± 70 ml, 
respectively. In the vascular territories supplied by 24 grafts, stress myocardial perfusion 
was normal in the territories allocated to 15 grafts, mildly to moderately reduced in 
territories of 4 grafts, and severely reduced in territories of 5 grafts. Rest perfusion was 
normal in 19 grafts, mildly to moderately reduced in 3 grafts, and severely reduced in 2 
grafts. Accordingly, perfusion was normal in the vascular territory of 15 grafts, ischemia 
was present in the territory of 6 grafts, while irreversible defects (indicating scar tissue) 
were present in the territory of 3 grafts.
Agreement between Coronary Angiography and SPECT
Percent diameter stenosis on angiography versus SPECT
A modest agreement of 63% (15 of 24 grafts; κ = 0.28; p = 0.13) was demonstrated 
between SPECT and percent diameter stenoses on coronary angiography (Table 9.5). 
SPECT perfusion and percent diameter stenosis did not agree in 2 of 10 grafts (20%) with 
nonsignificant stenosis, and in 7 of 14 grafts (50%) with significant stenosis. 
  Coronary angiography  
SPECT %DS <50% %DS ≥50% %AS <80% %AS ≥80%
Normal perfusion 8 7 10 5
Abnormal perfusion 2 7 2 7
Total 10 14 12 12
Table 9.5 
 Agreement between SPECT Perfusion and Coronary Angiography
 Only grafts with available SPECT (n = 24) were included. %DS = percent diameter stenosis; 
%AS = percent area stenosis; SPECT = single-photon emission computed tomography
 
  Doppler velocity 
SPECT CFVR ≥1.8 CFVR <1.8 Total
Normal perfusion 15 0 15
Abnormal perfusion 4 5 9
Total 19 5 24
Table 9.6 
 Agreement between CFVR and SPECT Perfusion 
 Only grafts with available SPECT (n = 24) were included. SPECT = single-photon emission 
computed tomography; CFVR = coronary flow velocity reserve
Hemodynamic evaluation of vein grafts
136
Percent area stenosis on angiography versus SPECT
SPECT and percent area stenoses showed fair agreement (17 of 24 grafts; 71%), when area 
stenoses <80% and ≥80% were considered nonsignificant or significant (κ = 0.42; p<0.05). 
Disagreement between SPECT and percent area stenosis occurred in 2 of 12 (17%) grafts 
with an area stenosis <80%, and in 5 of 12 grafts (42%) with an area stenosis ≥80%.  
 
Agreement between Doppler Velocity and SPECT
In 15 of the 15 grafts (100%) with normal perfusion on SPECT, CFVR was ≥1.8 (Table 9.6). 
Conversely, in 5 of 9 grafts (56%) with abnormal perfusion on SPECT, CFVR showed a 
value <1.8. SPECT and Doppler velocity provided similar information in 20 of 24 grafts 
(83%; κ = 0.61), illustrating good agreement between SPECT and CFVR (p = 0.001).  
Because the influence of scar tissue on CFVR is unpredictable, agreement between 
SPECT and CFVR was also established after exclusion of 3 grafts showing an irreversible 
perfusion defect. Of these 3 grafts, one had a CFVR <1.8, and 2 grafts had a CFVR >1.8. 
Agreement then improved to 90% (19 of 21 grafts; κ = 0.74). 
DISCUSSION
In this study the hemodynamic consequences of angiographically significant stenoses 
in vein grafts were explored by Doppler flow velocity assessment and SPECT perfusion 
imaging. The nonsignificant percent diameter stenoses on angiography showed a reduced 
CFVR in 22% and an abnormal SPECT study in 20%, indicating that these stenoses 
were hemodynamically significant. Alternatively, the angiographically significant 
percent diameter stenoses exhibited a normal CFVR in 52% and a normal SPECT in 
50%, indicating that these stenoses were hemodynamically nonsignificant. In addition, 
agreements between angiography and CFVR or SPECT were only modest. Accordingly, 
the results demonstrate that the angiographic stenosis severity did not correctly reflect 
the presence or absence of hemodynamic consequences in vein grafts, indicating the 
need for additional testing to assess the hemodynamic significance of the angiographic 
findings. CFVR agreed better with SPECT perfusion imaging than with percent diameter 
stenosis, suggesting that CFVR may also be used to assess the hemodynamic significance 
of a vein graft lesion.
Doppler Flow Velocity Assessment in Vein Grafts
In early studies the coronary flow reserve (CFR) was introduced in order to evaluate the 
physiology of coronary artery stenoses, visualized at angiography (20;21). At that time, 
absolute coronary blood flow could only be measured by perivascular flow transducers 
in “open chest” procedures. CFR was therefore validated in animal models and patients 
undergoing open heart surgery (1;20;22), though clinical use remained limited. When the 
diameter of intravascular catheter-based Doppler ultrasound devices could be reduced 
to 0.018 inch, measurement of flow velocity and CFVR in coronary arteries in patients 
during catheterization was realized. Absolute blood flow correlated well with Doppler-
derived flow velocity both in vitro and in vivo (12;13;23). Thereafter the value of Doppler 
CFVR was extensively researched in native coronary arteries (4;8;24;25). However, 
studies focusing on the use of Doppler measurements in vein grafts are limited. In our 
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study, the mean resting flow (APV) was not different in the grafts with ≥50% diameter 
stenosis (or ≥80% area stenosis) or without a significant stenosis on angiography, 
confirming that resting flow frequently remains normal despite the presence of stenoses, 
as demonstrated previously for native coronary arteries (3;20). However, the mean 
CFVR was significantly lower in the grafts with a significant stenosis on angiography 
(Table 9.3). Still, only a moderate inverse correlation was demonstrated for CFVR and 
quantitative analysis of the coronary angiogram (r = 0.30 for percent diameter stenosis; r 
= 0.28 for percent area stenosis) with a wide range for CFVR in both nonsignificant and 
significant stenoses. Indeed, when individual data were analyzed, many grafts with an 
angiographically significant stenosis had preserved CFVR and some grafts without a 
significant stenosis had reduced CFVR indicating the relative inability to determine the 
hemodynamic significance from angiography alone.
Value of SPECT Perfusion Imaging
SPECT perfusion imaging is a well-established technique by which to detect obstructive 
coronary artery disease by evaluating regional myocardial perfusion at rest and during 
stress. Excellent sensitivities and specificities of SPECT to detect stenoses in native 
coronary arteries were demonstrated (9;18;26). In addition, studies evaluating patients 
after CABG with SPECT showed good results for the assessment of graft disease. In 
50 patients with 119 bypass grafts a sensitivity of  80% with a specificity of 87% for 
the detection of >50% stenosis have been reported (10). In another study 88 grafts were 
studied late after surgery (4.0 ± 1.2 years) by SPECT, and a comparable sensitivity and 
specificity (83% and 88%, respectively) for the detection of >50% stenosis were shown 
(27). 
However, the agreement between SPECT and angiography is not perfect (5). In this 
study SPECT perfusion imaging agreed moderately with percent diameter stenosis 
(63%; κ = 0.28; p = NS). In particular, 20% of nonsignificant stenoses on angiography had 
abnormal SPECT perfusion results, and 50% of the angiographically significant stenoses 
had normal SPECT results. 
 
Agreement between Doppler CFVR and SPECT
More recently, for SPECT imaging the emphasis has shifted from detection of coronary 
artery disease to hemodynamic evaluation of stenoses. Comparative studies between 
SPECT imaging and Doppler assessment have been performed, demonstrating a good 
agreement (ranging from 72% to 96%) between these two techniques for the assessment 
of the hemodynamic consequence of an intermediate native coronary artery stenosis 
(5;19;28-30). In these studies, the cut-off value for CFVR to predict an abnormal SPECT 
study varied from 1.7 to 2.0. The best concordance (96%) between between Doppler 
assessment and SPECT imaging was obtained when a cut-off value for CFVR of 1.8 was 
used (19). 
Studies evaluating the hemodynamic consequences of bypass graft lesions are lacking. 
In this study, good agreement between Doppler assessment (with the use of the cut-off 
value of 1.8 for CFVR) and SPECT imaging was demonstrated in vein grafts (83%; κ = 
0.61; p = 0.001), suggesting that both SPECT imaging and CFVR assessment may be used 
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to characterize the hemodynamic consequences of vein graft stenoses. The agreement 
increased to 90% (κ = 0.74) when grafts subtending an area with infarcted tissue were 
excluded. In these regions SPECT findings are abnormal (irreversible defects), whereas 
CFVR may be preserved, if an intact graft subtends a partially infarcted region.
Clinical Implications
Vein graft disease occurs frequently after CABG, affecting 48% of grafts at 5 years and 
81% at ≥15 years (31). Still, revascularization after initial CABG is required in 19% of 
patients by 10 years (32). Our study shows that coronary angiography alone, currently 
widely used as gold standard, does not reliably reflect the hemodynamic consequences 
of stenoses in vein grafts. Thus further assessment of stenoses in vein grafts or recipient 
vessels is required. This study suggests that either SPECT perfusion imaging or CFVR 
assessment may be used to characterize the hemodynamic consequence of a vein graft 
lesion.
Limitations
SPECT perfusion imaging was not available in all patients who underwent coronary 
angiography with Doppler velocity measurements. For logistical reasons, this was only 
performed in 20 patients; in particular, the number of graft-related region with ischemia 
was small. However, the characteristics of the patients who underwent SPECT imaging 
resembled those of the entire population. 
No attenuation correction was performed with SPECT imaging, and therefore, some 
SPECT perfusion defects with normal CFVR may have been caused by attenuation.
Pressure measurements were not performed. The fractional flow reserve can be calculated 
as the ratio of distal coronary and aortic pressure during maximal hyperemia (33). Large 
studies investigating the fractional flow reserve in vein or arterial grafts are lacking.
CONCLUSION
Significant stenoses in vein grafts require further exploration to assess their hemodynamic 
significance. The Doppler velocity results agreed better with SPECT perfusion imaging 
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Defining the “gold standard”: A changing paradigm
Ami E. Iskandrian
J Nucl Cardiol 2005; 12, 5, 520-522
At the inception of nuclear cardiology, the accuracy of perfusion (planar and single-
photon emission computed tomography [SPECT]) and function (first-pass and gated 
equilibrium radionuclide angiography) was assessed against percent diameter stenosis 
(DS) by coronary angiography, a tradition that has changed very little over the past three 
decades and has spilled over to other imaging methods such as stress two-dimensional 
echocardiography and magnetic resonance (1). The foundation for such an approach 
was deeply rooted on the elegant work by Gould et al (2;3) showing a decline in the 
hyperemic coronary blood flow at approximately 50% DS of a coronary vessel in the 
animal model. Scores of articles using this threshold have not only shown that imaging 
works but, in the process, have reinforced the validity of DS as a measure of stenosis 
severity (1).
Then came the revelations that DS did not agree well with physiologic severity of 
stenosis when the latter was assessed by catheter-based techniques or by positron 
emission tomography. The pioneer work of many groups, notably those from the same 
institution as the authors of the current article in the Journal (4), showed a significant 
scatter between measures of physiologic severity (flow velocity reserve ratio, fractional 
flow reserve, and stenosis resistance) with DS, even when measured quantitatively by 
state-of-the-art methods (4-10). 
These results, as important as they are, are not unexpected, as coronary atherosclerosis 
in humans differs from ligature-induced stenosis in animal models in multiple ways. 
These include the presence of diffuse disease and differences in diameter of the vessel, 
length of stenosis, entrance and exit stenosis angles, location, serial lesions, endothelial 
dysfunction, microvascular dysfunction, vasomotion, and collaterals. It is intuitive to 
conclude that, if there is discordance between catheter-based physiologic measures of 
coronary stenosis and DS, then there must also be discordance between DS and imaging 
methods that reflect the physiologic relevance of stenosis severity, such as gated SPECT 
perfusion imaging. Such a confirmation has been previously reached in native coronary 




Obviously, with SPECT perfusion imaging, several factors affect regional myocardial 
tracer concentration in addition to myocardial blood flow (MBF) or, more precisely, 
myocardial blood volume. These include the changes in first-pass extraction fraction in 
relation to flow (which is tracer-dependent and has considerable species and individual 
differences), type of stress, type of imaging protocol, relative changes in MBF in 
relation to changes in cardiac output, myocardial viability, tracer kinetics, metabolic 
alterations, attenuation, scatter, and depth resolution (1). The differences in regional 
tracer concentration reflect relative flow differences rather than absolute or hyperemic 
MBF (relative flow reserve ratio [peak/resting flow] in culprit lesion compared with a 
normal zone). Given this complexity in the interrelationship between MBF and tracer 
concentration, it is not unexpected that imaging could not identify all coronary lesions 
or all patients with coronary lesions by coronary angiography. Experience has taught us 
another valuable lesson: interventions (such as statin therapy or conventional antianginal 
medications) that have little effect on DS could remarkably alter the perfusion results.
One final point worth mentioning is that catheter-based methods for assessing stenosis 
severity do not provide information on the area of myocardium at risk. Studies during 
stress, during rest, or with temporary balloon occlusion at the time of angioplasty have 
consistently shown a wide variability between coronary angiography and the area of 
ischemic myocardium or size of myocardial infarction (1). It would seem that those who 
try hard to show a perfect correlation between DS and imaging are indeed missing the 
point that a perfect correlation is neither logical nor expected and the beauty of imaging 
is the fact that it provides independent and complementary information to coronary 
angiography. And thank goodness for that; otherwise, it would have merely provided 
redundant information (11). These features of perfusion imaging explain very well why 
and how SPECT imaging works so well in risk assessment. Our challenges are to better 
understand the mechanisms of why few patients with left-main or three-vessel disease 
show no reversible perfusion abnormalities, to determine how to define ischemia in 
regions with prior partial-thickness infarcts, and to keep the pressure on industry about 
our needs for perfusion tracers with improved physical and biologic kinetics.
With regard to patients with prior coronary revascularization, both percutaneous 
coronary interventions and CABG have witnessed major changes in the past decade. 
The number of percutaneous coronary intervention procedures now exceeds those with 
CABG, and those patients referred to CABG are likely to be sicker, with more advanced 
disease and poorer target vessels. This shift is important to keep in mind, as American 
College of Cardiology/American Heart Association guidelines cite studies from a much 
earlier time with a different patient mix. It is not unusual now to see patients with 
recurrent symptoms at one year or earlier after CABG, and the five-year honeymoon 
period cited in these guidelines may apply to fewer patients (12-14).
In this issue of the Journal, Salm et al (4) examined the correlation between DS, Doppler 
flow velocity (78 grafts in 58 patients), and SPECT results (24 grafts in 20 patients) in 
patients after CABG. On the basis of 50% DS and a flow velocity reserve ratio of 1.8, 
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there was only a modest correlation between DS and reserve ratio or between SPECT 
and DS (4). However, SPECT and reserve ratios provided comparable data in 20 of 24 
grafts (83%). This study therefore extends the concepts gained in patients with native 
coronary stenosis to those with graft lesions. There are a few features of the study worth 
mentioning. First, this must have been an unusual group of patients who had CABG 
because there were only 1.2 grafts per patient among those who had SPECT imaging. 
Second, the use of 50% DS by the group who defamed this measurement appears to be 
interesting especially in vein grafts, which are known to be of larger diameter than native 
vessels. Third, we do not know from this study how to interpret the data in patients with 
more grafts and more severe disease such as stenosis in a graft to one branch of the left 
circumflex artery but no disease in a second branch, or vice versa (or any similar scenario 
in a different vascular bed). Fourth, we have no information on flow velocity reserve ratio 
in a control vessel for reasons discussed previously (perfusion pattern reflects relative 
rather than absolute flow reserve ratio). Finally, we do not know whether the adenosine 
dose was optimal in all grafts in all locations to produce a maximal response.
Nevertheless, the importance of this study rests on the need for a constant reminder that 
DS should be abandoned as a gold standard and future studies should use physiologic 
measures of coronary stenosis, which unfortunately are invasive and not that easy to 
perform by less expert individuals than those in the current study. This should not, 
however, be a green light signal that any discordance between SPECT and coronary 
angiography, which is still the most widely available method, should be explained 
by limitations of coronary angiography in every patient. The truth is probably that no 
single method has a monopoly on how to define the “gold standard” of ischemia, but 
at least there has been a shift in the paradigm and SPECT results are not always made 
the scapegoat (false positive or false negative). This observation did not go unnoticed 
by the Food and Drug Administration, which now does not insist on using coronary 





1. Iskandrian AE, Verani MS. Nuclear cardiac imaging principles and applications (3rd ed), Oxford University 
Press, New York 2003.
2. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis. Instantaneous 
flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. 
Am J Cardiol 1974;33:87–94.
3. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am 
Coll Cardiol 1990;15:459–474.
4. Salm LP, Bax JJ, Jukema JW, et al. Hemodynamic evaluation of saphenous vein coronary artery bypass grafts 
relative merits of Doppler flow velocity and SPECT perfusion imaging. J Nucl Cardiol 2005;12:545–552.
5. Serruys PW, De Bruyne B, Carlier S, et al. Randomized comparison of primary stenting and provisional 
balloon angioplasty guided by flow velocity measurement. Doppler Endpoints Balloon Angioplasty Trial 
Europe (DEBATE) II Study Group. Circulation 2000;102:2930–2937.
6. Albertal M, Regar E, Van Langenhove G, et al. Value of coronary stenotic flow velocity acceleration in 
prediction of angiographic restenosis following balloon angioplasty. Eur Heart J 2002;23:1849–1853.
7. Kern MJ. Coronary physiology revisited practical insights from the cardiac catheterization laboratory. 
Circulation 2000;101:1344–1351.
8. Pijls NHJ, Van Son JAM, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum 
coronary, myocardial and collateral blood flow by pressure measurements for assessing functional stenosis 
severity before and after PTCA. Circulation 1993;87:1354–1367.
9. Piek JJ, Van Liebergen RAM, Koch KT, Peters RJ, David GK. Clinical, angiographic and hemodynamic 
predictors of recruitable collateral flow assessed during balloon angioplasty coronary occlusion. J Am Coll 
Cardiol 1997;29:275–282.
10. Heller LI, Cates C, Popma J, et al. Intracoronary Doppler assessment of moderate coronary artery disease: 
comparison with 201Tl imaging and coronary angiography. FACTS Study Group, Circulation 1997;96:484–490.
11. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol 2004;11:171–185.
12. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients 
with chronic stable angina—summary article a report of the American College of Cardiology/American 
Heart Association Task Force on practice guidelines (Committee on the Management of Patients With 
Chronic Stable Angina). J Am Coll Cardiol 2003;41:159–168.
13. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary 
article: a report of the American College of Cardiology/American Heart Association Task Force on Practice 
Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002;106:1883–1892.
14. Cardiac radionuclide imaging. ACC/AHA/ASNC 2003 guideline update for the clinical use. Available from: 








Summary and future perspectives
150
INTRODUCTION
Coronary artery bypass grafting (CABG) is a commonly performed surgical procedure 
for alleviation of symptoms and prolonging survival for patients with coronary heart 
disease (CHD). Bypass graft disease is a common consequence, requiring coronary 
angiography for diagnosis. Coronary angiography is an invasive procedure that 
includes arterial puncture, x-ray exposition, and hospitalization. Complications include 
ventricular arrhythmias, myocardial infarction, cardiac perforation, necessary emergency 
CABG, and death, even though the risks are small. A noninvasive diagnostic method for 
the assessment of bypass graft anatomy and function is of great benefit. The aim of the 
thesis is to describe multiple modalities to examine coronary artery bypass grafts, and 
to further develop noninvasive imaging techniques to detect stenoses in native coronary 
arteries and bypass grafts in patients who experienced recurrent chest pain after CABG. 
Part I of this thesis (Chapters 1 and 2) reviews the research that has been performed in 
evaluating bypass grafts noninvasively using cardiovascular magnetic resonance (CMR) 
and computed tomography in earlier studies.
PART II  CARDIOVASCULAR MAGNETIC RESONANCE
This part of the thesis focuses on CMR flow velocity imaging in vein and arterial grafts. 
The aim of the study, described in Chapter 3, was to retrospectively test two previously 
described analysis methods of CMR flow measurements, and to compare their 
diagnostic accuracy in detecting diseased vein grafts. In 125 vein grafts of 68 patients 
volume flow parameters (volume flow, systolic and diastolic peak flow, diastolic-to-
systolic flow ratio at rest and during adenosine stress, and flow reserve) were derived 
from the CMR velocity maps. Method 1 implemented basal flow <20 ml/min or flow 
reserve <2, yielding a sensitivity and specificity of 70% and 38% in the detection of a 
diseased graft or recipient vessel. Method 2 used receiver operating characteristic (ROC) 
curve analysis and implemented all significant volume flow parameters in a logistic 
regression model, yielding a sensitivity of 74% with a specificity of 68% in the detection 
of a diseased graft or recipient vessel. Evaluating single and sequential grafts separately, 
this method yielded a sensitivity and specificity of 79% and 87% for single grafts, and 
62% and 94% for sequential grafts in the detection of ≥50% stenosis in grafts or recipient 
vessels. Using ROC curve analysis with logistic regression the specificity of the analysis 
method improved considerably. Best results were acquired when single and sequential 
grafts were separately analyzed.
In Chapter 4, two analysis methods for the CMR flow velocity maps, i.e. velocity and 
volumetric flow, are compared using flow velocity maps of vein grafts. Forty-nine patients 
with previous bypass surgery underwent coronary angiography and CMR with flow 
velocity measurements of single vein bypass grafts. Volume flow and velocity analysis of 
the CMR velocity maps was performed and compared. Bland-Altman analysis showed 
close agreement between both analyses. Comparison of ROC areas-under-the-curve of 
both analyses revealed no significant differences for detection of stenoses ≥70%. Diagnostic 
accuracy for volume flow and velocity parameters was 92% and 93%, respectively. 
Velocity analysis appears to be the method of preference, because this approach is less 
time-consuming and has a similar diagnostic accuracy as volume flow analysis.
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The hemodynamic significance of a bypass graft stenosis may not always accurately 
be determined from a coronary angiogram. A variety of diagnostic tests (invasive or 
noninvasive) are available to further characterize the hemodynamic consequence of a 
lesion. The objective of the study, presented in Chapter 5, was to perform a head-to-head 
comparison between single photon emission computed tomography (SPECT) perfusion 
imaging and CMR to evaluate hemodynamic significance of angiographic findings 
in bypass grafts. Fifty-seven arterial and vein grafts in 25 patients were evaluated by 
angiography, SPECT perfusion imaging, and coronary flow velocity reserve determination 
by CMR. Based on angiography and SPECT, 4 different groups could be identified: 1) no 
significant stenosis (<50%), normal perfusion; 2) significant stenosis (≥50%), abnormal 
perfusion; 3) significant stenosis, normal perfusion (no hemodynamic significance); 
and 4) no significant stenosis, abnormal perfusion (suggesting microvascular disease). 
Complete evaluation was obtained in 46 grafts. SPECT and CMR provided similar 
information in 37 of 46 (80%) grafts, illustrating good agreement (κ = 0.61, p<0.001). Eight 
grafts perfused a territory with scar tissue. When agreement between SPECT and CMR 
was restricted to grafts without scar tissue, it improved to 84% (κ = 0.68). Integration of 
angiography with SPECT categorized 14 lesions in group 1; 23 in group 2; 6 in group 3; 
and 3 in group 4. SPECT and CMR agreement per group was 86%, 78%, 100% and 33%, 
respectively. Head-to-head comparison showed good agreement between SPECT and 
CMR for functional evaluation of bypass grafts. CMR may offer an alternative method to 
SPECT for functional characterization of angiographic lesions.
In Chapter 6, a novel CMR phase-contrast sequence to measure flow velocity in arterial 
and vein grafts is introduced. The purpose of the study was to validate a CMR high-
resolution, phase-contrast sequence for quantifying flow in small and large vessels, 
and to demonstrate its feasibility to measure flow in bypass grafts. A breathhold, echo 
planar imaging (EPI) sequence was developed and validated in a flow phantom using 
a fast field echo (FFE) sequence as reference. In 17 healthy volunteers aortic flow was 
measured using both sequences. In 5 patients flow in the left internal mammary artery 
(LIMA) graft and aorta was measured at rest and during adenosine stress, and coronary 
flow reserve (CFR) was calculated; in 7 patients vein graft flow velocity was measured. 
When using the flow pump, the EPI sequence yielded an excellent correlation with the 
FFE sequence (r = 0.99; p<0.001 for all parameters). In healthy volunteers, aortic volume 
flow correlated well (r = 0.88; p<0.01). In patients, mean LIMA CFR was 2.70 ± 0.88 for 
nonstenosed grafts. Percentage LIMA flow of cardiac output was 0.71 ± 0.17% at rest, 
and 1.56 ± 0.52% during adenosine stress (p<0.01). For nonstenosed single vein grafts, 
mean average peak velocity was 11.6 ± 2.4 cm/s. The high-resolution, breathhold CMR 
velocity-encoded sequence correlated well with a free-breathing, FFE sequence. Using 
the EPI sequence, it is feasible to measure flow velocity in both LIMA and vein grafts, 
and in the aorta.  
PART III  COMPUTED TOMOGRAPHY
Part III of the thesis concentrates on multidetector row computed tomography (MDCT) 
imaging of coronary artery bypass grafts. In Chapter 7, a comprehensive assessment by 
16-detector row CT of patients after CABG is investigated. MDCT is a versatile modality to 
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evaluate stenoses in native coronary arteries and bypass grafts. Acquired MDCT data can 
additionally be used to assess left ventricular ejection fraction (LVEF). The purpose was to 
use MDCT for the assessment of bypass graft and coronary artery disease combined with 
evaluation of LVEF. Twenty-five patients underwent 16-detector-row CT examination and 
coronary angiography. Bypass grafts and nongrafted coronary artery segments at MDCT 
were evaluated on eligibility, patency and ≥50% stenosis. The MDCT data set was used 
to calculate LVEF and was divided into patients with no/subendocardial/transmural 
myocardial infarctions. Ninety vessels were evaluated: 14 arterial grafts, 53 vein grafts, 
and 23 nongrafted vessels. Of 225 segments, 17 were ineligible for evaluation because of 
metal clips. With MDCT, patency in segments of arterial grafts/vein grafts/nongrafted 
vessels could be evaluated with high accuracy in 100%/100%/97% of segments. In 
arterial grafts stenoses ≥50% did not occur at angiography, which was for all eligible 
segments correctly diagnosed with MDCT. Stenosis ≥50% could be correctly detected 
by MDCT with a sensitivity/specificity of 100%/94% for vein grafts, and 100%/89% 
for nongrafted vessels. Negative predictive value (NPV) was 100% for vein grafts and 
nongrafted vessels. In patients with transmural myocardial infarction, MDCT revealed 
a significant lower LVEF as compared with patients without or with subendocardial 
myocardial infarction (p<0.05). Comprehensive assessment of bypass grafts, nongrafted 
vessels, and LVEF is feasible with MDCT. Owing to the high NPV, this noninvasive 
approach may be used as gatekeeper before coronary angiography.
In order to evaluate MDCT accuracy, the aim of the study portrayed in Chapter 8, 
was to compare MDCT global and regional left ventricular (LV) function assessment 
with echocardiography and CMR. In 25 patients, who were referred for noninvasive 
angiography with 16-detector row CT, LV function assessment was also performed. 
A subsequent echocardiogram was performed, and in a subgroup of patients, CMR 
examination was completed to evaluate LV function. For global function assessment, 
LVEF was calculated. Regional LV function was scored using a 17-segment model and a 
4–point scoring system. MDCT agreed well with echocardiography for the assessment of 
LVEF (r = 0.96; bias 0.54%; p<0.0001), and regional LV function (κ = 0.78). Eight patients 
had no contra-indications and gave informed consent for CMR examination. A fair 
correlation between MDCT and CMR was demonstrated in the assessment of LVEF (r 
= 0.86; bias –1.5%; p<0.01). Regional LV function agreement between MDCT and CMR 
was good (κ = 0.86). MDCT agreed well with both echocardiography and CMR in the 
assessment of global and regional LV function. Global and regional LV function may 
accurately be evaluated by 16-detector row CT, and can be added to a routine CT image 
analysis protocol without need for additional contrast or imaging time.
PART IV  SPECT AND DOPPLER FLOW VELOCITY
Part IV focuses on the hemodynamic consequences of vein graft lesions. Coronary 
angiography is considered the gold standard in evaluating vein graft disease. However, 
angiography does not allow assessment of hemodynamic consequences of lesions. In 
the study presented in Chapter 9, hemodynamic consequences of significant stenoses 
in vein grafts were evaluated by Doppler velocity assessment, and results were 
compared with SPECT perfusion imaging. Coronary angiography was performed in 58 
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patients after CABG because of recurrent chest pain. During the procedure, Doppler 
velocity measurements were acquired before and after administration of adenosine. 
Of 58 patients (with 78 vein grafts), 20 patients (with 24 vein grafts) underwent SPECT 
perfusion imaging. Grafts were divided into those with nonsignificant percent diameter 
stenosis (<50%, n = 49), and those with significant percent diameter stenosis (≥50%, n = 
29). When a cut-off value for coronary flow velocity reserve (CFVR) of 1.8 was applied, 
modest agreement (69%, κ = 0.25, p<0.05) between CFVR and angiography was shown. 
Agreement between SPECT and angiography was also modest (63%, κ = 0.28, p = NS). 
SPECT and CFVR provided comparable information in 20 of 24 grafts with available 
SPECT, illustrating good agreement (83%, κ = 0.61, p = 0.001). Significant stenoses in vein 
grafts require further exploration to assess their hemodynamic significance. The Doppler 
velocity results agreed better with SPECT perfusion imaging than with percent diameter 
stenosis in the evaluation of vein graft function.
CONSIDERATIONS AND FUTURE PERSPECTIVES
This thesis aimed to describe multiple modalities to examine coronary artery bypass 
grafts, and to further develop noninvasive imaging techniques to detect stenoses in 
native coronary arteries and bypass grafts in patients who experienced recurrent chest 
pain after CABG. 
Several considerations must be regarded when examining patients after CABG by 
(non)invasive imaging modalities. To image bypass grafts is technically demanding for 
the different imaging modalities. Small vessels around the heart are constantly moving 
throughout the cardiac cycle. The temporal resolution of an imaging technique must be 
sufficient to avoid blurring in the acquired image. 
The course of arterial grafts, inserting at the subclavian artery, is extensive and requires 
a large acquisition window for a single scan in e.g. CMR or CT angiography. 
Spatial resolution must be adequate to depict narrowings in the small vessels. The 
diameter of bypass grafts is generally slightly larger than the diameter of native coronary 
arteries. However, for clinical use in diagnosing coronary heart disease a full examination 
of bypass grafts, recipient vessels and native coronary arteries is required in order to 
identify a target lesion for revascularization. Studies only focusing on bypass grafts are 
merely a first step in shaping the modality for eventual clinical use.   
The physiologic consequences of CABG on the heart’s vascularization are complex. In 
addition, when a stenosis in a bypass graft is visualized by any imaging modality, it 
may not have hemodynamic consequences. Due to e.g. competitive flow from a native 
coronary artery, a collateral circulation or a sufficient blood flow passing the stenosis, 
the myocardial region supplied by the graft may still function adequately. Conversely, 
absence of a stenosis does not necessarily imply that the graft performs well. Diffuse 
atherosclerosis in a graft may not show a focal lesion, but can still impair graft function. 
This emphasizes the importance of analyzing myocardial function in addition to bypass 
graft angiography. 
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X-ray coronary angiography is still widely used to diagnose bypass graft disease. Despite 
its disadvantages, it is a rapid test and most centers have experienced operating physicians. 
Noninvasive imaging should focus on further developing a gatekeeper function prior 
to x-ray coronary angiography. Future studies may focus on safely deferring patients 
that show no abnormalities. Conversely, patients diagnosed with progressive CHD may 
directly be referred for percutaneous intervention or (re-)CABG. At present, this is not 
common clinical practice since noninvasive tests lack a 100% specificity and NPV. Ideally, 
a noninvasive test should match the following criteria: a full anatomical examination of 
native coronary arteries, bypass grafts and recipient vessels, and analysis of myocardial 
function in one single test with 100% specificity and NPV, not being too time-consuming 
or a large burden for the patient, holding only minor complications, lacking the necessity 
for radiation exposure, and bearing low costs. Such a test does not exist, but different 
imaging modalities show great potential and are constantly being improved. 
Recently, developments in CMR angiography showed an improvement in diagnostic 
accuracy in detecting CHD using 3D whole-heart angiography with volume rendering 
in comparison with x-ray coronary angiography (1). Sensitivity, specificity, positive 
predictive value (PPV) and NPV in the detection of CHD were 82%, 91%, 78%, and 
93%, respectively. Visualized length of the major coronary arteries held up to 12.8 ± 3.4 
cm. Time to perform the total examination was shortened to less than 30 minutes. With 
the introduction of next-generation 3 Tesla MR scanners an significant advancement in 
signal-to-noise and contrast-to-noise ratio was established in comparison with 1.5 Tesla 
MR scanners (2). However, image quality and diagnostic accuracy in detecting stenoses 
in coronary arteries were similar. Future studies should focus on analyzing bypass grafts 
in addition to native coronary arteries using the latest CMR angiography techniques. 
CMR angiography may also be added to a functional MR study. A recent feasibility 
study presented a CMR protocol which included first-pass myocardial perfusion at 
rest, a myocardial viability analysis using delayed enhancement, and angiography of 
the proximal and middle coronary artery segments, with a total imaging time of 30-45 
minutes (3). CMR first-pass myocardial perfusion in a rest-stress protocol was shown 
to accurately detect CHD in comparison with SPECT myocardial perfusion imaging 
(4). These studies did not explicitly include patients with bypass grafts. Specifically in 
this patient group it is important to demonstrate that functional CMR examinations are 
feasible and yield similar diagnostic accuracies, as patients tend to be older, often present 
with more extensive heart disease or are unable to sustain an obligatory breathhold. 
High-dose dobutamine-atropine stress CMR with wall motion analysis was shown to 
provide a reliable examination after percutaneous intervention or CABG for patients 
suspected of having CHD (5). No CMR angiography was added to this protocol. 
Flow velocity measurements by CMR at rest and during stress are feasible for both vein 
and arterial grafts, and yield a good diagnostic accuracy in detecting vein graft disease, 
as described in this thesis. In earlier studies was demonstrated that CMR flow velocity 
measurements were also feasible in native coronary arteries (6-8). However, no one has 
succeeded in providing a complete flow velocity examination of all native coronary 
arteries and bypass grafts by CMR, thereby limiting its clinical use. 
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MDCT is another robust noninvasive modality in detecting or excluding stenoses in 
coronary arteries and bypass grafts, and combining a limited functional study of the 
myocardium in one scan is feasible. A comparative study between state-of-the-art CMR 
and CT angiography showed that both techniques yielded a similar high diagnostic 
accuracy (77% versus 80%, p = NS) in identification of coronary artery disease (9). The 
next-generation CT scanners contain 64 detectors for image acquisition, which is a factor 
4 higher than the last generation. Initial results demonstrate an excellent image quality, 
and display a high overall sensitivity, specificity, PPV, and NPV of 94%, 97%, 87%, and 
99%, respectively (10). Bypass grafts have not yet been investigated by 64-detector row 
CT. Functional examinations with MDCT are restricted to global LV function assessment 
and wall motion analysis at rest. Since patients’ radiation exposure is high using MDCT 
imaging, a second scan under pharmacological stress is impracticable.  
Gated SPECT myocardial perfusion imaging is the most established noninvasive imaging 
technique that is used as a gatekeeper prior to x-ray coronary angiography (11). Still, 
diagnostic accuracy in detecting or excluding coronary artery or bypass graft disease by 
this technique is not powerful enough, especially in obese patients, patients with poor 
LV function, or women. Furthermore, SPECT perfusion imaging does not provide data 
on coronary artery or bypass graft anatomy. Myocardial positron emission tomography 
(PET) imaging allows perfusion and viability imaging with low radiation exposure and 
high efficiency (12). Latest developments in PET-hardware include hybrid PET/CT-
scanners which have the power to provide a functional examination of the myocardium, 
and an anatomical delineation of native coronary arteries. Preliminary results promise 
great clinical potential in the detection of CHD (13). A rest/adenosine-stress protocol 
for PET/CT scanning was performed. Reported sensitivity, specificity, PPV, and NPV 
of PET/CT were 90%, 98%, 82%, and 99%, respectively, versus PET in combination with 
x-ray coronary angiography for clinical decision-making. Estimated radiation exposure 
using this technique was 10-12 mSv, whereas MDCT scanning alone holds a similar 8-
12 mSv, and a rest/stress SPECT imaging protocol 7 mSv (14). Using this technique it 
may become achievable to refer patients directly for percutaneous intervention or CABG 
without the mandatory diagnostic x-ray coronary angiography (15). Patients with bypass 
grafts have not yet been evaluated using this modality. Future studies will further specify 
the clinical capabilities of this technique.
In conclusion, noninvasive imaging modalities have shown great potential in detecting 
or excluding CHD in patients who experienced recurrent chest pain after CABG. New 
developments in the field of cardiovascular MR, MDCT and nuclear imaging are 
promising. Extended scientific effort may result in integrating diagnostic noninvasive 
imaging further in daily clinical practice. 
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Omleiding- of bypasschirurgie is een vaak uitgevoerde operatie voor het verlichten 
van ziekteverschijnselen en het verbeteren van overleving voor patiënten met angina 
pectoris. Atherosclerose van de coronaire omleidingen is een vaak voorkomend gevolg, 
dat middels hartcatheterisatie moet worden gediagnosticeerd. Hartcatheterisatie is 
echter een invasieve procedure, waarvoor het aanprikken van een slagader, blootstelling 
aan röntgenstraling en dagopname in het ziekenhuis nodig is. Complicaties houden 
in kamerritmestoornissen, hartinfarct, perforatie van het hart, noodbypassoperatie en 
cardiale dood, hoewel de risico’s hierop klein zijn. Een niet-invasieve diagnostische 
procedure voor het analyseren van anatomie en functie van de coronaire omleidingen 
zou een groot voordeel bieden. Het doel van dit proefschrift is het beschrijven van 
verschillende modaliteiten om coronaire omleidingen te analyseren en het verder 
ontwikkelen van niet-invasieve beeldvormingtechnieken om vernauwingen in natieve 
coronaire arteriën en omleidingen te detecteren in patiënten met terugkerende pijn op 
de borst na een bypassoperatie. Deel I van dit proefschrift (Hoofdstukken 1 en 2) geeft 
een overzicht van het onderzoek dat eerder is verricht naar het niet-invasief evalueren 
van coronaire omleidingen middels cardiovasculaire magnetische resonantie (CMR) en 
computertomografie. 
DEEL II  CARDIOVASCULAIRE MAGNETISCHE RESONANTIE
Dit deel van het proefschrift concentreert zich op bloedstroomsnelheidmetingen 
van veneuze en arteriële omleidingen middels CMR. Het doel van het onderzoek, 
beschreven in Hoofdstuk 3, was het retrospectief testen van twee eerder beschreven 
analyse methoden van bloedstroommetingen via CMR en het vergelijken van hun 
diagnostische nauwkeurigheid in het aantonen van zieke veneuze omleidingen. In 125 
veneuze omleidingen van 68 patiënten werden bloedstroommetingparameters (totale 
volume flow, systolische en diastolische piekstroom, diastolisch-naar-systolische flow 
ratio in rust en gedurende adenosine stress, en flow reserve) afgeleid van de CMR stro
omsnelheidafbeeldingen. Methode 1 implementeerde een basale volume flow <20 ml/
min of een flow reserve <2, welke een sensitiviteit van 70% en een specificiteit 38% in 
het aantonen van een zieke omleiding of ontvangend vat inhield. Methode 2 gebruikte 
“receiver operating characteristic” (ROC) curve analyse en implementeerde alle 
significante bloedstroommetingparameters in een logistisch regressie model, welke een 
sensitiviteit van 74% en een specificiteit van 68% in het aantonen van een zieke omleiding 
of ontvangend vat inhield. Wanneer enkelvoudige en meervoudige omleidingen apart 
werden geanalyseerd, had deze methode een sensitiviteit en specificiteit van 79% en 
87% voor enkelvoudige omleidingen en 62% en 94% voor meervoudige omleidingen 
in het aantonen van ≥50% stenose in omleidingen of ontvangend vaten. Wanneer ROC 
curve analyse met logistische regressie werd gebruikt, verbeterde de specificiteit van 
de methode aanzienlijk. Als enkelvoudige en meervoudige omleidingen apart werden 
geanalyseerd, werden de beste resultaten bereikt.
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In Hoofdstuk 4 werden twee verschillende analyse methoden voor de stroomsnelheid
afbeeldingen verkregen via CMR, namelijk volume flow en stroomsnelheidmetingen, 
vergeleken. Stroomsnelheidafbeeldingen van veneuze omleidingen werden hiervoor 
gebruikt. Negenenveertig patiënten met een bypassoperatie in hun voorgeschiedenis 
ondergingen hartcatheterisatie en CMR met het afbeelden van de bloedstroomsnelheid 
van enkelvoudige veneuze omleidingen. Volume flow en snelheidsmetingen van de 
afbeeldingen werden uitgevoerd en vergeleken. Bland-Altman analyse liet een goede 
overeenkomst tussen de analyses zien. Vergelijking van ROC oppervlakten-onder-de-
curve van de beide analyses toonde geen significante verschillen voor het detecteren 
van ≥70% stenose aan. Diagnostische nauwkeurigheid van de volume flow en 
snelheidsparameters was respectievelijk 92% en 93%. De stroomsnelheidanalyse lijkt de 
methode van voorkeur, want deze aanpak kost minder tijd en heeft een vergelijkbare 
diagnostische nauwkeurigheid als de volume flow analyse.
De hemodynamische significantie van een vernauwing in een omleiding kan niet altijd 
nauwkeurig middels hartcatheterisatie worden bepaald. Een keur aan diagnostische 
onderzoeken (invasief danwel niet-invasief) zijn beschikbaar om de hemodynamische 
consequentie van een laesie te karakteriseren. De opzet van het onderzoek, gepresenteerd 
in Hoofdstuk 5, was het uitvoeren van een directe vergelijking tussen “single-photon 
emissie computertomografie” (SPECT) perfusie afbeeldingen en CMR in het evalueren 
van de hemodynamische significantie van angiografische bevindingen in omleidingen. 
Zevenenvijftig arteriële en veneuze omleidingen in 25 patiënten werden middels 
coronaire angiografie, SPECT perfusiemeting van het myocard, en CMR flow reserve 
bepaling geëvalueerd. Gebaseerd op coronaire angiografie en SPECT konden 4 groepen 
worden onderscheiden: 1) geen significante stenose (<50%), normale perfusie; 2) 
significante stenose (≥50%), abnormale perfusie; 3) significante stenose, normale perfusie 
(geen hemodynamische significantie); en 4) geen significante stenose, abnormale perfusie 
(microvasculaire aandoening van het myocard suggererend). Een volledige evaluatie 
werd in 46 omleidingen verkregen. SPECT en CMR verschaften vergelijkbare informatie 
in 37 van de 46 (80%) omleidingen, wat een goede overeenkomst (κ = 0.61, p<0.001) 
aanduidde. Acht omleidingen perfundeerden een myocardgebied met littekenweefsel. 
Wanneer de overeenkomst tussen SPECT en CMR tot omleidingen zonder littekenweefsel 
in hun perfusiegebied werd beperkt, verbeterde het tot 84% (κ = 0.68). Integratie van 
coronaire angiografie met SPECT deelde 14 laesies in groep 1 in, 23 in groep 2, 6 in groep 
3 en 3 in groep 4. De overeenkomst tussen SPECT en CMR per groep was respectievelijk 
86%, 78%, 100% en 33%. Directe vergelijking toonde goede overeenstemming aan tussen 
SPECT en CMR voor de functionele evaluatie van omleidingen. CMR zou een alternatief 
voor SPECT voor de functionele karakterisering van angiografische laesies kunnen 
bieden. 
In Hoofdstuk 6 wordt een nieuwe CMR sequentie om de doorstroming in arteriële en 
veneuze omleidingen te meten geïntroduceerd. Het doel van de studie was om een 
hoog resolutie, fasecontrast CMR sequentie te valideren in het meten van doorstroming 
in grote en kleine vaten en om aan te tonen dat deze sequentie tevens geschikt is om 
doorstroming in omleidingen te meten. Een “echo planar imaging” (EPI) sequentie 
werd ontwikkeld en middels een fantoom gevalideerd tegen een “fast field echo” (FFE) 
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sequentie. In 17 gezonde vrijwilligers werd de doorstroming van de aorta gemeten 
middels beide sequenties. In 5 patiënten werd de doorstroming in de linker arteriële 
omleiding en aorta gemeten in rust en gedurende adenosine stress en werd de flow 
reserve berekend; in 7 patiënten werd de doorstromingssnelheid in veneuze omleidingen 
gemeten. Voor het fantoom had de EPI sequentie een uitstekende correlatie met de FFE 
sequentie (r = 0.99; p<0.001 voor alle parameters). Voor de gezonde vrijwilligers was er 
een goede correlatie voor de aortadoorstroming (r = 0.88; p<0.01). Voor de patiënten was 
de gemiddelde flow reserve van de arteriële omleidingen zonder stenosen 2.70 ± 0.88. 
Percentage doorstroming van de arteriële omleidingen van het hartdebiet was 0.71 ± 
0.17% in rust en 1.56 ± 0.52% gedurende adenosine stress (p<0.01). Voor enkelvoudige 
veneuze omleidingen zonder vernauwingen was de gemiddelde pieksnelheid 11.6 ± 2.4 
cm/s. De hoog resolutie CMR snelheidsgeëncodeerde sequentie correleerde goed met de 
referentie sequentie. De EPI sequentie is geschikt om doorstroming te meten in arteriële 
en veneuze omleidingen en de aorta. 
DEEL III  COMPUTERTOMOGRAFIE
Deel III van het proefschrift richt zich op multidetector computertomografie (MDCT) 
van omleidingen. In Hoofdstuk 7 wordt een uitgebreide 16-detector MDCT evaluatie 
van patiënten na een omleidingoperatie onderzocht. MDCT is een veelzijdige modaliteit 
om vernauwingen in natieve coronaire arteriën en omleidingen te beoordelen. Met 
de verworven MDCT data kan tevens de linker kamer ejectiefractie (LVEF) worden 
bepaald. Het doel was om MDCT te gebruiken voor de evaluatie van omleidingen en 
natieve coronaire arteriën, gecombineerd met de bepaling van de LVEF. Vijfentwintig 
patiënten ondergingen een 16-detector CT onderzoek en coronaire angiografie. Op de CT-
afbeeldingen werden omleidingen en niet-gegrafte coronaire segmenten op geschiktheid 
voor evaluatie, doorgankelijkheid en ≥50% stenose onderzocht. De LVEF werd bepaald 
uit de MDCT data sets en de resultaten werden in patiënten met geen/subendocardiale/
transmurale myocardinfarcten opgesplitst. Negentig vaten zijn onderzocht: 14 arteriële 
omleidingen, 53 veneuze omleidingen en 23 niet-gegrafte arteriën. Van de 225 segmenten 
waren 17 segmenten niet geschikt voor evaluatie vanwege metalen clips. Met MDCT 
kon de doorgankelijkheid van de segmenten van arteriële omleidingen/veneuze 
omleidingen/niet-gegrafte arteriën met hoge nauwkeurigheid worden geëvalueerd, in 
respectievelijk 100%/100%/97% van de segmenten. In de arteriële omleidingen werden 
geen stenosen van ≥50% gezien bij angiografie, wat voor alle geschikte segmenten 
correct met MDCT werd gediagnosticeerd. Vernauwingen ≥50% konden correct met 
MDCT worden gedetecteerd met een sensitiviteit/specificiteit van 100%/94% voor 
veneuze omleidingen en 100%/89% voor niet-gegrafte arteriën. Negatief voorspellende 
waarde was 100% voor veneuze omleidingen en niet-gegrafte arteriën. Bij patiënten 
met een transmuraal myocardinfarct werd een significant lagere LVEF waargenomen 
in vergelijking tot patiënten zonder infarct of met een subendocardiaal infarct (p<0.05). 
Een uitgebreide evaluatie van omleidingen, niet-gegrafte arteriën en LVEF is mogelijk 
met MDCT. Vanwege de hoge negatief voorspellende waarde zou deze niet-invasieve 
benadering als een poortwachter voor de coronaire angiografie kunnen dienen. 
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Om de nauwkeurigheid van MDCT te evalueren was het doel van de studie, beschreven 
in Hoofdstuk 8, het vergelijken van een MDCT onderzoek van globale en regionale 
linker ventrikel (LV) functie met echocardiografie en CMR. In 25 patiënten, die voor 
een niet-invasieve 16-detector CT angiografie waren verwezen, werd tevens een LV 
functie reconstructie vervaardigd. Vervolgens werd een echocardiogram gemaakt en 
in een subgroep patiënten een CMR onderzoek om de LV functie te bepalen. Voor de 
globale functie evaluatie werd de LVEF berekend. Regionale LV functie werd middels 
een 17-segmentmodel en een 4-puntscoringsysteem gescoord. MDCT vertoonde goede 
overeenstemming met echocardiografie in de bepaling van LVEF (r = 0.96; bias 0.54%; 
p<0.0001) en regionale LV functie (κ = 0.78). Acht patiënten hadden geen contra-
indicaties en gaven toestemming voor een CMR onderzoek. Een redelijk goede correlatie 
tussen MDCT en CMR in de evaluatie van LVEF werd aangetoond (r = 0.86; bias –1.5%; 
p<0.01). Voor regionale LV functie liet MDCT een goede overeenstemming met CMR 
zien (κ = 0.86). MDCT kwam goed overeen met zowel echocardiografie als CMR in de 
evaluatie van globale en regionale LV functie. Globale en regionale LV functie kunnen 
nauwkeurig met 16-detector CT worden bepaald en kunnen aan een routine CT analyse 
protocol worden toegevoegd zonder dat extra contrast of onderzoekstijd nodig is.    
DEEL IV  SPECT EN DOPPLER STROOMSNELHEID
Deel IV richt zich op de hemodynamische consequenties van vernauwingen in veneuze 
omleidingen. Hartcatheterisatie wordt beschouwd als de gouden standaard in het 
evalueren van vernauwingen in veneuze omleidingen. De hartcatheterisatie geeft 
echter geen uitsluitsel over de hemodynamische consequenties van de vernauwingen. 
In de studie gepresenteerd in Hoofdstuk 9 werden de hemodynamische consequenties 
van significante stenosen in veneuze omleidingen met Doppler stroomsnelheidmetingen 
geëvalueerd en de resultaten vergeleken met SPECT perfusie beeldvorming. 
Hartcatheterisatie werd in 58 patiënten na bypassoperatie uitgevoerd vanwege 
terugkerende pijn op de borst. Gedurende de procedure werden Doppler 
stroomsnelheidmetingen voor en na toediening van adenosine verkregen. Van de 58 
patiënten (met 78 veneuze omleidingen) ondergingen 20 patiënten (met 24 omleidingen) 
SPECT perfusie beeldvorming. Omleidingen werden ingedeeld in diegenen met een 
niet-significant percentage diameter stenose (<50%, n = 49) en diegenen met een 
significant percentage diameter stenose (≥50%, n = 29). Wanneer voor coronaire 
flow velocity reserve (CFVR) een afbreekpunt van 1.8 werd toegepast, werd een 
matige overeenstemming (69%, κ = 0.25, p<0.05) tussen CFVR en angiografie gezien. 
Overeenstemming tussen SPECT en angiografie was tevens matig (63%, κ = 0.28, p = NS). 
SPECT en CFVR verschaften vergelijkbare informatie in 20 van de 24 omleidingen met 
een beschikbare SPECT, wat een goede overeenkomst aangaf (83%, κ = 0.61, p = 0.001). 
Significante vernauwingen in veneuze omleidingen vereisen verdere exploratie naar 
hun hemodynamische significantie. Het resultaat van Doppler stroomsnelheidmetingen 
kwam beter overeen met SPECT perfusie beeldvorming dan met percentage diameter 




Dit proefschrift had tot doel het beschrijven van verschillende modaliteiten in het 
onderzoeken van omleidingen en het ontwikkelen van niet-invasieve technieken om 
vernauwingen in natieve coronaire arteriën en omleidingen te detecteren bij patiënten 
met terugkerende pijn op de borst na bypasschirurgie. 
Een aantal overwegingen moeten worden genoemd als patiënten na bypasschirurgie 
met (niet-)invasieve modaliteiten worden onderzocht. Het afbeelden van omleidingen 
vraagt veel van de techniek van de verschillende afbeeldingmodaliteiten. Kleine vaten 
rond het hart zijn gedurende de hartcyclus constant aan het bewegen. De temporele 
resolutie van een afbeeldingtechniek moet toereikend genoeg zijn om vaagheid van het 
verkregen beeld te vermijden.  
Het verloop van arteriële omleidingen met hun insertie in de arteria subclavia is 
langgerekt en heeft een groot “acquisition window” voor een enkele scan nodig in 
bijvoorbeeld CMR of CT angiografie.  
Spatiële resolutie moet adequaat zijn om vernauwingen in de kleine vaten af te beelden. 
De diameter van omleidingen is over het algemeen iets wijder dan de diameter 
van natieve coronaire arteriën. Voor gebruik in de kliniek bij het diagnosticeren van 
ischemische hartziekten is echter een volledig onderzoek van omleidingen, ontvangende 
vaten en natieve coronaire arteriën nodig om een target laesie voor revascularisatie te 
identificeren. Studies die zich alleen op omleidingen richten zijn slechts een eerste stap 
in het vormen van de modaliteit voor zijn uiteindelijke gebruik in de kliniek. 
De fysiologische consequenties van een bypassoperatie op de doorbloeding van het hart 
zijn complex. Als bovendien een stenose in een omleiding middels een afbeeldingmodaliteit 
wordt gevisualiseerd, hoeft het geen hemodynamische consequenties te hebben. Door 
bijvoorbeeld competitieve doorstroming van een natieve coronaire arterie, een collaterale 
circulatie of voldoende stroming langs een stenose kan het gedeelte van het myocard, 
dat door de omleiding van bloed wordt voorzien, nog steeds adequaat functioneren. 
Tegengesteld hieraan hoeft afwezigheid van een stenose niet te impliceren dat een 
omleiding goed werkt. Diffuse atherosclerose in een omleiding hoeft geen focale laesie 
te laten zien, maar kan wel de functie van de omleiding aantasten. Dit benadrukt het 
belang om hartfunctie naast angiografie van de omleidingen te analyseren. 
Hartcatheterisatie met coronairangiografie wordt nog veelvuldig gebruikt om zieke 
omleidingen te diagnosticeren. Ondanks de nadelen is het een snel onderzoek en de 
meeste centra hebben ervaren specialisten in dienst. Niet-invasieve beeldvorming zou 
zich moeten richten op het verder ontwikkelen van een poortwachterfunctie vóór de 
hartcatheterisatie. Vervolgstudies zouden zich kunnen richten op het veilig verwijzen van 
patiënten die geen afwijkingen laten zien. Tegengesteld hieraan zouden patiënten waarbij 
progressieve ischemische hartziekte wordt vastgesteld meteen voor percutane interventie 
of (re)bypasschirurgie kunnen worden doorverwezen. Nu is dit niet gewoonlijk in de 
klinische praktijk, omdat niet-invasieve onderzoeken een 100% specificiteit en negatief 
voorspellende waarde missen. Idealiter zou een niet-invasieve test aan de volgende 
criteria moeten voldoen: een volledig anatomisch onderzoek van natieve coronaire 
arteriën, omleidingen en ontvangende vaten én analyse van hartfunctie in één enkele 
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test met 100% specificiteit en negatief voorspellende waarde, niet te tijdrovend of een te 
grote belasting voor de patiënt, slechts kleine complicaties met zich meebrengend, geen 
blootstelling aan straling nodig en niet te duur. Zo’n onderzoek bestaat niet, maar de 
verschillende afbeeldingmodaliteiten zijn veelbelovend en worden constant verbeterd. 
Recent hebben ontwikkelingen in CMR angiografie een verbetering in de diagnostische 
nauwkeurigheid in het aantonen van ischemische hartziekten laten zien, gebruikmakend 
van 3D “whole-heart” angiografie met volume rendering in vergelijking met 
hartcatheterisatie (1). Sensitiviteit, specificiteit, positief en negatief voorspellende waarde 
in het aantonen van ischemische hartziekte waren respectievelijk 82%, 91%, 78%, en 
93%. Gevisualiseerde lengte van de hoofdkransslagaders was 12.8 ± 3.4 cm. Tijdsduur 
van het totale onderzoek was ingekort tot minder dan 30 minuten. Met de introductie 
van de volgende generatie 3 Tesla MR scanners werden significante verbeteringen 
in signaal-ruis en contrast-ruis ratio in vergelijking tot 1.5 Tesla MR scanners bereikt 
(2). Beeldkwaliteit en diagnostische nauwkeurigheid in het aantonen van stenosen in 
coronaire arteriën waren echter gelijk. Studies zouden zich verder moeten richten op het 
analyseren van omleidingen naast natieve coronaire arteriën, gebruikmakend van de 
laatste CMR angiografie technieken. 
CMR angiografie kan ook aan een functioneel MR-onderzoek worden toegevoegd. 
Een recente studie presenteerde een uitvoerbaar CMR protocol, dat bestond uit een 
myocardperfusie en -viability analyse middels “delayed enhancement” én angiografie 
van de proximale en middelste segmenten van de hoofdkransslagaders met een totale 
onderzoeksduur van 30-45 minuten (3). CMR myocardperfusie in een rust-stress 
protocol kon nauwkeurig een ischemische hartziekte aantonen in vergelijking tot SPECT 
myocardperfusie beeldvorming (4). Deze studies hadden niet expliciet patiënten met 
omleidingen geïncludeerd. Specifiek in deze patiëntengroep is het belangrijk aan te 
tonen dat functionele CMR onderzoeken uitvoerbaar zijn en dezelfde diagnostische 
nauwkeurigheid omvatten, omdat patiënten vaak ouder zijn, met meer uitgebreide 
hartziekte zich presenteren of de noodzakelijke ademinhouding niet kunnen volhouden. 
Hooggedoseerde dobutamine-atropine stress CMR met wandbeweginganalyse verschafte 
een betrouwbaar onderzoek na percutane interventie of bypasschirurgie bij patiënten 
die werden verdacht een ischemische hartziekte te hebben (5). Geen CMR angiografie 
was aan dit protocol toegevoegd.
Doorstromingsmetingen middels CMR in rust en gedurende stress zijn uitvoerbaar 
voor zowel veneuze als arteriële omleidingen en hebben een goede diagnostische 
nauwkeurigheid in het aantonen van zieke veneuze omleidingen, zoals in dit proefschrift 
wordt beschreven. In eerdere studies is aangetoond dat CMR doorstromingsmetingen 
ook uitvoerbaar zijn in natieve coronaire arteriën (6-8). Niemand is het echter gelukt een 
compleet doorstromingsonderzoek van alle natieve coronaire arteriën en omleidingen 
middels CMR uit te voeren, daarmee zijn klinische toepassing beperkend.   
MDCT is een andere robuuste, niet-invasieve modaliteit in het aantonen of uitsluiten 
van stenosen in coronaire arteriën en omleidingen en het combineren van een beperkt 
functieonderzoek van het myocard is mogelijk in één scan. Een vergelijkende studie 
tussen hoogstaande CMR en CT angiografie liet zien dat beide technieken een zelfde 
hoge diagnostische nauwkeurigheid (77% versus 80%, p = NS) in het aanwijzen van 
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een ischemische hartziekte bezitten (9). De volgende generatie CT-scanners hebben 64 
detectoren voor het construeren van een afbeelding, wat een factor 4 hoger is dan de 
vorige generatie. Initiële resultaten geven een uitstekende beeldkwaliteit weer en laten 
algeheel een hoge sensitiviteit, specificiteit, positief en negatief voorspellende waarde 
van respectievelijk 94%, 97%, 87% en 99% zien (10). Omleidingen zijn nog niet met 64-
detector CT onderzocht. Functioneel onderzoek middels MDCT is beperkt tot globale 
LV functie evaluatie en wandbewegingsstoornissen in rust. Aangezien de röntgenstrali
ngsbelasting van de patiënt hoog is met MDCT beeldvorming, is een tweede scan onder 
farmacologische stress onuitvoerbaar. 
Gated SPECT myocardperfusie beeldvorming is de meest gevestigde niet-invasieve 
techniek, die als poortwachter voor de hartcatheterisatie wordt gebruikt (11). Toch is 
de diagnostische nauwkeurigheid in het aantonen of uitsluiten van een ischemische 
hartziekte middels deze techniek niet krachtig genoeg, specifiek bij obese patiënten, 
patiënten met een slechte LV functie of vrouwen. Voorts verschaft SPECT perfusie 
beeldvorming geen data over de anatomie van coronaire arteriën of omleidingen. Met 
myocard positron emissie tomografie (PET) beeldvorming kunnen perfusie- en viability-
afbeeldingen met een lage stralingsbelasting en een hoge efficiëntie worden verkregen 
(12). De laatste ontwikkeling in PET-apparatuur omvat hybride PET/CT-scanners, 
die een functioneel onderzoek van het myocard en een anatomische uitlijning van de 
natieve coronaire arteriën kunnen combineren. De eerste resultaten zijn veelbelovend 
in het aantonen van een ischemische hartziekte (13). Een rust/adenosine-stress 
protocol voor PET/CT werd uitgevoerd. Gemelde sensitiviteit, specificiteit, positief en 
negatief voorspellende waarde van PET/CT waren respectievelijk 90%, 98%, 82% en 
99%, versus PET in combinatie met hartcatheterisatie voor klinische besluitvorming. 
Geschatte stralingsbelasting middels deze techniek was 10-12 mSv, terwijl alleen MDCT 
een vergelijkbare 8-12 mSv inhield en een rust/stress SPECT beeldvormingprotocol 
7 mSv (14). Met deze techniek zou het haalbaar kunnen worden om patiënten direct 
voor percutane interventie of bypasschirurgie te verwijzen zonder de noodzakelijke 
diagnostische hartcatheterisatie (15). Patiënten met omleidingen zijn nog niet onderzocht 
middels deze modaliteit. Toekomstige studies zullen de klinische capaciteiten van deze 
techniek verder specificeren. 
Concluderend hebben niet-invasieve beeldvormingmodaliteiten veelbelovende resultaten 
laten zien in het aantonen of uitsluiten van een ischemische hartziekte in patiënten 
met terugkerende pijn op de borst na bypasschirurgie. Nieuwe ontwikkelingen op het 
terrein van de cardiovasculaire MR, MDCT en nucleaire beeldvorming zijn hoopvol. 
Voortgaande wetenschappelijke inspanning kan resulteren in het nader integreren van 
diagnostische, niet-invasieve beeldvorming in de dagelijkse, klinische praktijk. 
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Figure 2.1, Chapter 2, Page 20 
 Typical magnetic resonance (MR) acquisition protocol. (A) Typical plan-scan for cardiovascular 
magnetic resonance (CMR) angiography. Axial imaging volume (horizontal lines); volume 
used for localized shimming (large box); position in the right hemidiaphragm of the respiratory 
navigator (rectangular box); position of a saturation band for suppression of image artifacts (left 
box). (B) With the use of axial scout images, the three-point plan-scan is used to select three 
points in space, one at the origin of the coronary artery or bypass graft, one at the most distal 
point, and one in the middle of the first two points. From this information, an imaging plane is 
automatically calculated in plane with the coronary artery or bypass graft of interest. (C) CMR 
angiography of a patient with a bypass of the left coronary system (white arrow) and a visible 
native right coronary artery (black arrow). This imaging approach can be used clinically to 
assess bypass graft patency. AO = aorta; LV = left ventricle. (Courtesy of H.J. Lamb)
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Figure 2.2, Chapter 2, Page 21 
 Whole-heart CMR angiography of a vein bypass graft to the right coronary artery at different 
rotation angles. (Courtesy of Dr. H. Sakuma)
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Figure 2.8, Chapter 2, Page 31
 For the evaluation of MSCT angiograms, several imaging displays can be used. (A) Original 
axial slice. (B) Curved multiplanar reconstruction of a vein graft. (C) Maximum intensity 
projection of an arterial graft. (D) For an overview of the coronary arteries and bypass grafts, 
3D volume-rendered reconstructions can be useful.
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Figure 7.1, Chapter 7, Page 104
 Example of an arterial and a vein graft. A, a 3D reconstruction of the heart and vessels. The 
white arrows highlight a left internal mammary artery graft to the left anterior descending 
artery from its left subclavian artery origin to the anastomosis. B, after the anastomosis 
the recipient vessel is occluded, also illustrated as multiplanar reformat reconstruction. 
The asterisk represents a vein graft to the posterior descending branch (anastomosis not shown). 
The native RCA is severely diseased. Ao = aorta; RCA = right coronary artery; LV = left ventricle; 
PA = pulmonary artery
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Figure 7.2, Chapter 7, Page 105 
 Example of a patient with multiple vein grafts. A, a 3D reconstruction of the heart, revealing 
4 grafts (white arrows). Two patent grafts supply the obtuse marginal branch and the second 
diagonal branch, respectively; 2 grafts are totally occluded. Lateral from the graft origins, metal 
clips have been placed for identifying the graft locations (white arrowhead marks one of the 
clips). The vein graft to the second diagonal branch has a significant stenosis at its ostium. B and 
C, the multiplanar reformat reconstruction and coronary angiography of the ostium stenosis 




Eindelijk, na jaren van gestaag doorwerken en doorzetten, is het volbracht. Jaren 
waarin mij de mogelijkheid is gegeven veel te leren, zowel op wetenschappelijk gebied 
als in persoonlijke ontwikkeling. Mijn dank is groot aan iedereen die mij daarin heeft 
bijgestaan! 
Mijn wetenschappelijke queeste begon bij de afdeling Cardiologie van het Leids Universitair 
Medisch Centrum (LUMC) bij Prof. Dr. A. van der Laarse. In het cardiobiochemielabora
torium zou het onderzoek over hypertriglyceridemie mijn onderwerp worden. Door een 
samenloop van externe omstandigheden kwam hieraan voortijdig een eind. Beste Arnoud, 
ik wil je bedanken voor je vertrouwen in mij. Ik heb onze (helaas korte) samenwerking als 
prettig ervaren. 
Gelukkig vond ik een voortzetting bij de cardiale beeldvorming, een samenwerking tussen 
de afdelingen Cardiologie (onder leiding van Prof. Dr. E.E. van der Wall) en Radiologie 
(onder leiding van Prof. Dr. A. de Roos) van het LUMC, waar de in dit proefschrift 
beschreven onderzoeken zijn uitgevoerd. Financieel werd het onderzoek door het 
Interuniversitair Cardiologisch Instituut Nederland (ICIN) ondersteund.
Graag wil ik de cardiologen bedanken die mij tijdens de opzet en uitvoering van de studies, 
het analyseren van de data en het schrijven van de artikelen hebben begeleid. Mede dankzij 
jullie zijn mijn artikelen als zodanig tot stand gekomen en in vooraanstaande tijdschriften 
gepubliceerd.
Alle (ex-)inwoners van de Cardiologie “tuin” (Susan, Eva, Mascha, Fleur, Natasja, Sander, 
Sweder, Astrid, Maartje, Monique, Philippine, Joanne, Pascalle, Miriam, Bart, Gabe, Sven, 
Bas, Su San, Saskia, Marleen) wil ik bedanken voor steun, medeleven en vooral voor veel 
gezelligheid. Susan, bedankt dat je me in de opstartfase geduldig hebt ingewerkt in het 
MRI-onderzoek. Joanne, bedankt voor je hulp bij de CT- en MRI-onderzoeken en bij de 
beeldanalyse. Voor de ICT ondersteuning wil ik Tom en Hylke bedanken. 
Van de afdeling Radiologie wil ik de MRI technici, onder wie Hildo Lamb, graag bedanken 
voor het ontwerpen van de MRI flow sequentie, de uitleg over MRI techniek en de nuttige 
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 The Road goes ever on and on
  Down from the door where it began.
 Now far ahead the Road has gone,
  And I must follow, if I can,
 Pursuing it with eager feet,
  Until it joins some larger way
 Where many paths and errands meet.
  And whither then? I cannot say.
  J.R.R. Tolkien 

